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Abstract 
Protein misfolding and aggregation are linked to various forms of dementia and amyloidoses, 
such as Alzheimer’s, Parkinson’s, and Creutzfeldt Jakob diseases. Although the primary 
misfolding proteins are disease-specific and structurally diverse, the related disorders share 
numerous symptoms and cellular malfunctions. A sustainable cure remains so far out of reach.  
The highly complex nature of the associated cellular deficiencies challenges our understanding of 
primary causes and consequences in the disease progression. To focus on the toxic properties 
and pathogenic gain-of-function mechanisms of misfolded structures in cells, we applied a set of 
artificial β proteins directly folding into amyloid-like oligomers and fibrils. Amyloid-related 
proteotoxicity appeared sequence-dependently in human, murine neuronal, fungal, and 
bacterial cells. The interplay between elevated surface hydrophobicity and structural disorder 
among the β proteins and their cellular interactors was critical for toxicity. Small distributed 
oligomers correlated to elevated toxicity. 
Protein-rich plaques or misfolded assemblies appear in patients often simultaneously in different 
cellular compartments and in the extracellular space. To analyze site-specific toxicities and 
vulnerabilities, we targeted the β proteins specifically into distinct compartments. Aggregation in 
the cytoplasm was highly toxic and interfered with active nucleo-cytoplamsic transport in both 
directions, including the translocation of NF-κB and mRNA. We compared our results to human 
disease-associated mutants of Huntingtin, TDP-43, and Parkin, causing comparable transport 
defects. Remarkably, toxicity of the β proteins was strongly reduced when targeted to the 
nucleus. Aggregates localized in dense nucleolar foci caused no transport inhibition. Only protein 
aggregation in the cytoplasm led to sequestration and mislocalization of numerous proteins with 
extended disordered regions, including factors involved in nucleo-cytoplasmic transport of 
proteins and mRNA (importin α and THOC proteins). Nuclear β proteins in contrast behaved very 
inert, potentially being shielded by nucleolar factors such as nucleophosmin (NPM-1).  
In presence of cytoplasmic aggregation vital signaling processes were impaired, further 
destabilizing cellular homoeostasis. The mRNA accumulated in enlarged “nuclear RNA bodies”. 
Depletion of cytoplasmic mRNA consequently resulted in a reduction of protein synthesis. 
Impairment of nucleo-cytoplasmic transport caused by cytoplasmic protein aggregation may 
thus seriously aggravate the cellular pathology initiated by misfolding and aggregation in human 
amyloid diseases. Our findings suggest that novel therapeutic strategies may improve nucleo-
cytoplasmic transport, utilize the nuclear proteostasis for aggregate removal, or increase the 
cellular resilience towards misfolded structures in general.  
  IX 
Zusammenfassung 
Proteinmissfaltung und -aggregation wird mit neurodegenerativen Krankheiten wie Alzheimer, 
Parkinson und der Creutzfeldt-Jakob-Krankheit, sowie mit systemischen Amyloidosen in Verbindung 
gebracht. Auch wenn sich anfangs die Hauptbestandteile der Proteinaggregate krankheitsspezifisch 
unterscheiden, so kommt es bei den verschiedenen Demenzerkrankungen doch oft zu ähnlichen 
Symptomen und zellulären Fehlfunktionen. Eine nachhaltige Heilung ist bisher nicht möglich. 
Die Komplexität der auftretenden zellulären Fehlfunktionen erschwert eine klare Unterscheidung von 
primären Ursachen sowie deren Folgen und Nebenwirkungen. Um uns auf die toxischen 
Eigenschaften und die toxische Wirkung von missgefalteten Strukturen in Zellen zu konzentrieren, 
setzen wir eine Reihe von künstlichen β Proteinen ein, welche direkt amyloide Oligomere und 
Aggregate bilden. Die Toxizität der β Proteine trat sequenzabhängig in menschlichen, neuronalen, 
Pilz- und Bakterienzellen auf. Erhöhte Hydrophobie an der Proteinoberfläche und unstrukturierte 
Sequenzbereiche wurden als kritische strukturelle Merkmale der β Proteine und ihrer zellulären 
Interaktionspartner im Zusammenhang zur Toxizität identifiziert. Auch korrelierten kleinere, über das 
Zytoplasma verteilte Oligomere mit hoher Toxizität. 
Proteinaggregate treten in Patienten in verschiedenen Kompartimenten der Zelle und im 
extrazellulären Raum auf, oft an mehreren Stellen gleichzeitig. Um die Toxizität in verschiedenen 
Kompartimenten und deren Sensibilitäten zu untersuchen, schickten wir die β Proteine mittels 
Signalsequenzen gezielt in bestimmte zelluläre Kompartimente. Aggregation im Zytoplasma war 
hochtoxisch und störte den aktiven Transport zwischen Zytoplasma und Zellkern, einschließlich der 
Translokation von NF-κB und mRNA. Wir reproduzierten unsere Ergebnisse mit 
krankheitsassoziierten Mutanten von Huntingtin, TDP-43 und Parkin, welche vergleichbare 
Transportdefekte verursachten. Bemerkenswerterweise reduzierte sich die Toxizität der β Proteine 
stark, wenn sie in den Zellkern geschickt wurden. Hier sammelten sich die β Proteine in dichten 
Aggregaten in den Nukleoli. Dabei traten keine Transportprobleme auf. Nur Proteinaggregation im 
Zytoplasma verursachte (Ko-)Aggregation und Fehllokalisation zahlreicher zellulärer Proteine, 
besonders von solchen mit längeren unstrukturierten Bereichen. Dazu zählten auch Faktoren, welche 
den Transport von Proteinen und mRNA zwischen Zytoplasma und Zellkern vermitteln (Importin α 
und THOC Proteine). Die β Proteine im Zellkern verhielten sich im Gegensatz sehr unauffällig. 
Anscheinend wurden sie zusätzlich durch nukleoläre Faktoren wie Nukleophosmin (NPM-1) 
abgeschirmt. 
Aggregation im Zytoplasma beeinträchtigte die Übermittlung lebenswichtiger zellulärer Signale, was 
die zelluläre Homöostase weiter destabilisierte. Die mRNA hat sich dabei in vergrößerten „nukleären 
RNA Körperchen“ angesammelt. Die fehlende mRNA im Zytoplasma führte zu einer Abnahme der 
Proteinsynthese. Die von Proteinaggregaten verursachten Defekte im molekularen Transport 
zwischen Zytoplasma und Zellkern könnten so ernsthaft zur Verschlimmerung der zellulären 
Funktionsfähigkeit in neurodegenerativen und anderen  Proteinfehlfaltungserkrankungen beitragen. 
Neue Therapieansätze könnten in einer Verbesserung des Kerntransports, in einer Verminderung von 
Aggregaten durch Proteostasissysteme im Zellkern, oder in einer generellen Stärkung der zellulären 
Resilienz gegenüber fehlgefalteten Proteinen zu finden sein. 
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  Foreword  ∙  1 
Foreword 
Cells are the elementary units of life, comprising all forms of uni- and multicellular organisms, from 
bacteria and archaea over fungi and plants to animals. A healthy cell or organism contains the entire 
hereditary information to regulate all vital cellular functions in its natural environment, and for 
passing on this information to the next generation.  
Cells originate from preexisting cells and create new life through cellular division (Robert Remak, 
Rudolf Virchow; Magner 2002). The first primordial cells, surrounded by a lipid membrane, formed 
presumably around 4 billion years ago on earth in terrestrial, anoxic fields (Mulkidjanian 2012). Basic 
inorganic chemicals and electric discharges were most likely enough to produce the first organic 
molecules of life: amino acids and nucleobases (Miller 1953, Miller 1959, Oro 1961).  
 
Cells assemble from different classes of biomolecules. The cellular DNA (deoxyribonucleic acid) 
contains the inheritable sequence information that is transcribed into different types of RNAs 
(ribonucleic acids). A part of them is subsequently translated into functional and structural proteins. 
In addition to the nucleic acid sequence, information is embodied in cells through the localization 
and activity of cellular factors (King 1999, Zhou 2004). Proteins are complex biomolecules 
synthesized by ribosomes that translate the sequence information encoded in an mRNA molecule 
into a polypeptide chain. Thereby, amino acids are polymerized in a linear chain like pearls in a 
necklace, selecting from more than 20 natural amino acids harboring different physicochemical 
properties in their side chains. As biochemical catalysts, proteins modify the cell by synthesis of 
A B 
Figure 1 | Creation of the first elements of life on earth in hot volcanic vents. (A) Stanley Miller simulated in his famous 
“primordial soup” experiment conditions prevailing at hot geothermal springs on the young earth around four billion years 
ago. Heating water created a humid atmosphere containing methane, ammonia, water and hydrogen. Electrical discharges 
were run resembling those present on the forming earth. Intense UV-light created free radicals reacting further into small 
organic molecules. In the condensate, Miller found four amino acids (glycine, alanine, aspartic and glutamic acid) and a 
couple of organic molecules, such as formic acid, acidic acid, lactic acid, and urea (Miller, Science, 1953 and 1959). Later, 
improved electrical discharge experiments found a much higher variety of amino acids and organic chemicals (Johnson 2008 
Science), including the ones discovered on a meteorite falling in Australia in 1969 (Ring 1972). (B) A volcanic vent in the 
Yellowstone National Park with geothermal springs similar to those, where presumably the first biomolecules and 
primordial cells originated billions of years ago (photo by Jeremy Doorten, stockxchng, 2007). 
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biomolecules, such as lipids, carbohydrates, and metabolites. Proteins are involved in sensing, 
transmitting, and regulating extra- and intracellular information. And proteins are cellular building 
blocks on their own (e.g. in membranes, cytoskeleton). 
Unlike a pearl necklace, polypeptide chains are in large part not unstructured, flexible chains. Most 
proteins fold into defined three-dimensional structures in which they are active. Protein folding is 
caused by the molecular forces between the individual amino acids and their cellular environment. 
The density of factors within a cell is extremely high (around 300 mg/mL), perpetually resulting in 
interactions between the mostly solvated molecules.   
 
The high density of proteins and other biomolecules in a cell poses a permanent challenge to its 
proteome. Specific interactions permanently execute the elementary actions of life. Productive 
interactions have been selected during billions of years of evolution. At the same time, undesirable 
erroneous interactions need to be prevented, which is one major task of molecular chaperones.  
Evolution, however, has not come to an end. Spontaneous genetic mutations occur constantly, 
introducing mostly adverse modifications into protein sequences. On some areas of life, evolution 
has less direct influence, such as at high, post-reproductive age (Lahdenpera 2004). Mutations and 
aging phenomena leading to protein misfolding and deleterious cellular interactions are believed to 
set the ground for numerous forms of dementia and other amyloidoses. In how many ways 
misfolded protein accumulations are harmful, and which mechanisms enable cells to keep 
aggregation under control, still remains insufficiently understood. I hope the insights gained in this 
study may contribute to a better understanding of the fundamental biology of proteins and 
proteotoxicity. At best, it may inspire future research on the therapy of prevalent human disorders, 
to provide human health and wellbeing.  
A B 
Figure 2 | Crowding of biological macromolecules inside of a cell. (A) Computer model of a bacterial cytoplasm including 
the most abundant macromolecules at experimentally determined concentrations (figure from McGuffee 2010). (B)
Cytoplasmic macromolecular complexes (green), cytoskeleton (red) and membranes (blue) of a eukaryotic cell visualized by 
cryoelectron tomography (figure from Medalia 2002).  
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Introduction 
Molecular forces in protein folding  
The molecular forces playing a role in protein folding are the same fundamental forces as for any 
other forms of molecular interactions within a cell. The mainly non-covalent interactions comprise 
electrostatic bonds, van der Waals forces, and hydrogen bonds, and are individually relatively weak 
and transient. As the free energy of protein folding usually lies in the range of a few non-covalent 
interactions (10-40 kJ/mol), every individual of them is very important and contributes to the final 
conformation of a folded protein (Pace 1975, Dill 1990). 
Ionic bonds 
A number of amino acids contain charged chemical groups, which electrostatically attract or repulse 
each other. The force and the energy of these interactions are weakened immensely by the high 
polarity of water and the presence of salt ions in a cell. However, they can become very strong in the 
interior of a protein fold, or within cellular membranes. Shielding charged groups from the 
surrounding aqueous solvent can strengthen electrostatic forces up to 20 fold in biological systems. 
The energy of an ionic bond is described by E = q+q- /  (ε0εrr) (E = energy; q = charge; r = distance; 
ε0 = electric field constant; εr = relative dielectric field constant, in water 78.5 at 298K, within a 
protein down to ~4). The strength of ionic bonds lies between 10-30 kJ/mol (Winter/Noll 1998, p. 
5f). Posttranslational modifications of proteins, such as phosphorylation, acetylation, or methylation, 
can modify local charges and pKA values and thereby induce conformational changes.  
Van der Waals forces 
Van der Waals forces are an order of magnitude weaker than electrostatic interactions (1-4kJ/mol). 
They originate from fluctuations of electron density around atomic nuclei, creating temporary 
electrical dipole moments. These induce a similar asymmetry in neighboring atoms, leading to 
attractive interactions.  Van der Waals forces are especially important when a number of atoms 
come very close together (r6 dependence, r = distance between dipoles). The forces integrate over 
many densely packed, sterically matching structures, as they occur inside a folded protein or in the 
carbohydrate chains of membrane lipids (Winter/Noll 1998. p. 6-8).  
Hydrogen bonds 
Hydrogen bonds are a major stabilizer of secondary structures in proteins, and they coordinate the 
pairing of nucleotides in DNA and RNA structures (Winter/Noll 1998. p. 8f). Looking closer, hydrogen 
bonds originate in the relatively high electronegativity of an atom (in biomolecules mainly oxygen 
and nitrogen) covalently bound to hydrogen, creating a dipole along the bond. The partially positively 
charged hydrogen attracts partially negatively charged hydrogen bond acceptors. In proteins, 
hydrogen bonds are formed between the amide and carboxyl group of peptide bonds, but also 
among side chain residues. The hydrogen bonding potential of most donors and acceptors are 
satisfied in many natively folded structures (Stickle 1992).  
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In contrast to electrostatic interactions, the strength and energy of hydrogen bonds are highly angle- 
and distance-dependent, providing directionality during protein folding, in protein structures and 
among the interactions of proteins and ligands. Optimized during evolution, energetics and kinetics 
of hydrogen bond formation therefore allow the rapid folding of most proteins, conferring stability 
and providing specificity required for selective macromolecular interactions (Hubbard 2010). 
Covalent bonds 
Cystein residues are able to covalently link different side chains within one or between two 
polypeptide chains. With the help of a reversible oxidizing agent (glutathione) two thiol groups (-SH) 
are coupled to disulfide bonds and thereby covalently link and conformationally restrict two 
otherwise much more flexible polypeptide regions. Disulfide bonds especially play a role in proteins 
residing within the endoplasmic reticulum, mitochondrial intermembrane space and the extracellular 
space, as in the cytoplasm reducing conditions are prevalent.  
 
 
 
  
Figure 3 | Molecular forces and bonds 
between amino acid residues of a 
polypeptide chain. The intramolecular 
forces determine the conformational 
fold and the stability of a protein or a 
complex. This three-dimensional 
structure lays the foundation for 
enzymatic reactivity and interactions 
with other biomolecules in a cell.  
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Water structure and hydrophobic effect – key drivers of protein 
folding 
Life originated in water, presumably in anoxic geothermal fields containing high concentrations of K+, 
Zn2+, Mn2+, and phosphate, resembling the internal milieu of present day cells (Mulkidjanian 2011). 
Water is the natural solvent, surrounding most biomolecules. The surfaces of proteins are in 
permanent contact to their water shells. Water even plays a coordinating or catalytic role in 
enzymes. Serine proteases have catalytically active water molecules in their active center (Perona 
1993), and contain water channels securing substrate specificity due to the formation of hydrogen-
bonded networks (Krem 1998). In the active center of Rubisco, water molecules coordinate an Mg2+ 
ion important for the stability of the overall structure (Matsumura 2012).  
Water is a very special molecule. Its high polarity and its ability to form hydrogen bonded networks 
results in an unusually large heat capacity, elevated melting and boiling temperatures, an increased 
density after melting, a high thermal conductivity, and the phenomenon of surface tension (Levy 
2006). When water forms hydrogen bonds (water-water or water-protein), energy is released in form 
of enthalpy, but the change in entropy is negative, since the free movement of water molecules 
becomes restricted (at room temperature ~80% of possible hydrogen bonds are maintained). 
Similarly, a protein lowers its Gibbs energy upon folding into the native structure, but its own 
entropy decreases. However, proteins fold surrounded by water molecules that are very restricted in 
motion on the protein surface, but released upon compaction of the structure into higher entropy 
states. Protein folding energetics are therefore a complex balance act of the whole system, and often 
can be directed by external influences in one or another direction (Bryan 1992). 
 
A B 
Figure 4 | Entropy of water molecules and a polypeptide chain in the unfolded and in the folded state, and conserved 
structured water molecules in the center of Rubisco, coordinating substrate molecules. (A) An unfolded polypeptide chain 
contains many surface accessible hydrophobic side chains, which disturb the water structure and create a shell of 
conformationally restricted water molecules. Upon folding, the hydrophobic amino acid residues are buried in the interior 
of the protein and release many structured water molecules into states of higher entropy, providing free energy for the 
folding process. (B) Twenty structured water molecules in the active center of Rubisco coordinate the binding of NADPH. 
Three of these water molecules (W1, W2, and W3) are thereby coordinated by a central Mg2+-ion, which stabilizes the 
activated Rubisco structure, and directly interacts with bound 6-phosphogluconate (figure from Matsumura 2012). 
 6  ∙  Introduction 
The hydrophobic effect 
Water can form up to four hydrogen bonds in a tetrahedral fashion, leading to its ability to form 
three-dimensional hydrogen bonded networks and to its liquid nature under atmospheric pressure. 
In direct contact to nonpolar side chains or solutes, water loses its hydrogen bonding partners and 
orientates itself in a way to minimize the loss or distortion of residual hydrogen bonds. In the first 
and second hydration shell around such hydrophobic molecules, water therefore arranges in a 
constrained, entropically very unfavorable way, which consequently leads to the removal of 
hydrophobic molecules or groups from the water surface. This exclusion of hydrophobic surfaces 
from water is widely known as “hydrophobic effect”, and it is a major driver of protein folding (Bolen 
2008, Dill 1990). 
The hydrophobic effect directs extended amino acid chains to fold in a way that clusters its 
hydrophobic groups in the interior of a protein structure, which thereby compacts into its native 
three-dimensional conformation. The importance of the hydrophobic effect is further demonstrated 
by intrinsically unstructured proteins or protein segments that usually lack hydrophobic groups, but 
largely consist of charged and polar residues (Dyson 2005, Dunker 2008). However, water seems to 
be a poor solvent for the protein backbone itself (or polyglycine as a model system), driving even 
purely polar polypeptides into molten globule or folded states, which also contributes to the collapse 
of e.g. polyglutamine polypeptides (Tran 2008). 
The importance of water structure for protein folding is furthermore demonstrated by both 
chaotropic reagents and water structure enhancers. Guanidinium hydrochloride or urea disturb the 
water structure and weaken the hydrophobic effect and backbone hydrogen bonding up to a point 
where proteins start to unfold (Zou 1998). TMAO (trimethylamine-N-oxide) enhances water structure 
and long-range spatial order, increasing the number and strength of hydrogen bonds per water 
molecule, which further discourages water-backbone interactions and stabilizes protein structures 
(Zou 2002).  
Stability-flexibility equilibrium of protein structures 
Finally, temperature plays an important role in protein folding, as it affects water structure. The 
native fold of proteins usually evolved to be stable around the physiological temperatures of its 
organism. The stability-flexibility equilibrium is specifically balanced to allow precise conformational 
alterations during molecular recognition, catalysis, and degradation, and to facilitate the functional 
evolution of protein sequences (Somero 1995, Bloom 2004).  
With higher temperature, higher kinetic energy states become accessible and entropy becomes more 
important (ΔG = ΔH – TΔS). Entropy generally favors disorderedness, and proteins unfold usually 
cooperatively at their specific melting temperature. Lower temperature increases water structure, 
influencing the strength of the hydrophobic effect, which initially may stabilize protein structures, 
but also leads to cold denaturation of proteins (Dias 2010). Nature uses the different, although often 
compensating and yet only partially understood temperature dependences of enthalpy and entropy 
to specifically adapt protein stability and flexibility to the physiological conditions of its respective 
organisms.  
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Water structure and the hydrophobic effect are elementary for biological structures and interactions. 
The key drivers form phospholipid bilayers surrounding cells and cellular compartments, but they 
also cause the assembly of protein fibrils and aggregates, a usually undesirable side effect in living 
cells (Lazaridis 2013).  
The physical forces explained here are simulated by “forcefields” in computer algorithms, describing 
specific energy potentials. Protein folding and dynamics is studied in silico with the ultimate goal of 
predicting three-dimensional structures, conformational dynamics, or the effect of small molecule 
drugs on protein structure and function (Dill 2012).  
 
 
  
Figure 5 | The number of hydrophobic residues within a protein (αA-crystallin) correlates to the environmental 
temperature of different teleost fish species, adapting the thermal stability of the protein and its chaperone-like activity.
The number of hydrophobic residues reflects both, the stability of the protein influenced by the temperature dependent 
hydrophobic effect, as well as the surface hydrophobicity necessary for the chaperone-like activity of αA-crystallin. (A)
Physiological temperature ranges of different fish species (figure from Posner 2012). (B) Negative correlation between the 
total number of hydrophobic residues within αA-crystallin and the average physiological temperature of the respective 
fishes (figure from Posner 2012). 
A B 
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Cellular protein folding – and its challenges 
Proteins fold into three-dimensional structures 
Proteins, although being synthesized as a linear chain of amino acids, adopt specific three-
dimensional structures to become active in a cellular environment. These functional structures are 
called the “native state”. In principal, the complete information about the three-dimensional 
arrangement is already present in the DNA sequence, encoding the exact amino acid sequence of a 
protein (Anfinsen’s dogma). As proteins are synthesized from 20 proteinogenic amino acids, the 
theoretical number of possible conformations of a polypeptide is enormous, way too large to fold 
into them serially (described by Cyrus Levinthal in 1969).  
The folding of proteins, however, does not occur as a random process, but is directed by local 
molecular forces. These forces act within the protein itself, between the protein and its solvent, and, 
during its biogenesis in vivo, come from the ribosome, from molecular chaperones as well as the 
entire cellular surroundings. This includes other proteins, metabolites, salts, and water (Bryan 1992). 
Protein folding is therefore highly dependent on the local environment, on molecular crowding, and 
the local ionic composition (Zimmerman 1991; see Levy 2006 p. 9). Excluded volume effects influence 
protein folding rates and equilibria. Molecular crowding and confinement generally increase the 
rates of slow, transition-state-limited associations and decreasing the rates of fast, diffusion-limited 
association reactions (Zimmerman 1991, Zhou 2008). 
The amino acid sequence itself, therefore, determines the structure of a protein only in context of 
the prevailing conditions. 
 
A fully flexible polypeptide chain could in principle fold into an almost indefinite number of 
conformations. However, polypeptide chains sterically and energetically prefer specific orientations, 
which lead to a limited number of common geometrical secondary structures. Due to the planar 
peptide bond (ω = 180°/0°), every amino acid in a polypeptide chain orientates itself by two torsion 
angles (φ, ψ) towards the previous and the following residue. Steric limitations within the chain 
A B 
Figure 6 | Steric confinements of the polypeptide torsion angles result in favorable regular conformations. (A) Next to the 
planar peptide bond (ω = 180°), torsion angles of ± 60° and ± 45° for φ and ψ are sterically most favored (Siegel 2011; figure 
from https://www.quora.com/Why-are-most-alpha-helices-in-proteins-right-handed). (B) Naturally occurring φ and ψ
angles are plotted in a Ramachandran plot and reveal common secondary structures (figure from Principles of Biochemistry, 
Pearson Prentice Hall, 2006). The chiral nature of L- amino acids mostly hinders the formation of left-handed α-helices due 
to bulky residues (besides glycine). Planar β-sheets exist in a parallel or antiparallel alignment. 
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energetically favor distinct bond angles, others only rarely occur. Conformations of neighboring 
residues from protein crystal structures are summarized in a Ramachandran plot (Ramachandran 
1963). The right-handed α-helix as well as parallel and antiparallel β-sheets are the most common 
secondary structures, next to special conformations such as the collagen triple-helix, the left-handed 
α-helix, the 310- or the π-helix. 
Energy landscapes describe the conformational space and the kinetic barriers of a protein under its 
specific conditions. Changes in the local environment modify the folding pathways, creating new 
downhill routes or altering kinetic barriers, so that proteins fold into different accessible states. 
Modifying local chemistry influences the conformational directions of a protein fold. Thereby, 
molecular chaperones can change the energetic landscape and the downhill routes towards states of 
lower energy. Changes in the energy landscapes are realized through the elementary forces 
described above. This can happen through direct cellular interactions, influences on water structure 
and dynamics, or the local ion composition. Chaperones modulate folding directions by mechanisms 
such as binding and release, iterative annealing, or steric confinement (Brinker 2001, Jewett 2004, 
Kovacs 2005).  
 
Diversity of folding – superfast folders, molten globules, complex folding pathways 
Most natural protein structures combine α-helical and β-sheet conformations connected via turns 
and linker regions. Except for short polypeptides, protein folding is usually not a one-step process. 
Rather, proteins fold stepwise from a structurally very unstable unfolded state through one or more 
folding intermediates into their native conformation. An unfolded polypeptide is not a completely 
extended, but rather a dynamic disordered state that in vivo is often stabilized by chaperones. 
Folding intermediates appear in the energy landscape as valleys down the road to the native state. 
Rather compact conformations with many intramolecular contacts close to the native state, but 
increased conformational dynamics are called “molten globules” (Haynie 1993, Bartlett 2009, 
Redfield 2004).  
For many proteins, an initial hydrophobic collapse buries hydrophobic residues in the core of a 
molten globule structure, which progressively readjusts contacts and bond angels into the stable and 
defined native state. While the hydrophobic collapse often happens within milliseconds (Kim 2008), 
Figure 7 | Energy landscape of protein folding and 
aggregation. An ensemble of unfolded, fluctuating 
conformations at high energy levels are found at the top 
of the folding funnel. The polypeptides quickly collapse 
into states of lower energy, such as molten globules. 
Partially folded states and folding intermediates reside in 
local energy minima, before they successively adjust their 
intramolecular contacts into the native state. Achieving 
intermolecular contacts, especially between incompletely 
folded polypeptides, may cause misfolding into 
oligomeric states, amorphous aggregates, or very stable, 
highly ordered amyloid fibrils. All these misfolded 
structures might be more or less toxic to a cell (Chiti 
2006). Chaperones influence protein folding by 
smoothening energy landscapes, decreasing high energy 
barriers towards the native structure, preventing 
misfolding and aggregation, and thereby optimizing the 
efficiency of productive folding (figure modified from 
Hartl 2009). 
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refinement and progression into the final structure varies from submilliseconds for very small 
polypeptides with simple folds up to seconds, minutes, hours, or days (Bryan 1992, Aronsson 1997). 
Superfast folders include the all-helical λ-repressor (Huang 1995), but also the small β-barrel cold 
shock protein CspB (Schindler 1995, Zeeb 2005). Long folding times are rather typical for complex 
multidomain proteins, especially those containing mixed α-helical/β-sheet architectures with 
numerous long-range interactions (Aronsson 1997, Zhou 2002). Intrinsic structural properties 
including proline cis-trans isomerizations, formation of long-distance hydrogen bonds, or buried 
polar interactions in a hydrophobic environment can furthermore cause slow folding (Waldenburger 
1996).  
Molecular chaperones promote protein folding in a cellular environment 
The rate-limiting steps in protein folding in vitro often slow down the process of folding into native 
structures due to energetic reasons. Kinetically trapped folding intermediates accumulate in energy 
wells. Kinetics with folding half-times of minutes, hours, or days observed in vitro obviously explain 
the need for promoting efficient protein folding in cells. This enhancement in cellular protein folding 
is carried out by specialized folding catalysts, the molecular chaperones.  
Mechanistically, chaperones support protein folding through binding and stabilization of partially 
folded intermediates, partial unfolding and release of the polypeptide chain, creation of a protein 
folding environment with defined biophysical properties (e.g. hydrophobic, polar, or charged 
surfaces), and through steric confinement and application of mechanical forces on the polypeptide 
chains (Hartl 2009, Kim 2013). In terms of energy landscape, chaperones create an efficient folding 
pathway by smoothening the downhill road towards the native state, or by increasing the energetic 
barriers towards off-pathway intermediates and misfolded states (Mashagi 2013). Thereby 
chaperones are able to direct folding pathways to functional native conformations and to avoid 
routes leading to misfolding and aggregation. In many cases, efficient folding is achieved through a 
collaborative network of different structural and functional classes of chaperones on a substrate 
protein (Young 2004).  
However, in the crowded environment of a cell, efficient protein folding is not only a problem of 
achieving correct intramolecular interactions. Not yet properly folded polypeptide chains engage 
easily in unspecific interactions with other cellular factors. Stretches from different protein molecules 
encountering each other may mutually disturb their folding pathways and induce misfolding. 
Especially hydrophobic stretches are prone to cluster among each other. Transiently interacting 
molecules might finally assemble in higher molecular weight oligomers and aggregates. To prevent 
misfolding and aggregation is the second major function of molecular chaperones. These recognize 
and bind to polypeptide stretches which are prone to unspecific interactions and usually become 
buried in the native state. Chaperones hold these structures in a folding competent state and shield 
them from potential disturbances. Repeated cycles of binding and release and folding in isolated 
chambers give proteins the chance to fold into their native conformation. Proteins that were 
unsuccessful in folding correctly are rebound or delivered to downstream chaperones, 
mechanistically described as kinetic partitioning in protein folding (Rothman 1989, Hardy 1991, Hartl 
2011).  
Further chaperon functions lie in intracellular protein transport, oligomeric assembly, conformational 
maintenance, refolding of denatured proteins, and assistance in degradation (Hartl 2009). 
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Protein misfolding causes toxicity in cells – loss- and gain-of-function 
Proteins need to fold efficiently into stable and functional structures, putting opposing pressures on 
the evolution of optimal sequences (Bartlett 2009). Proteins exposing unspecific interaction surfaces 
that are potentially deleterious to the cell have been removed or adapted to safe conformations (e.g. 
Monsellier 2007). In addition, molecular chaperones evolved to promote proper folding and rescue 
unsuccessful folding attempts. Chaperones thereby increase the available sequence space of a 
cellular proteome and buffer phenotypic variation (Rutherford 2003).  
Nevertheless, (partially) unfolded proteins expose regions susceptible to unspecific interactions. As 
protein folding pathways are very dependent on surrounding forces and conditions, it may happen 
that a folding polypeptide chain leaves its routes to the native state and follows an off-pathway 
downhill route into a kinetically trapped state, or into a stable misfolded conformation with stable 
nonnative intramolecular interactions. These under normal conditions inaccessible states may be of 
similar or even higher thermodynamic stability than the native state (Hartl 2009).  
Protein function is strongly dependent on native structure. Misfolded proteins are therefore in most 
cases unable to fulfill their cellular activity. This loss-of-function phenomenon is being discussed as 
one major origin of cellular toxicity: incapable of tolerating or substituting the activity of an essential 
protein, a cell may lose its ability to sustain. Toxicity occurring due to this loss-of-function principle is 
expected to be highly sequence-dependent, since a specific functional loss would lead to a 
characteristic disease phenotype.  
Parkin, an E3 ubiquitin ligase, promotes mostly degradation-independent ubiquitination of proteins 
involved in signal transduction, transcriptional regulation, DNA repair, endocytosis, and cellular 
trafficking. In Parkinson’s disease, mutations within the polypeptide sequence of Parkin or high levels 
of oxidation stress seem to cause the protein to misfold and aggregate, rendering Parkin’s native 
function inactive. The respective defects at least contribute to neuronal toxicity (Winklhofer 2008). 
Beyond their functional loss, misfolded protein structures continuously expose nonnative regions on 
their surface, which represents a permanent hazard in cells. Such stretches carry the potential to 
engage in unspecific aberrant interactions, especially with other misfolded proteins, but also with 
native cellular factors (Hortschansky 2005, Olzscha 2011). The initial formation of misfolded 
structures (monomers, dimers, small oligomers) and the subsequent growth are described by a 
nucleation and growth mechanism. Oligomeric species that appear early during an aggregation 
process are often considered as transient. However, they may reorganize further into stable, highly 
ordered amyloids (Auer 2007), the microscopically visible hallmarks of neurodegenerative diseases. 
The self-propagating mechanism of misfolded conformations by templating, which has been 
described for prion proteins before (Creutzfeldt-Jakob disease), seems to apply for a number of 
neurodegenerative disease proteins as well. Proposed proteins include Aβ, tau, α-synuclein, and 
mutant SOD (Kretzschmar 2013, Münch 2011, Aguzzi 2009, Kraus 2013). Misfolded structures coming 
into contact to other cellular molecules may engage in unspecific interactions, induce and propagate 
misfolding, and recruit a growing number of other molecules into misfolded assemblies. The Aβ 
fragment Aβ(25-35) has been shown in vitro to strongly promote misfolding and aggregation of firefly 
luciferase. Moreover a wide variety of native proteins co-precipitated in amorphous aggregates along 
with Aβ(25-35)(Konno 2001). Similarly, in human cells, especially vulnerable sequences or metastable 
proteins were sequestrated into growing cellular aggregates (Olzscha 2011, Suhr 2001).  
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Non-native, misfolded protein conformations therefore gain potentially harmful functions that were 
not present in their native conformation, which is described by the “toxic gain-of-function 
hypothesis” (Winklhofer 2008). Together, loss- and gain-of-function contribute to the pathogenesis 
of neurodegenerative diseases, although their individual contribution undoubtedly varies depending 
on the sequence and associated disease and remains to be defined in many cases. 
The loss-of-function phenotype of a disease protein is expected to be very protein and disease 
specific. For signaling and transcription factors, it has been shown that small alterations of their fine-
balanced levels can determine cell fate. In neural stem cells, transcription factors control cell 
proliferation, multipotency, neurogenesis, and the generation of specific neuronal classes at the 
correct time and location, ultimately deciding about life or death of a cell. For example, minor 
changes in the relative levels of the transcription factors Pax6, Hes1, and Neurog2 are crucial for 
neural stem cell self-renewal and the generation of cortical neurons or basal progenitor cells 
(Sansom 2009). Alterations in the levels of other, e.g. non-essential proteins might be rather 
tolerated by cells under normal conditions. Parkin is involved in cellular stress responses, promoting 
cell survival and further aggravating pathogenic effects upon misfolding (Henn 2007). However, the 
native functions of many neurodegenerative disease associated proteins and the consequences of 
their respective functional losses remain still unclear. 
The toxic gain-of-function of misfolded protein conformations on the other hand is discussed to 
underlie the many common symptoms observed among the various protein misfolding diseases. 
Misfolded proteins of unrelated sequences accumulate into similar molecular assemblies (oligomers, 
aggregates, fibrils), which suggests similar mechanisms behind their toxic effects on cells. Toxicity 
may arise from protein sequestration, signaling malfunctions, membrane permeabilization (Lashuel 
2002, Soto 2003), or increased appearance of radicals. Multiple malfunctions crossing tolerable 
thresholds finally pile up in proteostasis collapse and cell death (Hipp 2014, Labbadia 2015).  
Toxic loss-of-function and toxic gain-of-function may contribute to disease pathology to variable 
degrees in different forms of dementia or amyloidoses. Toxicity ultimately becomes multifactorial, 
complex in its nature, and tremendously challenging to analyze and understand.   
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Structural features of misfolded assemblies: oligomers & amyloid fibrils 
Microscopically visible protein deposits and inclusions are the hallmark of neurodegenerative and 
other protein misfolding diseases. These proteinaceous aggregates consist of one or a few major 
protein components in addition to a mixture of other misfolded proteins, metal ions, 
glycosaminoglycans, and other biomolecules (Armstrong 2008).  
Isolated from patients, such aggregates have been shown to consist of protein fibrils (the amyloids), 
which similarly can be produced in vitro from most proteins under specific, often mildly denaturing 
conditions. Isolated amyloids were highly structured and ordered. They usually assembled from 
protofilaments of 2-5 nm in diameter, which can twist together forming rope-like higher fibrils, or 
associate laterally to long and narrow ribbons. For many fibrils, X-ray fiber diffraction has revealed 
β-sheet strands running perpendicular to the long axis of the fibrils, consequently termed “cross 
β-sheet” structures. These fibrils bind amyloid specific dyes, such as Thioflavin T and Congo Red, 
despite their unrelated sequences. Solid-state NMR has demonstrated first atomic details on the 
example of transthyretin, showing extended β-strands and a crystal-like uniformity (Jaroniec 2002). 
Cryo-electron microscopy and Fourier transform infrared spectroscopy furthermore revealed the 
presence of highly planar β-sheets in amyloids (Zandomeneghi 2004), opposed to more twisted 
β-sheet structures in native proteins (Chothia 1981). Forcing the β-strands into a planar 
conformation limits their length in amyloid cores, where the β-strands run perpendicular to the fibril 
axis (Chiti 2006). 
Functional amyloids and non-chromosomal inheritance by prions 
Rarely, functional amyloid structures have been found in vivo. In such cases, the amyloid 
conformation constitutes the native state of certain proteins. Escherichia coli functionalize curlin 
fibrils to mediate binding to host proteins and inert surfaces. Mammalian melanosomes, lysosome-
related organelles in melanin pigment producing epidermal cells, store a highly aggregation-prone 
protein (Pme17) in functional amyloid structures that are involved in melanosome biogenesis. Also, 
peptide hormones in secretory granules of the endocrine system are stored in a fibrillary form (Maji 
2009). Thus, native amyloid conformations exist in cells, even though nucleation and assembly has to 
be highly regulated and controlled in these systems (Fowler 2007).  
Other proteins associated with functional amyloids are the prion proteins Ure2p and Sup35p from 
Saccharomyces cerevisiae. They exist in either a soluble or an aggregated state, giving rise to distinct 
phenotypes that are inherited to daughter cells. Sup35 is involved in termination of mRNA 
translation, facilitating the read-through of stop codons in [PSI+] cells (Krishnan 2005 nature). Ure2p 
only binds the transcription factor Gln3p in its native state, whereas its conversion to amyloid results 
in the activation of a series of associated genes in [URE3] cells. As prions, these proteins transfer this 
conformation through contact to equal sequences in their soluble conformation. Switching between 
a soluble and an amyloid conformation therefore enables these proteins to regulate gene expression 
and transmit an epigenetic phenotype (Chiti 2006).  
Sequence effects on amyloid formation 
Amyloid formation is likely a common property of proteins and peptides. This may be explained by 
the properties of protein backbones comparable to simple artificial polymers. However, the protein 
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sequence crucially influences the stability of a native state, its susceptibility to and rate of misfolding, 
or in other words, the energetics of multiple accessible conformations and the kinetics of their 
conversion.  
A high hydrophobicity, a low net charge, and a high propensity to convert from α-helical to β-sheet 
structure have been described as major factors leading to a high aggregation propensity of partially 
unfolded states (Chiti 2003, Calamai 2003). At the same time, most of the natively unstructured 
proteins comprise a low hydrophobicity and a low net charge (Uversky 2000). Hydrophobic patches 
on proteins especially promote unspecific interactions in an aqueous environment (hydrophobic 
effect). Substitutions in sequence regions playing a central role for nucleation or formation of 
amyloid cores can reduce or increase the aggregation propensity of proteins. Longer hydrophobic 
stretches are less frequent and are usually buried inside of a protein fold, however regularly present 
at interaction surfaces. Here they are often surrounded by polar or charged “gatekeeper” residues 
that decrease the overall aggregation propensity, and at the same time represent recognition signals 
for the cellular quality control machinery (Beerten 2012, Sant'Anna 2014).  
High global or local net charge may hinder self-association. Decreasing charge by substitutions within 
a sequence or by binding of macromolecules with a high compensatory net charge usually facilitates 
aggregation (Konno 2001, Krishnan 2005). The net charge of 84% of sequences noted in the Protein 
Data Bank (PDB) falls within a range of ±10 (Lawrence 2007). Thus, extreme net charge is rather rare 
in native proteins, likely due to requirements of folding, engaging in specific interactions, and 
degradability.  
Beyond hydrophobicity and charge, a low propensity of forming α-helices, a high propensity of 
forming β-sheet structure, or, related to that, certain patterns of hydrophilic and hydrophobic 
residues can promote the formation of amyloid structures. Especially polypeptide segments that are 
sterically self-compatible and offer enough flexibility assemble into zipper-like repeating patterns 
(Sawaya 2007). The entire human proteome has been analyzed for segments able to form tightly 
complementary interfaces with itself, permitting the formation of steric zippers as a central core of a 
fibril. In this amylome, nearly all proteins have been found to contain certain self-complementary 
regions, which therefore need to be constrained through folding or by chaperon interactions within a 
cell (Goldschmidt 2010).  
The described sequence features influencing amyloid formation have been rationalized in algorithms 
for aggregation propensity predictions, such as the Zyggregator (Tartaglia 2008).  
Oligomeric assemblies and the multiplicity of protein states 
Research of the past decades has revealed that next to native globular states and insoluble amyloids, 
a polypeptide chain can adopt a multitude of intermediate conformations. Not all proteins form 
stable folds, some exist in very dynamic unfolded states, and many proteins with a stable globular 
core contain longer disordered regions. Various forms of oligomeric species have been observed. 
Proteins carrying specific mutations, distinct peptide fragments, or a general decline in protein 
folding maintenance were associated to low-molecular-weight oligomers forming on- or off-pathway 
to amyloids (Chiti 2006).  
  Introduction  ∙  15 
 
Low-molecular-weight oligomers can exist in equilibrium with monomers and fibers, or they can 
precede fibril formation. Such spherical or chain-like protofibrillar structures have been described for 
α-synuclein, Aβ peptides, amylin, polyQ sequences, transthyretin, immunoglobulin light chains, and 
others. Certain antibodies specifically recognize oligomers, independently of their sequence, 
suggesting that such assemblies can be defined by common structural features (Kayed 2006, 
Mamikonyan 2007).  
 
Oligomer levels correlated much more to toxicity in cells or to the disease pathology of Alzheimer’s 
disease patients than large fibrils, which might even act as sink of misfolded structures (Lue 1999, 
Haass 2007). Of course, toxicity is not necessarily caused exclusively by a single structure, but may 
integrate effects of several distinct states, leading to a highly complex problem. Identification, 
isolation, and characterization of such metastable oligomers or protofibrils are highly challenging, but 
would certainly help to understand the nature and influences of such assemblies in cells (Chiti 2006, 
Knowles 2014).   
Figure 8 | Overview over cellular protein 
folding and misfolding, the multiplicity of 
conformational states, and pathways of 
interconversion. Nascent chains emerging 
from ribosomes are initially slowed-down in 
folding. Initial secondary structure elements 
start to form, protected by chaperones, until 
the nascent chain is fully released from the 
ribosome. From here, proteins can fold into 
their native state. Misfolded conformations 
appear transiently and reverse into native 
states, are degraded to peptides and free 
amino acids, or stabilize in forms of ordered, 
amyloid-like fibrils or amorphous aggregates. 
The cellular quality control system guards 
and regulates all these processes. Only if 
misfolding and aggregation overwhelm the 
cellular folding and degradation system, they 
may become a challenge for cellular 
maintenance and survival (figure from 
Tyedmers 2010). 
Figure 9 | Transmission electron micrographs of Aβ42 oligomers and fibrils. In vitro generated oligomers of Aβ42 (related to 
Alzheimer’s disease) formed disc-shaped pentamers or hexamers of rather disordered structure, showing a higher toxicity 
on primary cultures of mouse cortical neurons than β-sheeted protofibrils or fibrils (Ahmed 2010). Early fibrils are twisted 
around each other and become highly ordered after longer times of incubation. Thickness of oligomers and fibrils varied 
between 2-10 nm. Figures from Ahmed 2010 (left two images) and Finder 2010 (right two images). 
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Molecular chaperones 
A molecular chaperone has been defined as any interacting protein that promotes folding and 
assembly into functionally active conformations without being present in the final structure (Hartl 
1996). Molecular chaperones are involved in every aspect of protein synthesis, maintenance, and 
degradation. Guarding of newly synthesized proteins begins when these emerge at the ribosome and 
ends when protein structures need to be unfolded for degradation. 
Cellular protein biosynthesis  
α-helices may form within nanoseconds in vitro. In vivo, the translational speed of ribosomes is 
considerably slower (~4 amino acids per second for eukaryotes, ~20 amino acids per second in 
bacteria; Hartl 2009). As soon as peptide bonds are formed, initial folding interactions begin within 
the ribosome. However, the limited space restricts growing polypeptides to α-helical conformations 
within the 10 nm long and 2 nm wide exit tunnel. Interactions with ribosomal RNA (rRNA) may 
already promote conformational compaction (Lu 2005, Bhushan 2010). However, structural 
rearrangements might occur once the N-terminus emerges from the exit tunnel (Bhushan 2005). 
Incomplete chains usually do not achieve any stable fold or are prone to aggregation (Parker 1981). 
Only complete proteins or domains offer the necessary information and thermodynamic energy to 
stabilize native conformations. Especially large β-sheet rich domains and complex α/β-folds contain 
long-distance interactions, and the respective interaction sites may not be available yet. Nascent 
chains therefore expose peptide segments lacking their native interaction partners, which makes 
them prone to participate in unspecific interactions. Especially in a highly crowded environment of a 
cell (300 mg/mL protein), cotranslational protection is highly necessary, which is provided by the first 
instance of chaperones.  
Chaperones guarding the nascent chain  
The ribosomal exit tunnel prevents non-native interactions of the emerging polypeptide chain. 
Interestingly, in E. coli, ribosomes themselves have been suggested to exert a chaperon-like refolding 
activity, especially the 23S rRNA, as they promote folding and mediate refolding of denatured 
proteins (Kudlicki 1997). Emerging nascent chains need to be shielded from unfavorable intra- and 
intermolecular interactions. This is achieved by ribosome-associated chaperones such as trigger 
factor (TF) in prokaryotes and specialized Hsp70 and nascent chain-associated complexes (NAC) in 
mammals.  
TF (~50 kDa) consists of a ribosome and a nascent chain binding domain, next to its peptidylprolyl 
cis/trans isomerase (PPIase). The PPIase recognizes stretches of eight amino acids enriched in basic 
and aromatic residues (Ferbitz 2004, Lakshmipathy 2007). Every domain of TF can take part in 
nascent chain binding, which enables TF to accommodate a wide range of polypeptides. TF primarily 
shields emerging hydrophobic chains from non-native interactions. Its subsequent release from the 
nascent chain promotes folding of the polypeptide and provides energy for this ATP-independent 
process. Then TF dimerizes, partially masking its substrate-binding regions (Kaiser 2006). TF does not 
exist in eukaryotes, but the heterodimeric α-/β-NAC complex (33/22 kDa) might fulfill a similar 
function. NAC associates with ribosomes and short nascent chains (del Alamo 2011, Preissler 2012) 
and most likely functions in parallel with MPP11/Hsp70L1 (Otto 2005, Jaiswal 2011). NAC knockouts 
in yeast have resulted in a strong upregulation of stress inducible chaperones (del Alamo 2011). 
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Combinatorial knockouts of NAC and Ssb strongly enhanced aggregation of newly synthesized 
proteins (Koplin 2010).  
A subset of proteins is capable of autonomous folding. This is often true for small α-helical proteins, 
which straightforwardly fold into their native states.  Chaperone dependence increases strongly with 
the length of polypeptide chains and the distance of long-range interactions. Chaperons ease folding 
for bacterial proteins with an average size of ~30 kDa in E. coli, while the average human protein 
reaches over 50 kDa (Wolff 2014). 
Chaperone networks for folding, maintenance, and degradation 
Downstream of the ribosome, the cellular chaperone systems form a complex network of factors, 
which guarantee proper protein folding, quality control, and maintenance of a healthy proteostasis 
(Hartl 2009). Already as the nascent chain emerges, Hsp70s and their Hsp40 cochaperones 
(DnaJ/DnaK in E. coli) cooperate with TF in shielding the polypeptide from harmful interactions. 
Specific chaperone functions partially overlap, as single knockouts of e.g. TF or DnaK in E. coli are 
tolerated by cells under non-stress conditions, and the remaining chaperones widen their substrate 
spectrum (Deuerling 1999). However, under stress or upon multiple chaperon deletions (e.g. TF and 
DnaK), cells experience enhanced protein aggregation up to their inability to synthesize and fold new 
proteins (Calloni 2012).  
The multifunctional Hsp 70/Hsp40 system 
“The constitutively expressed Hsc70 and stress-inducible forms of Hsp70 are central players in 
protein folding and proteostasis control” (Hartl 2011). They shield the cellular proteome from 
hazardous interactions, prevent misfolding and aggregation, and promote folding through cycles of 
binding and release. DnaK, the bacterial Hsp70, recognizes hydrophobic strands surrounded by 
positive charges, which are often buried in the core of folded proteins (Rüdiger 1997), but which 
become prone to aggregate when exposed. Hsp70s perform an ATP-dependent reaction cycle. ATP 
binding, hydrolysis, and ADP release in the nucleotide-binding domain of Hsp70 are allosterically 
coupled to substrate binding and release. ATP binding opens the peptide-binding pocket allowing 
substrates to enter. ATP hydrolysis leads to a closed binding pocket with low substrate on and off 
rates (Kim 2013, Hartl 2011).  
Hsp70 is regulated by cochaperones and nucleotide exchange factors (more than 40 Hsp40s in 
humans; DnaJ, GrpE in E. coli), primarily through stimulating ATP hydrolysis that stabilizes Hsp70-
substrate interactions (Qiu 2006). ADP release becomes accelerated by Hsp110 (Polier 2010) and 
Hsp170. A new cycle of ATP binding results in substrate release, which is either properly folded, or 
rebound to Hsp70 or further downstream chaperones (Mayer 2010).  
Hsp40s bind with their conserved J-domains to the nucleotide-binding domain of Hsp70. Specialized 
Hsp40s function as chaperones themselves and recruit nonnative substrates to Hsp70. Mammalian 
DnaJB1 and yeast Sis1p mediate the transport of misfolded proteins into the nucleus, where they 
become degraded by the proteasome (Park 2013). This process currently seems to arise as an 
important cellular pathway for removal and degradation of aggregation prone structures from the 
cytosol.  
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Hsp70s are furthermore of major importance for protein targeting. Mitochondrial proteins encoded 
by the nuclear genome are synthesized in the cytoplasm tagged by a mitochondrial targeting signal. 
Hsp70 guards (partially) unfolded mitochondrial precursor proteins through the cytoplasm to 
mitochondria. As the proteins become imported through the mitochondrial import complexes (TOM, 
TIM), they are immediately grasped by mtHsp70 with its open substrate binding site (Neupert 2007). 
 
 
Chaperonins – single molecule folding chambers 
Chaperonins (Hsp60s) are large double-ring complexes (7-9 subunits of ~60kDa) with a central cavity. 
They offer substrate proteins an isolated chamber with a dynamic and active surface. Chaperonins 
create an optimal folding environment and allow proteins to fold independently from surrounding 
factors that risk their misfolding and aggregation.  
GroEL from bacteria, Hsp60 in mitochondria, and Cpn60 in Chloroplasts are chaperonins that 
encapsulate proteins with lid-shaped cochaperones (GroES, Hsp10, Cpn10/20). The archaeal 
thermosome and the eukaryotic TRiC (TCP-1 Ring Complex) contain a built-in lid with an iris-like 
opening mechanism. The chaperonins offer a chamber to enclose proteins or domains of up to 60-
70 kDa size. In case of TRiC, partial encapsulation of single domains with successful folding has been 
shown for proteins of >100 kDa (Rüßmann 2012). 
Figure 10 | Overview of chaperones in the bacterial and eukaryotic cytoplasm, stabilizing the nascent chain and 
promoting folding of their substrates to the native state. The nascent chains interact with trigger factor (TF) or NAC in 
conjunction with specialized Hsp70 complexes. Members of the DnaJ/K or Hsp70/40 family mediate co- or posttranslational 
folding or distribute proteins to downstream chaperones. Depending on the sequence, the protein substrates are delivered 
to the chaperonins GroEL/ES or TRiC, or chaperones of the Hsp90 family. Numerous cofactors support the folding process 
(such as nucleotide exchange factors, NEFs) or mediate substrate recognition (such as the Hsp70-Hsp90 organizing protein, 
HOP). The numbers indicate the percentage of interacting proteins as part of the total proteome (figure from Hartl 2011). 
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The chaperonins interact with about 10% of newly synthesized proteins. Obligate GroEL substrates 
(around 85 E.coli proteins) are typically proteins with complex α/β-folds being kinetically trapped in 
folding intermediates that need to be resolved (Kerner 2005). Well-established TRiC substrates 
include the cytoskeletal actin and tubulin as well as proteins with β-propeller/WD40 domains (Dekker 
2008, Yam 2008). Upon substrate binding, GroEL forms a hydrophobic folding chamber encapsulating 
mostly molten-globule like structures that partially lack native long-distance interactions. ATP-
dependent GroES binding leads to a conformational transition, resulting in a hydrophilic, negatively 
net charged inner surface (Hartl 2011). The substrate protein has now ~10 sec for folding along an 
undisturbed, folding-optimized energy landscape. The chaperonins promote rather compact, native-
like conformations (Brinker 2001, Chakraborty 2010). Rebinding of not yet folded structures allows 
multiple rounds of folding within the chaperonins, before a still misfolded protein might ultimately 
be delivered to degradation (Hartl 2011). 
Interestingly, the eukaryotic chaperonin TRiC has been shown to modify oligomeric species of polyQ 
expanded versions of the Huntingtin’s disease protein in cooperation with Hsp70, rendering them 
less toxic in a yeast model (Behrends 2006). 
The Hsp90 chaperone family of activators and regulators  
Hsp90 chaperones are a highly conserved essential chaperone family promoting the maturation of a 
wide range of substrate proteins. Hsp70s transfer many substrates to Hsp90 for the completion of 
folding and for functional activation with the help of HOP (Hsp90 organizing protein), which bridges 
the two chaperones with its TPR (tetratricopeptide repeat) domains (Scheuffler 2000). Substrates 
include a variety of proteins involved in signal transduction, protein trafficking, receptor maturation, 
especially kinases and receptor proteins, assigning Hsp90 chaperones the role of an important 
cellular regulator (Taipale 2010). Applying Hsp90 inhibitors simultaneously inhibited multiple cellular 
singling pathways important for cancer growth (Neckers 2007), however concurrently induced a 
general stress response (Labbadia 2015). 
Hsp90 itself has been found to preferentially recognize intrinsically unstable kinases rather than 
binding to distinct sequence motives on their substrates. Its cochaperone CDC37 serves as an 
adaptor that binds to kinase folds and recruits Hsp90. Hsp90-kinase associations decrease after 
stabilization of the kinases by folding or by binding to stabilizing small molecules or natural ligands 
(Taipale 2012). 
Disaggregases – chaperones reversing aggregation 
Beyond promoting folding and refolding, certain chaperones are able to disassemble and remodel 
misfolded protein oligomers and aggregates.  
Hsp104 is a hexameric ring AAA+ ATPase with a central pore, through which misfolded substrate 
proteins are (presumably) translocated and thereby disentangled. Hsp104 from yeast is driven by 
ATP hydrolysis and collaborates with Hsp70 and Hsp40 (Doyle 2009). The disaggregase complex 
resolves disordered aggregates as well as amyloids. Homologues of Hsp104 are found in bacteria, 
fungi, protozoa, chromista, and plants, however not in metazoan (animals). The bacterial homologue 
ClpB lacks the ability to disaggregate amyloid fibrils with stable “cross-β” cores (DeSantis 2012). 
Reasons for the loss of Hsp104 from metazoan are unclear (Shorter 2011). A generally advanced 
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proteostasis network may have decreased the selective pressure to keep the disaggregase during 
evolution. Alternatively, the potential risk of producing soluble misfolded species by Hsp104 through 
disassembly of rather “safe” amyloid species might have been disadvantageous.  
Recently Hsp110, so far known as a nuclear exchange factor (NEF) of Hsp70, has been found to 
disaggregate disordered aggregates (of Luciferase or GFP) in the mammalian cytoplasm and in vitro 
in collaboration with Hsp70 and Hsp40. However, this complex failed to remodel amyloid forms of 
α-synuclein or the yeast prion Sup35 (Shorter 2011). Hsp110 seems to accelerate Hsp70 kinetics by 
its NEF activity, and Hsp70 relies on numerous cofactors for efficient disaggregation. Putative 
substrate interactions of Hsp110 remain unclear (Rampelt 2012). Metazoan disaggregases are so far 
poorly understood, although their contribution to the proteostasis network would be highly 
interesting regarding the appearance of amyloid diseases.  
Small heat shock proteins 
Small heat shock proteins contain a highly conserved “α-crystallin” domain of 100 amino acids. This 
common core is flanked by extensions that mediate dynamic oligomerization and client recognition 
(Eyles 2010). Small heat shock proteins prevent aggregation through binding and/or release of 
unfolded or misfolded structures. These can then be transferred in a soluble state via other 
chaperones for functional reactivation or degradation. Small heat shock proteins do not require ATP 
hydrolysis, although they may be regulated by ATP binding (Bakthisaran 2015).  
Many small heat shock proteins have been found in the deposits associated to protein misfolding 
diseases. Moreover, chaperones prevented nucleation and aggregation of amyloid fibril formation of 
Aβ peptides, polyglutamine sequences, and other aggregation prone proteins (see below; 
Bakthisaran 2015). Overexpression of small heat shock proteins has been associated with 
stabilization of tumor cells (Bakthisaran 2015). This circumstance demonstrates the importance of a 
factor-specific fine-tuning and a proteostasis network-wide orchestration to create a healthy folding 
environment within a cell.  
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Protein degradation as part of the proteostasis network 
A multiplicity of factors cooperates in promoting protein homoeostasis (proteostasis). Together they 
form the cellular proteostasis machinery or proteostasis network (PN). The mammalian proteostasis 
network consists of ~400 proteins involved in biosynthesis, ~300 proteins involved in 
conformational maintenance, and ~700 proteins involved in degradation (Kim 2013). Imbalances 
within the network due to cell stress or aging may lead to an overload of the cellular proteostasis 
capacity, which in turn results in aberrant misfolding and aggregation. However, cells monitor and 
sense local disturbances and react with compartment-specific stress response pathways to increase 
their stress tolerance. Responses include an increase in chaperone levels, a decreased protein 
synthesis, or the activation of degradation pathways. Ultimately, if stress becomes too strong or 
persistent, cellular proteostasis might collapse, and cells with defective essential functions undergo 
cell death. A proteostasis collapse is thought to underlie numerous human protein misfolding 
diseases (Balch 2008, Kim 2013, Hipp 2014). An efficient removal of misfolded structures is therefore 
essential to maintain a healthy cellular environment. 
The ubiquitin-proteasome-system (UPS) 
Proteins have specific cellular lifetimes, before they are hydrolyzed into peptides and amino acids. 
Proteins that cannot be successfully folded by the chaperone system are targeted for degradation 
earlier. The major cellular signal for the specific degradation of proteins consists of a polyubiquitin 
chain. The small globular ubiquitin (8.5 kDa) is ligated to specific lysine residues on target proteins for 
mono- or polyubiquitination (Vijai-Kumar 1987). All possible linkages were found in cells, such as 
mixed and branched ubiquitin chains, whereby the ubiquitination is interpreted protein- and context-
specific (Malette 2012, Zhang 2013 J, Komander 2012). Membrane proteins are monoubiquitinated 
or K63-linked for endocytic uptake and lysosomal degradation (Mukhopadhyay 2007).  
A multifaceted network of ubiquitin ligases rules over the fate of proteins 
Ubiquitin is transferred on substrate proteins via ubiquitin-activating enzymes (E1, accompanied by 
hydrolysis of ATP), ubiquitin-conjugating enzymes (E2), and ubiquitin ligases (E3). E3 ligases transfer 
ubiquitin from E2 to substrate proteins, mostly directly or via a thioester bonds (Pickart 2001). 
Ubiquitin is covalently attached to substrate proteins mostly via isopeptide bonds between 
Ubiquitin’s carboxyl terminus and the lysine side chain amine on substrate proteins. Linkage also 
occurs to cysteine or methionine residues. The human genome encodes more than 600 E3 ligases 
accounting for the high flexibility and specificity of the UPS. Most E3 ligases comprise of a RING 
domain, a cysteine- and histidine-rich sequence binding two zinc ions, which stabilizes the entire 
protein structure. Other domains increase the variety beyond the RING domains, among them the 
huge family of cullin-RING ubiquitin ligases (CRLs) with almost 300 members, SH2, SH3, ankyrin 
repeat, or ubiquitin-like domains (Deshaies 2009, Sarikas 2011, Hua 2011).  
A prominent E3 ligase is CHIP (carboxyl terminus of Hsc70-interacting protein). CHIP ubiquitinates 
fatally misfolded Hsp70 and Hsp90 substrates (Ballinger 1999, Connell 2001) and mediates stress 
recovery by targeting Hsp70 and a broad range of other chaperones for proteasomal degradation 
(Qian 2006). CHIP plays a role in aggresome formation. Together with Hsp70 and BAG3, CHIP 
interacts with the microtubule motor dynein, demonstrating an organized process involving 
chaperones and the transport machinery in the cellular aggresome formation (Zhang 2011).  
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The proteasome – regulated protein destruction 
Polyubiquitinated proteins are targeted to the 26S proteasome for degradation (Ciehanover 1978). 
The eukaryotic proteasome contains a 20S core supplemented by one or two 19S regulatory caps. 
The barrel-shaped core complex with proteolytic activities degrades proteins into peptides ranging 
from 4 to 25 residues. The 19S caps recognize ubiquitinated proteins, unfold their substrates 
powered by AAA ATPases, and target the polypeptide chains into the proteolytic 20S core. 
Otherwise, the proteolytic centers are inaccessible for folded proteins outside of the central cavity. 
Studies employing proteasome inhibitors have shown that 80-90% of cellular proteins are degraded 
by proteasomes (Rock 1994). The degradation machineries are distributed over cytoplasm and 
nucleus, where they either remain present after cell division or become actively imported. ER 
proteins are retro-translocated to the cytoplasm for proteasomal degradation (ERAD pathway). 
Deubiquitinating enzymes (DUBs) recycle ubiquitin molecules by cleaving the ε-amide before 
degradation of a substrate (Voges 1999).  
 
 
A significantly increased proteasome activity was found to accelerate protein degradation in human 
embryonic stem cells that replicate continuously without signs of aging (Vilchez 2012). A distinct 
proteasomal core subunit with a large hydrophobic pocket is expressed in activated T cells. It 
produces peptides with hydrophobic, bulky C-termini, optimal anchor motifs for MHC-I (major 
histocompatibility complex I) presentation. An optimized oxyanion furthermore increases substrate 
processing (Huber 2012). Bulky aromatic surfaces improve the immune defense, non-immune cells 
however produce peptides that are potentially less challenging for cellular proteostasis (Kalim 2012).  
  
Figure 11 | Cryo-electron microscopy structures of the 26S proteasome in a functional model of substrate degradation. 
Polyubiquitinated (Ub) substrates (S) are bound by ubiquitin receptors (Rpn10, Rpn13) on the 19S regulatory subunit. A 
conformational switch, performing a 25° rotation of the Rpns and a shift of the AAA ATPase (blue), may transfer the 
substrate to the opening cleft and activate Rpn11, followed by deubiquitination of the substrate protein. Further 
conformational changes of the AAA ATPase enable unfolding of the substrate protein and its movement into the core 
particle (red), harboring the proteolytic activities and cleaving the protein into short polypeptides (figure from Unverdorben 
2014). 
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Endoplasmic reticulum-associated degradation (ERAD) 
Secretory and transmembrane proteins are recognized by the signal recognition particle (SRP). 
Consequently, they become translocated cotranslationally through the heterotrimeric Sec61 channel 
(translocon) into the membrane or lumen of the endoplasmic reticulum (ER). Secretory proteins fold 
in the ER lumen, where they may acquire disulfide bonds, N-linked glycans, or oligomerize into higher 
complexes. Proteins that do not achieve their native state are retained in the ER or recycled from 
downstream compartments (e.g. Golgi). From here, they are retrotranslocated to the cytoplasm for 
proteasomal degradation (McCracken 1996). The ER specific Hsp70 chaperone BiP (binding 
immunoglobulin protein) recognizes hydrophobic stretches on the surface of misfolded structures, 
prevents their aggregation, allows for additional rounds of folding, or keeps the structures soluble for 
degradation. 
 
 
Luminal ERAD substrates are then retrotranslocated most likely through Sec61 to the cytoplasm by 
AAA ATPases. p97 (cdc48 in yeast) potentially disentangles proteins from other bound factors and 
extracts ERAD substrates with force, driven by ATP hydrolysis (Rape 2001, Richly 2005). For some 
substrates, the 19S regulatory particle, comprising six nonequivalent AAA ATPases, has been shown 
to be sufficient for substrate export from the ER (Lee 2004). A significant fraction of cellular 
proteasomes is ER associated. Arriving in the cytoplasm, ERAD substrates are ubiquitinated and 
released from the ER membrane. Finally, they become degraded by the proteasome with or without 
previous deglycosylation (Römisch 2005).   
  
Figure 12 | Overview over the individual steps of ER-associated protein degradation (ERAD). Misfolded membrane or ER-
luminal proteins are recognized by chaperones, such as BiP (Hsp70 family) and are targeted to retro-translocation. They are 
extracted to the cytoplasm by AAA ATPases, such as p97 (cdc48) or the 19S regulatory particle of the proteasome.
Ubiquitination by associated Ubiquitin E3 ligases releases ERAD substrates from the membrane, followed by proteasomal 
uptake and degradation (figure from Vembar 2008). 
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Bulk and chaperone-mediated autophagy 
The UPS degrades single proteins after unfolding one by one and contributes a major part to regular 
protein turnover in cells. Beyond this, mammalian cells utilize autophagy to degrade whole 
organelles and harder-to-unfold or aggregated proteins, but also lipids, nucleic acids, and 
polysaccharides. Two trafficking pathways deliver substrates into the lysosomal lumen, where an 
array of hydrolytic enzymes mediates degradation at an acidic pH. The endocytic route recycles 
integral and peripheral membrane proteins and lipids. And upon inhibition of autophagy in cells and 
mice, protein aggregates start to form (Yamamoto 2014, Rubinsztein 2011).  
Substrate delivery to lysosomes can appear highly specific mediated by receptors (chaperone-
mediated autophagy, CMA) or in form of macroautophagy. Here, a complex machinery of proteins 
forms cytoplasmic membrane-surrounded vesicles that envelope cargo, which consists of 
surrounding cytoplasmic material, but also selectively enriched substrates. These include 
ubiquitinated, non-ubiquitinated, and aggregated proteins, mitochondria, peroxisomes, and invading 
pathogens.  
Autophagic clearance of aggregated proteins relies on Alfy, p62, and NBR1. By multimerizing, p62 
forms an “inclusion” to initiate a macroautophagic site that sequesters specific adaptor proteins, 
such as Alfy. Loss of Alfy was found to prevent the clearance of intracellular inclusions, and Alfy 
overexpressions decreased polyglutamine toxicity (Filimonenko 2010). Together with NBR1, such a 
complex interacts with autophagic effectors (among them Atg5, Atg12, Atg16L, and LC3) to form 
autophagosomes. These fuse with hydrolytic endosomes or lysosomes. Alfy is a nuclear protein that 
becomes exported to the cytoplasm in response to cellular stress in a Crm1-dependent manner. Alfy 
overexpression enhanced the clearance of misfolded proteins, such as polyQ-expanded Huntingtin or 
α-synuclein (Filimonenko 2010).  
CMA relies on the direct import of proteins into the lysosomal lumen. Chaperones that recognize a 
specific pentapeptide motif (KFERQ or similar) traffic such substrates to the lysosomal membrane, 
from where LAMP2A directly translocates the cargo into the lysosomal lumen (Yamamoto 2014). 
α-synuclein is a substrate to CMA and apparently able to block lysosomal protein import, especially 
when mutated (see below, Cuervo 2005). 
Autophagy seems to play a special role in neurons. The autophagic response under starvation or 
inhibition of mTor signaling is robust in most organs, but observed rarely in the mouse brain. 
Macroautophagy was deleterious under neuronal stress, and its inhibition protected neurons and 
promoted recovery. Autophagic vesicles have to travel long distances through neurites for lysosomal 
fusion in the soma. Autophagy may therefore protect from an accumulation of misfolded structures, 
but, when overactive, also disturb the highly complex architecture of differentiated neurons. More 
knowledge about autophagic fine-tuning in the central nervous system and specific autophagic 
pathways is therefore desirable to elaborate potential therapeutic strategies for neurodegenerative 
disorders (Yamamoto 2014).  
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Maintaining and restoring proteostasis under misfolding stress 
Successful protein folding and conformational maintenance are essential for cellular survival. 
Although many key players have been identified, research is far from understanding how individual 
components of the proteostasis network (PN) are interconnected, and how this network is 
orchestrated during specific forms of cellular stress. Several stress response pathways have been 
described including the cytosolic heat shock response (HSR), the unfolded protein response (UPR) in 
the endoplasmic reticulum, and the mitochondrial UPR. Other forms of cellular stress may 
furthermore challenge the cell with increased appearance of misfolded structures and induce related 
responses, as in case of inflammation, starvation, or oxidative stress. Activating cellular stress 
response pathways induces cellular PN factors (chaperones, UPS, autophagic and antioxidative 
factors), increasing the cellular capacity to cope with misfolded and damaged structures (Fulda 2010, 
Hipp 2014).  
Heat shock response  
The heat shock response was originally discovered as a cellular response to mild heat stress. The 
response increases the tolerance against otherwise lethal conditions. These include misfolding and 
oxidative stress, toxic substances, or starvation, demonstrating the broader scope of the cellular 
mechanism. During its initiation, general transcription and translation are halted to alleviate the 
burden of newly synthesized structures. The main mediator activated under such conditions is heat 
shock factor 1 (Hsf1). Released from associated chaperones, Hsf1 binds to heat shock elements in the 
promotor regions of effector genes. Some “heat shock proteins” are constitutively expressed, others 
are strongly activated in response to cellular stress, such as Hsp27 and Hsp70. Inducible heat shock 
proteins promote cellular regeneration together with various cofactors (such as Hsp40s, CHIP). They 
increase the cellular folding capacity or target misfolded structures for degradation (Fulda 2010). 
Controlled activation of Hsf1 was shown to promote longevity by maintaining proteostasis, whereas 
its downregulation reduced lifespan and accelerated the formation of protein aggregates in C. 
elegans (Hsu 2003). 
Unfolded protein response (UPR) 
The endoplasmic reticulum is responsible for the biosynthesis and posttranslational modification of 
all secretory and transmembrane proteins. This is especially challenging in secretory cells of the 
pancreas or the hypophysis, or in neuronal cells with complex membrane architectures (Ramirez 
2011). The unfolded protein response (UPR) is generally transmitted through activation of ER 
resident factors (Fulda 2010, Schröder 2005). The transcription factors are presumably bound by the 
Hsp70 chaperone BiP and become released once BiP is overwhelmed by (mis-)folding substrates. 
IRE1 and PERK are transmembrane kinases, dimerizing, and autophosphorylating in response to ER 
stress. IRE1 splices an mRNA encoding the transcription factor XBP1 (Yoshida 2001). PERK 
phosphorylates eIF2α, resulting in translational suppression, but allowing translation of specific UPR 
response genes (Teske 2011). The Golgi transmembrane protein ATF6 releases its cytoplasmic 
transcriptionally active domain upon stress to the nucleus (Okada 2003). The UPR response generally 
aims at balancing ER protein load and folding capacity. Factors include chaperones, oxidoreductases 
(PDI), and proteins of the ERAD pathway.  
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The UPR is regulated by negative feedback mechanisms. Several phosphatases dephosphorylate 
eIF2α, among them protein phosphatase 1 (PP1), induced in late ER response by ATF4. In addition, 
PERK is inhibited by binding to the Hsp40 cochaperone P58IPK, which is induced by IRE1/XBP1 during 
ER stress (Yan 2002). Duration and intensity of the stress response pathways play a critical role in the 
decision between cell survival and apoptosis (Marciniak 2004). However, also in unstressed cells a 
weak UPS activation can be detected (spliced mRNA), most likely adjusting the folding capacity to the 
protein synthesis load (Schröder 2005). 
The mitochondrial unfolded protein response (UPRmt) 
Only a small number of mitochondrial proteins are encoded by the mitochondrial genome. Most 
mitochondrial proteins are transcribed from nuclear DNA. Proteins translated in the cytoplasm are 
then imported in an unfolded, Hsp70 bound state through TIM and TOM complexes in the inner and 
outer mitochondrial membranes (Neupert 2007, Neupert 2012). Folding is supported by 
mitochondrial chaperons, such as Hsp60/Hsp10 and Hsp70 (Hartl 1987, Cheng 1989). Mitochondria 
monitor their own proteostasis and control their own unfolded protein response (UPRmt; Haynes 
2010, Jovaisaite 2014). The mitochondrial electron transport chain consists of large protein 
complexes. Disruption of their stoichiometry may be one source of mitochondrial protein folding 
challenges (Yoneda 2004). Increased production of reactive oxygen species (ROS) also triggers the 
UPRmt (Runkel 2013). During times of rapid growth, the UPRmt has been shown to promote 
mitochondrial proliferation (in C. elegans; Tsang 2002). 
The UPRmt is a stress-response pathway that expands the folding capacity and prevents deleterious 
protein aggregation under normal physiology and in disease. Misfolded structures of the 
mitochondrial matrix are degraded to peptides by ClpP, which activates transcription factors such as 
ATFS-1. The peptides are then exported to the cytoplasm (Haynes 2010). ATFS-1 induces 
transcription of mitochondrial chaperones, proteases, genes involved in ROS detoxification and 
mitochondrial protein import. Parkin and PINK1 have been furthermore implicated in inducing 
mitophagy (Geisler 2010). 
Figure 13 | Three branches of the 
unfolded protein response (UPR). 
Stress sensors and signal 
transducers ATF6, PERK, and IRE1 
become activated upon 
appearance of misfolded proteins 
within the ER or other stressors. 
The responses are transmitted by 
different mechanisms: ATF6 by 
proteolysis and phosphorylation, 
PERK by oligomerization and 
mRNA cleavage, and IRE1 by site-
specific mRNA splicing. Whereas 
all three pathways serve to 
increase the ER folding capacity, 
PERK and IRE1 additionally slow 
down protein synthesis rates to 
restore proteostasis in the ER 
(figure from Walter 2011). 
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Figure 14 | Exponential increase of dementia in human patients of higher 
age (UK Dementia report 2007, Borjesson-Hanson 2004). 
Neurodegenerative protein misfolding diseases 
Numerous human neurodegenerative diseases are related to protein misfolding and aggregation. The 
inclusions observed in different parts of the brain are disease-dependent. They contain one or a 
small number of major protein(s) that drive(s) the sequestration of other factors into the 
accumulations.   
Dementia 
Alzheimer’s, Huntington’s and Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and the prion 
disorder Creutzfeldt-Jakob disease are all different forms of dementia. The term describes a 
collection of symptoms comprising a decline of memory, reason, communication skills, and motoric 
control. The symptoms are caused by a progressive shrinkage of disease specific neurons and brain 
regions.  
The cognitive and physical decline is not only a huge burden for patients, but affects partners and 
families. As human populations age, incidences of neurodegenerative diseases increase dramatically, 
and the burden of cognitive decline constitutes a significant social and economic factor. In 2010, 36 
million people were affected worldwide by various forms of dementia, a number predicted to double 
within the next 20 years (Prince 2013). Global costs were estimated to amount to US $600 billion, 
comprising direct medical costs, social and informal care (Wimo 2013). This sum corresponds to 1% 
of global GDP (World Development Indicators database, World Bank, July 1st 2011). 
Various forms of dementia are diagnosed by cognitive assessment. Similar symptoms impede a 
definite diagnosis. Genetic diagnostics exist for hereditary cases such as Huntingtin. Magnetic 
resonance imaging (MRI) is applied to examine shrinkage of specific cortical regions (Frisoni 2010). 
Young people can be affected by neurodegenerative disorders, but the prevalence of dementia 
increases severly with age. As a 
Swedish study examined, around 
30% of 85 years old and 50% of 95 
years old suffer from dementia 
(Borjesson-Hanson 2004). For 
prevention or reversion, there are 
no effective treatments available 
yet. Therapies mainly attempt to 
slow down the disease 
progression by mental and 
physical activity. Avoidance of 
potential risk factors, such as 
obesity, diabetes, high 
cholesterol, inflammation, or high 
blood pressure, may improve 
health in general and delay 
symptoms of dementia at higher 
age.   
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Alzheimer’s disease 
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder characterized by a progressive loss 
of cognitive functions, appearance of psychiatric symptoms (depressions, hallucinations), and 
increasing difficulties in physical activities that often occur incrementally. AD is accompanied by a 
huge loss of brain volume mainly caused by neuronal shrinkage and loss of processes and synapses. 
Patients in an early phase already lost around 40% of their synapses in neocortex hippocampus. This 
decline in connectivity correlates highly with the cognitive decline of Alzheimer patients, much better 
than with the pure burden of aggregates (Scheff 2006 Neurobiol Aging/J Alz Dis, Palop 2003, 
Knobloch 2008, Gomez-Isla 1996).  
However, quantifications of neurons and synaptic connections are still a challenge in the human 
brain. AD is a very complex disease, most likely caused by multiple genetic and environmental factors 
defining a lifetime risk in the background of a general physiological decline during aging. Even a 
continuum between “normal aging” with asymptomatic lesions and developing AD based dementia 
seems plausible (Serrano-Pozo 2011).  
On the molecular level, the two pathological hallmarks of AD are extracellular amyloid plaques and 
intracellular neurofibrillary tangles (NFTs). The extracellular plaques are highly enriched in 
aggregated forms of Aβ, the amyloid β peptide (Glenner 1984).  
Signaling and structural functions of the amyloid precursor protein (APP)  
APP is a highly conserved transmembrane protein with a large ectodomain, a single transmembrane 
region (partially overlapping with the Aβ sequence), and a short cytoplasmic tail. Homologs of the 
APP have been found in invertebrates and vertebrates. The latter encode two more APP like proteins 
(APLP1, APLP2) without Aβ-like sequence. While APLP1 is predominantly expressed in the human 
brain, APP is ubiquitously expressed in all cells in humans, APLP2 rather in peripheral tissues (Huang 
2011).  
The family members proposedly function as cell surface receptors and play key roles in neuronal 
development, cell adhesion, synaptic plasticity, and long-term memory (Huang 2011, Zheng 2011). 
Interestingly, only double knockouts including APLP2 are lethal, indicating partially overlapping 
functions (Huang 2011). APP binds to intra- and extracellular factors and is enriched at synaptic sites, 
allowing APP to engage in interactions between different cells. Knockout mice showed defects in 
long-term potentiation and poorly formed neuromuscular synapses (Huang 2011, Zheng 2011). The 
cellular interactions of individual domains and cleavage products still need to be investigated in more 
detail to reveal a better picture of their biological significance.  
Processing of APP, production of Aβ variants, and related pathophysiology 
Aβ is produced by sequential cleavage of APP (Kang 1987) by β-secretases (BACE1) and γ-secretases. 
A competing α-secretase cleaves APP in the middle of the Aβ sequence and thereby prevents Aβ 
production. In AD patients, β-secretase activity was found to be increased to 185% of non-AD 
individuals, whereas α-secretase activity declined to 81% (Tyler 2002).  
γ-secretase is an integral membrane protein complex with a membrane-embedded aspartyl 
protease. It cleaves APP within the hydrophobic part of the membrane, releasing Aβ into the ER 
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lumen, extracellular space, and endosomes.  Due to its conformational flexibility, γ-secretase is able 
to produce different Aβ peptides of varying length, from Aβ37 to Aβ46. The usually predominant 
species is Aβ40, next to Aβ42 (5-15% of the total pool, extended by Ile and Ala; Steiner 2008, Masters 
2012). Increasing the Aβ42/Aβ40 ratio caused e.g. by mutations in γ-secretase is implicated in early 
onset of familiar AD and in increased disease progression. Aβ42 is more aggregation prone and was 
found to form the initial inclusions in the brain, from which aggregation starts to seed (Findeis 2007).  
 
Distinct mutations in APP and presenilin 1 and 2 (part of the γ-secretase complex) cause an early 
onset of AD (<60 years; Tanzi 2012). Most of the found mutations were associated with an increased 
appearance of Aβ42 and other neurotoxic Aβ products. A deletion of a single glutamate within Aβ, 
E693Δ, completely prevents the formation of insoluble amyloid plaques in favor of soluble Aβ 
oligomers. Despite the fact that amyloid imaging revealed not more amyloid depositions than in age-
matched healthy controls, patients carrying the E693Δ mutant closely resembled AD symptoms 
(Tomiyama 2008).  
Susceptibility for late-onset AD (>65 years) is influenced by a very common gene polymorphism. 
Lipoproteins (HDL, LDL) transport lipids and cholesterol in form of soluble protein-lipid particles 
through the circulatory and lymphatic systems. Apolipoprotein E4 (ApoE4) binds and complexes Aβ in 
the cerebrospinal fluid with 20-fold lower affinity than ApoE3, and thereby decreases Aβ clearance 
by 40%. The ApoE4 variant has a negative influence on the AD risk factor cholesterol and decreases 
the age of AD onset in a dose-dependent manner (heterozygous, homozygous; Tanzi 2012). Recently, 
a strong protective but rare mutation was found close to the aspartyl protease β-site in APP. The 
A673T allele decreases the peptide deposition, whereas other mutations at the same site (such as 
A673V) strengthened AD symptoms. The result supports the hypothesis that lowering Aβ levels are 
protective. The A673T allele also protects against cognitive decline in elderly people not suffering 
from Alzheimer’s disease, suggesting similar mechanisms behind various forms of cognitive decline 
(Jonsson 2012).  
Cytoplasmic neurofibrillary tangles and cytoplasmic APP cleavage products  
Besides the amyloid plaques, cytoplasmic neurofibrillary tangles were already mentioned by Alois 
Alzheimer in his original autopsy case report. Neurofibrillary tangles consist of the microtubule 
stabilizing Tau protein (MAPT), which in a hyperphosphorylated form dissociates from the 
microtubules (Bancher 1989). Consequently, microtubules start to depolymerize and Tau 
oligomerizes and aggregates into paired helical filaments (PHFs) in the cytoplasm (Alonso 1996, 
Alonso 2001).  
Cytotoxic properties have also been described for the short C-terminal APP intracellular domain 
(AICD), which is released into the cytoplasm during protease processing of APP. In absence of the 
Figure 15| Aβ sequence including proteolytic cleavage sites within the amyloid precursor protein (APP). α-secretase 
cleaves in the middle of the Aβ sequence, preventing Aβ production. The combined cleavage of β- and γ-secretases 
creates Aβ40 or Aβ42 (figure adapted from Findeis 2007). Longer hydrophobic stretches are labeled in yellow, the Aβ 
“aggregation core” (Aβ16-22 ) is surrounded by two charged residues (blue) and forms highly ordered β-sheet fibrils 
in vitro (Balbach 2000). The C-terminal hydrophobic stretch corresponds mainly to the membrane spanning helix of APP.  
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respective caspase cleavage site in mutant APP transgenic mice, Aβ-related phenotypes such as 
synaptic, behavioral, and electrophysiological abnormalities were absent in spite of abundant 
amyloid deposits (Galvan 2006, Saganich 2006). Such findings demonstrate the still poor 
understanding of the primary molecular causes of AD, despite of the many correlations and 
associations that have been described.  
Amyloid cascade hypothesis 
Tau exists in six splicing isoforms of 352-441 amino acids length and contains at least 30 
phosphorylation sites. Under normal conditions, tau is a soluble, most likely unstructured protein. It 
resides predominantly in axons and the residual neuronal cytoplasm (Huang 2009, Mandelkow 2012). 
Several mutations within the Tau gene can cause frontotemporal dementia with Parkinsonism, 
affecting e.g. the microtubule-binding repeat domains. Interestingly, this form of dementia is 
characterized by intense neurofibrillary tangle formation without elevated amyloid depositions 
(Hutton 1998, Poorkaj 1998). On the contrary, Aβ-induced neurodegeneration depends on 
cytoplasmic tau. Tau depleted neurons in presence of Aβ do not show neurodegeneration (Rapoport 
2002). In mice, knockout of Hsp110, a potential disaggregase or holdase, led to hyperphosporylation 
of tau and to neurodegeneration (Eroglu 2010). Aggregated Aβ has been shown to induce 
hyperphosporylation of tau accumulating mostly in the neuronal soma and dendrites (Zheng 2002). 
The potential of mutated tau causing dementia on its own and the requirement of tau for 
transmitting the toxic impact of Aβ led to the “amyloid cascade hypothesis”: abnormal cleavage of 
APP combined with insufficient Aβ clearance results in senile plaque accumulation, which triggers tau 
hyperphosphorylation and tangle formation within cells (Hardy 2002).  
The impact of cholesterol and other lipids on Alzheimer’s disease 
Cholesterol is highly enriched in human brains, especially in insulating myelin sheath surrounding 
nerve fibers. Cholesterol concentrates within “lipid rafts”, increases the order in membranes, and 
affects membrane fluidity. Non-amyloidogenic APP processing by α-secretase happens outside of 
lipid rafts and is promoted by low cholesterol levels (Kojro 2001). In contrast, β- and γ-secretases 
colocalize at least transiently with APP in lipid rafts, and high cholesterol stimulates their activity. The 
specificity of the intramembrane cleavage of γ-secretase is remarkably sensitive to membrane 
thickness. Varying the lipid components towards a lowered thickness leads to an increased Aβ42/43 
production (Winkler 2012).  
The essential ω-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) was ascribed to mediate 
the inverse correlation between increased fish intake and dementia (Grimm 2013). DHA reduces 
intra-neuronal Aβ levels as well as tau phosphorylation by inhibiting β- and γ-secretase activities in a 
dose-dependent manner. Overall, the lipid environment appears as a critical parameter at the origin 
of distinct Aβ species (Grimm 2013). Early treatments with statins that lower cholesterol levels could 
offer preventive functions, as demonstrated in mice (Refolo 2001, Kurata 2012). 
Missing links in Alzheimer’s disease 
The discovery of associated mutations to AD strengthens the notion of a causative role of Aβ and Tau 
in neurodegeneration. How toxicity is transferred from extracellular Aβ plaques into cells and 
translated into hyperphosphorylation and fibrillarization of Tau in the cytoplasm is still rather 
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unclear. Extracellular Aβ was shown to potentially erroneously modulate important membrane 
receptors, such as the nicotinic acetylcholine receptors (nAChR; Buckingham 2009). It was 
demonstrated on postmortem AD brains that fibrillar Aβ binds in nanomolar concentrations to the 
α7-nAChR subtype, an interaction that could be blocked by specific antagonists (Ni 2012). Disturbing 
signaling pathways across the cellular membrane and intracellular compartments could be one 
plausible way of transmitting extracellular protein misfolding into intracellular toxicity. However, 
pharmaceutical treatments that inhibit acetylcholinesterase performed only modestly in slowing AD 
progression (Raina 2008).  
But extracellular Aβ seeds are potentially not the only or major initiator of cell death in AD. In 
hippocampal rat neurons, the direct transfer of microinjected Aβ oligomers between connected cells 
demonstrated the potential pathogenicity of intracellular Aβ species. Transmission of Aβ oligomers 
was dependent on dendritic and axonal contacts between the neurons and caused disruption of 
tubulin structures and cytotoxicity (Nath 2012). The ambiguity about Aβ species affecting neurons 
primarily in form of extracellular plaques or intracellular oligomers reveals how less is still known 
about the pathogenic roles of various misfolded species and the sequence of pathological events that 
have been described for distinct neurodegenerative diseases. 
Huntington’s disease 
Huntington’s disease (HD) is the most common inherited neurodegenerative disorder with a 
prevalence of 1 per 17,500 inhabitants in Europe, North Amerika and Australia, but only 1 per 
250,000 in Asia (Pringsheim 2012). Patients suffer from uncontrolled motor movements as well as 
cognitive and emotional deficits. Preferentially, cortical and striatal brain regions are affected by 
shrinking and cell death. Cytotoxicity in HD is ascribed to the appearance of protein aggregates in 
patients carrying an extended CAG repeat in the Huntingtin gene. CAG encodes extended 
polyglutamine (polyQ) sequences within the N-terminal region of the ~350 kDa Huntingtin protein 
(Htt). The repeats explain not only the 
inheritability of the disease, but their number is 
directly correlated to the age of HD onset. While 
the majority of the population contains less than 
24, most HD patients carry 40-65 CAG repeats 
(The Huntington's Disease Collaborative 
Research Group 1993). The Htt gene is composed 
of around 70 separated exons with alternative 
splicing variants. N-terminal Htt fragments with 
an extended polyQ tract, preceded by a 17 
amino acid stretch (N17) and followed by a 
polyproline and glutamine rich region, are most 
often found in intraneuronal inclusions (DiFiglia 
1997). N17 has been shown to contain a 
switchable ER-targeting and a nuclear export 
signal. These signals are controlled by stress-
dependent phosphorylation and acetylation, 
modulating the localization and the toxicity of 
Htt and its fragments (Atwal 2011, Maiuri 2013). 
Figure 16 | Negative relationship of CAG repeat length 
and age of disease onset of HD patients. Age of 
neurological onset is directly inversely correlated to the 
age of onset (red). Duration of disease from onset to 
death remains fairly constant between 15-18 years (blue 
curve; figure from Finkbeiner 2011). 
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The polyproline stretch forms a flexible helix that influences solubility and aggregate formation 
(Dehay 2006). Localization, solubility, and conformational stability of the entire fragment in turn 
affect its cellular toxicity. 
Nuclear aggregates of ubiquitinated, truncated Htt in the brains of patients appeared as a hallmark of 
HD. Lacking a C-terminal nuclear export sequence of the full-length protein, Htt fragments may 
increasingly enter the nucleus and form inclusions (Xia 2003). However, already early on a study 
examining adult HD patient brain tissues described a majority of cytoplasmic aggregates in dystrophic 
neurites (neuronal projections, axons, and dendrites). Only in young patients, nuclear inclusions were 
predominant (DiFiglia 1997). Despite the fact that cytoplasmic aggregates were often found in 
coexistence with intranuclear inclusions, often the latter made it into the title of publications 
(“Huntington’s Disease intranuclear inclusions contain truncated, ubiquitinated Huntingtin protein”, 
Sieradzan 1999). Using an improved antibody against the N-terminal sequence, Gutekunst et al. 
discovered “that neuropil aggregates are much more common than nuclear aggregates” (Gutekunst 
1999). These Htt aggregates again appeared especially in dendrites and dendritic spines in the brains 
of HD patients. 
The first transgenic Huntington’s disease mice 
expressing polyQ extended Htt exon 1 (including the 
R6/2 line analyzed in this study) displayed a 
progressive neurological phenotype between 9 and 
12 weeks of age, dying 2-3 weeks later (Mangiarini 
1996). In human cell culture experiments, mutant 
Htt exon 1 containing polyQ tracts of various 
lengths mostly accumulated in the cytoplasm of e.g. 
HEK293T or SH-SY5Y neuroblastoma cells. In 
primary neuronal cell cultures, such Htt fragments 
are rather imported into the nucleus, indicating a 
cell-type and fragment specific localization. The 17 
N-terminal amino acids preceding the polyQ tract of 
human Htt have been described to contain a 
leucine-rich nuclear export sequence, which is 
recognized by the exportin CRM1 (Leptomycin B 
sensitive; Maiuri 2013). This export sequence may 
compete with e.g. cellular attempts to transfer 
misfolded fragments to the nucleus for degradation 
(Park 2013), which may thus be one reason for the 
different localizations in distinct cellular 
environments. 
Besides the presence of microscopically visible aggregates in different cellular (sub-)compartments, 
their presence and selective visibility (due to e.g. specific antibodies applied) does not necessarily 
describe a causative link to neuronal shrinkage or disease progression. Large aggregates might be a 
source or a sink for less visible and rather transient structures that can harm cells at different sites, 
which leads us to central questions of this study: which misfolded structures are especially toxic, 
where and how do they severely damage living cells?  
Figure 17 | Nuclear (○) and neuritic (●) inclusions in 
juvenile and adult patients. Whereas huntingtin 
aggregates of young HD patients were mainly detected in 
the nucleus, most aggregates were found in neurites 
(cytoplasm) of cerebral neurons in adult HD patients
(figure from DiFiglia 1997). 
  Introduction  ∙  33 
Biological function of full length Huntingtin and amyloid formation 
Full length Htt is a multidomain protein with a C-terminal nuclear export signal (Xia 2003) that is not 
present in the aggregated N-terminal fragments found in inclusion bodies. Full length Htt is 
completely soluble and has no homology to other proteins. Htt is expressed within cytoplasm, ER and 
Golgi, at the highest levels in neurons of the central nervous system (Cattaneo 2005).  
Htt is essential during embryogenesis as demonstrated in mice. In embryonic and adult mice and in 
cell culture, Htt has been shown to protect from apoptotic cell death after various apoptotic stimuli 
(Leavitt 2006, Zeitlin 1995). Htt is found in neurites and at synapses, where it associates with 
vesicular structures and microtubules and seems to be involved in vesicle trafficking (Cattaneo 2005). 
Heterozygous animals carrying only one Htt gene display no phenotype. However, they display motor 
and cognitive dysfunctions if an N-terminal fragment (Htt exon 1-4) is being expressed (Duyao 1995, 
Nasir 1995, Zeitlin 1995). Overall, various native functions of Htt are still intensely investigated.  
Htt fragments form to cross β-sheet structures. In contrast to the hydrophobic aggregation cores of 
most other amyloid fibrils, the polar nature of the glutamine side chain is thought to form hydrogen-
bonded polar zippers through linkages between main-chain and side-chain amides (Perutz 1994). 
However, the polyglutamine flanking sequences (N17 and C-terminal polyproline region) play an 
important role for the assembly of nonfibrillar oligomers and for toxicity (Hoop 2014, Lyubchenko 
2012).  
Parkinson’s disease 
With a prevalence of 1% at age 65 and 5% at age 85, Parkinson’s disease (PD) is the second most 
common neurodegenerative disorder. Symptoms of Parkinson’s disease are typically chronic and 
slowly progressive with a mean duration of 15 years from diagnosis to death. Patients suffer from 
muscle tremor, rigidity, postural instability, sleep disorder, and dementia (Shulman 2011).  
Pathologically, PD is defined by neurodegeneration of dopaminergic cells within the Substantia nigra. 
Here, α-synuclein forms the core and major component of cytoplasmic protein-rich inclusions termed 
Lewy Bodies (described by the neurologist Friedrich Lewy in 1912). With 60% of neuronal death 
within the Substantia nigra, losses are substantial when symptoms appear. Lewy Bodies were found 
throughout the central nervous system and the neuronal periphery. Symptoms of PD can also 
accompany other neurodegenerative disease, summarized by the “syndromes of parkinsonism”. 
These interrelations demonstrate obvious difficulties in defining and differentiating between related 
neurodegenerative diseases. On the other hand, findings of Lewy Body pathology might appear 
without apparent clinical manifestations (Shulman 2011).  
PD has been considered as a sporadic disorder influenced by environmental triggers, such as 
pesticides (Priyadarshi 2000). Meanwhile, a number of associated genetic variants were identified. 
Mutations in the SNCA gene (encoding α-synuclein; A53T, A30P, or E46K) or gene duplications 
leading to increased α-synuclein levels were associated with early-onset and rapid disease 
progression (Shulman 2011). α-synuclein associates with presynaptic vesicles and consists of an 
amphipathic N-terminus, a hydrophobic core, and a negatively charged, unstructured C-terminus 
(Ulmer 2005).  
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Interestingly, α-synuclein was found to be degraded by chaperone-mediated autophagy (CMA). Due 
to its CMA specific recognition motif (V95KKDQ99), α-synuclein is selectively translocated into 
lysozymes for degradation. Moreover, the pathogenic A53T and A30P mutants bound lysozymes 
more strongly, but inhibited translocation and degradation, causing an arrest of cellular CMA 
functions. The pathogenic mutants inhibited not only their own degradation, but also that of long-
lived and misfolded sequences (Cuervo 2005). Such gain-of-functions might ultimately develop into 
significant proteostasis challenges, especially since α-synuclein assembles into oligomeric and 
fibrillary β-sheet structures on its own.  
A set of genes has been especially related to autosomal recessive juvenile forms of PD: Parkin, PINK1, 
and DJ-1, whereby loss- and gain-of-function seem to be especially interrelated. Under cell stress, 
Parkin is acting most likely downstream of the mitochondrial kinase PINK1 (PTEN-induced kinase) 
towards pro-survival signaling (Winklhofer 2008, Lo Bianco 2004). Parkin and PINK1 have been 
implicated in induction of mitophagy by polyubiquitination of VDAC1 (Geisler 2010), which may 
cause mitochondrial apoptosis (still controversial; Kroemer 2007, Alavian 2014). On the other hand, 
mutations in both of the proteins, Parkin and PINK1, mutually affect their stability and aggregation 
(Um 2009, Um 2010), and Parkin itself was found as an enriched component in Lewy Bodies (Chung 
2001). Also, short C-terminal truncations of Parkin result in cytoplasmic aggregation of the proteins 
(Winklhofer 2003). Neuroprotection under mild stress may therefor transform into misfolding and 
aggregation, when the cellular stress overwhelms Parkin’s own folding equilibrium. 
Although currently available therapies delay disability and prolong life expectancy, none was able to 
interfere considerably with the neurodegenerative process. New therapeutic avenues include viral 
vectors intervening in the dopamine equilibrium and transplantation of fetal nigral cells into the 
striatum. Interestingly, the fetal cells developed Lewy Bodies only a few years after transplantation 
despite their own “young age”, suggesting a strong influence of the local environment (Shulman 
2011, Obeso 2010). 
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Nucleo-cytoplasmic transport of proteins and RNAs 
Subcellular compartmentalization and proteostasis  
Cells are subdivided into several compartments to allow different chemistry taking place and to 
separate cellular functions. Major compartments comprise the cytoplasm, nucleus, endoplasmic 
reticulum (ER), Golgi network, mitochondria, and cell membranes. There are further sub-
compartments with specific activities exist, such as the nucleoli (ribosome assembly), euchromatin 
(active genes), heterochromatin (inactive genes), Hsf1 foci (active during proteome stress), various 
snRNPs (small nuclear ribonucleoprotein particles for RNA processing) in the nucleus (Matera 2009, 
Francastel 2000).  
Although some cellular subcompartments can be completely created by self-assembly, many require 
the incorporation of additional molecules (proteins, lipids) into preexisting structures to grow and 
proliferate (Noda 2002). Thousands of proteins are actively targeted into cellular locations, 
addressed via specific targeting sequences that are incorporated into the polypeptide chains 
(Sabatini 1971, Akopian 2013). Different subcellular biochemistries bear specific challenges for 
proteostasis, promoting cellular functions such as protein synthesis and folding in the cytoplasm, 
energy metabolism in mitochondria, preservation of genetic material in the nucleus, or an oxidizing 
milieu in the ER. Every compartment possesses its distinct proteostasis machinery corresponding to 
the prevalent conditions. 
Nuclear envelope and nuclear pores 
Recently, the cellular interactors of amyloid-like aggregates were identified in human cells. Toxicity 
may originate from an impairment of cellular pathways related to these interactors, which also 
included several factors involved in molecular nucleo-cytoplasmic transport (Olzscha 2011). During 
the course of this study, we furthermore observed a disturbed morphology of the nuclear envelope 
and a speckled chromatin structure in cells with protein aggregates.  
In neurons of C. elegans, glutamate triggered excitotoxicity leading to neurodegeneration was found 
to increase the permeablility of nuclear pores via elevated calcium levels. The nuclear barrier and 
transport machinery appeared to be compromised, finally supporting cell death by apoptosis (Bano 
2010 Cell Death Diff/Nucleus). Nuclear irregularity has furthermore been observed in hippocampal 
and neocortical biopsies of Alzheimer’s disease patients, often in association with neurofibrillary 
tangles (Sheffield 2006).  
All these indications made us interested in studying the efficiency of nucleo-cytoplasmic transport in 
cells affected by protein aggregation. Subcellular and nucleo-cytoplasmic transport is essential for 
many cellular functions, especially for stress signaling, inducing cellular responses to cope with e.g. 
increased amounts of misfolded structures or reactive oxygen species. Very recently, morphological 
abnormalities of nuclear were described in cells expressing mutant Huntingtin (Liu 2015). Studies on 
the C9orf72 repeat expansion related to ALS/FTD documented a compromised nucleo-cytoplasmic 
transport in different model systems (Freibaum 2015, Jovicic 2015, Zhang 2015).  
The nuclear envelope separates the nuclear matrix from the cytoplasm. The envelope is composed of 
two lipid membranes contiguous with the ER. Membranes of the nuclear envelope are underlaid by a 
fibrous sheet of proteins. This lamina consists mostly of α-helical intermediary filaments of type V 
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(lamins) that associate to integral or peripheral membrane proteins, which furthermore connect to 
chromatin-associated proteins. Lamins dissociate upon phosphorylation early during mitosis, 
although their degree of disassembly remains uncertain (Guettinger 2009).  
 
The only (known) passages through the nuclear envelope are the nuclear pores. They are dynamic 
and selective tunnels formed by large protein assemblies, the nuclear pore complexes (NPCs). 
Molecules up to a size of around 30 kDA can freely passage these molecular sieves, larger proteins 
need to be actively transferred. In addition, many smaller biomolecules (proteins, RNA) are actively 
sorted between the two compartments. Their location and gradients between cytoplasm and nucleus 
are essential for their cellular function and for maintaining homeostasis.  
Active nucleocytoplasmic transport is mediated by transport complexes that recognize specific 
targeting signals on their cargos. Substrate binding, low-affinity interactions with nucleoporins (NPC 
proteins) during translocation, and substrate release are the major steps in this process. Many 
transport proteins that mediate nucleo-cytoplasmic transport belong to the family of karyopherin β 
proteins. They are a family of at least 20 relatively large proteins of around 100 kDa and a weak 
sequence homology (identities of typically 15-20%). Known structures comprise ~20 HEAT repeat 
domains of ~40 amino acids length. HEAT repeat domains fold into pairs of α-helices stacked 
together in a slightly twisted parallel fashion. This “superhelical” architecture leads to an inner 
concave and an outer convex surface, whereby N- and C-terminal arches can often be distinguished 
(Cook 2007). 
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Figure 18 | The main structural features of the nuclear envelope and nuclear pore complexes. A Inner and outer nuclear 
membranes (INM/OUM) are separated from the perinuclear space (PNS), contiguous with the ER lumen. INM proteins link 
the nuclear envelope membrane to the undelaying lamina and to chromatin, whereas ONM proteins connect to the 
cytoskeleton. The lamin B receptor, for example, connects to B-type lamins and to chromatin-associated heterochromatin 
protein 1 (HP1). Other proteins are linked to DNA replication, nuclear envelope assembly, and gene regulation. B Nuclear 
pore complexes (NPCs) are large macromolecular assemblies of up to 120 MDa with eight-fold rotational symmetry. They 
are built from around 30 different nucleoporins (Nups), assembled from subcomplexes forming building blocks. The central 
channel of the NPC is filled with FG-repeat proteins, providing interaction sites for transport receptors (figure from 
Güttinger 2009). 
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Nucleo-cytoplasmic targeting of proteins 
Proteins intended for active cellular localization contain specific targeting sequences that are 
recognized by transport receptors or adaptor proteins (first suggested for ER proteins by Günter 
Blobel; Sabatini 1971). Classical nuclear localization signals (NLS) can be monopartite, consisting of a 
cluster of 3-5 positively charged residues, or bipartite with a second cluster of lysine or arginine 
residues following a 10-12 residue long linker (Kalderon 1984). Nuclear export sequences (NES) on 
proteins for cytoplasmic localization are leucine-rich sequences. They are harder to predict as they 
show a higher variation and can be similar to regions hidden in hydrophobic cores of folded proteins 
(la Cour 2004). 
Nuclear import 
Classical NLSs are recognized by importin α proteins with two clusters of lysine-binding pockets, 
which recognize the two stretches of a bipartite sequence. A series of tryptophans engages in 
hydrophobic interactions with the aliphatic tails of the lysine residues, while the positively charged 
amino groups find their negatively charged counterparts in nearby acidic residues.  
Importin α proteins are adaptor proteins with an importin β-binding domain (IBB). Although most 
karyopherin β proteins bind their cargo directly at the inner concave surface, NLS cargoes seem to be 
an exception to that rule. Once a ternary complex of NLS-cargo:importin α:importin β is formed, it 
translocates through the nuclear pores into the nucleus. Here the complex encounters Ran, a 24 kDa 
GTPase. RanGTP binding causes the dissociation of karyopherin β complexes and a release of the 
cargo. The release is triggered by direct steric interference with the cargo binding sites, and 
allosterically through conformational changes. Thereby, the IBB domain of importin α is expelled 
from importin β. The IBB domain appears largely disordered, but likely folds back on the NLS binding 
sites, leading to an autoinhibited state. Another karyopherin β is transportin 1, recognizing M9 NLSs 
of many mRNA binding proteins involved in RNA processing and nuclear export (Cook 2007).  
Nuclear export 
Importin α needs to be returned to the cytoplasm, which is mediated by its specific exporter CAS. 
Only the auto-inhibited conformation of importin α is recognized by CAS in the presence of RanGTP, 
and the complex dissociates upon entry in the cytoplasm. Nuclear export of a broad variety of 
cytoplasmic cargo proteins is mediated by the exportin Crm1, which binds NES generally with lower 
affinities. Crm1-dependent transport can be inhibited by the small molecule drug Leptomycin B 
(LMB) that covalently attaches to a cysteine residue on Crm1 and thereby interferes with cargo 
binding (Fornerod 1997, Cook 2010).  
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The Ran cycle 
The dissociation of export complexes is triggered by the hydrolysis of RanGTP to RanGDP in the 
cytoplasm. Already at the NPC, Ran binding proteins (RanBP1, RanBP2) promote the dissociation of 
RanGTP from karyopherins and stimulate RanGAP1-mediated (GTPase activating protein) hydrolysis. 
RanGDP has only a very low affinity for karyopherins. Sumoylation localizes RanGAP to the 
cytoplasmic face of NPCs through interactions with RanBP2.  
RanGDP is recycled back into the nucleus by its specific importer NTF2. Back in the nucleus, the 
chromatin associated RCC1 (with a seven-bladed β-propeller structure) functinos as a RanGEF 
(guanidine exchange factor) and mediates nucleotide exchange (Cook 2007). Restoring nuclear 
RanGTP ultimately gives directionality to the whole nucleo-cytoplasmic transport process.  
Messenger RNA processing and nuclear export 
Transcription, processing, and nuclear export of messenger RNAs (mRNAs) are tightly coupled in the 
eukaryotic cell. Large RNA-protein complexes form and proceed in a dynamic manner in functional 
small nuclear ribonucleoprotein particles (snRNPs, or “snurps”). snRNPs are distinct from other 
nuclear subcompartments, such as nucleoli or Hsf1 related stress granules (Metz 2004, Biamonti 
2010).  
The THO complex is one of the key factors of this process. THO is conserved from yeast to human. 
The complex associates during snRNP biogenesis, prevents base pairing between nascent RNA and its 
DNA template, and recruits processing factors. THO finally mediates nuclear export only of fully 
processed mRNA. Several THO proteins (human: Thoc1-7) are part of the human TREX 
(transcriptional export) complex in conjunction with additional factors that are dynamically 
integrated and released (Jimeno 2010). Thoc4 (Aly/Ref) directly interacts with Thoc2 and Thoc5 
linking a TREX core protein, UAP56, to the cap-binding protein CBP80 (Chi 2013). CBP80 itself is part 
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Figure 19 | Karyopherin β proteins (also known as importins or exportins) mediate nuclear import and export, driven by the 
Ran cycle. (A) Importins recognize cargo in the cytoplasm at specific binding sites, which partially overlap with RanGTP binding 
sites after translocation through the nuclear pore complex (NPC) into the nucleus. Exportins bind cargo and RanGTP in the 
nucleus and translocate to the cytoplasm, where GTP hydrolysis triggers the release of both factors. (B) RanGAP (GTPase-
activating protein) maintains a high concentration of RanGDP in the cytoplasm. NTF2 transports RanGDP back into the nucleus, 
where RCC1 restores RanGTP to maintain the gradient (figures from Cook 2007). 
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of the cap-binding complex (CBC), which binds cotranscriptionally to the 5’-cap of pre-mRNA and is 
involved in splicing by the spliceosome and in transcriptional regulation. UAP56 is an RNA helicase 
and a core component of TREX. The complex furthermore interacts with the exon-junction complex 
(EJC) that marks splicing sites (Chi 2013, Erkmann 2004). 
 
The majority of mRNA export occurs independently of karyopherin β proteins or Ran. The 
heterodimeric complex Tap:p15 directly interacts with nucleoporins. p15 shows significant sequence 
homology with NTF2 (recycling RanGDP). Tap (or Nxf1) is a multi-domain protein with an RNA binding 
domain (RBD) and a nucleoporin binding site. Tap:p15 works in conjunction with the TREX complex, 
the exon-junction complex (EJC), Aly/Ref (Thoc4), which additionally bind RNA as an adaptor 
complex, and DbP5, an ATP-dependent helicase (Cook 2007). Nxf1 has been demonstrated to change 
into an open, mRNA-binding conformation once it made contact to Thoc4/5 binding sites on the TREX 
complex, indicating “that TREX provides a license for mRNA export by driving Nxf1 into a 
conformation capable of binding mRNA” (Viphakone 2012, Müller-McNicoll 2013). 
 
Figure 20 | Different classes of RNAs and their nuclear export pathways. Biogenesis, processing, and nuclear export of 
RNAs are usually highly coupled and regulated processes. Different classes of RNAs employ different nuclear export 
systems. Besides mRNA, all other RNA classes are exported by exporters of the karyopherin β family (tRNA by exportin-t, 
miRNA by exportin-5, snRNA and rRNA by Crm1), driven by the RanGTP/RanGDP cycle. The majority of mRNA transport is 
conducted Crm1/Ran-independently. Processing and transport include several huge protein complexes and associated 
factors, such as the exon-junction-complex (EJC) and the transcriptional export complex (TREX) comprising the THO 
proteins. The heterodimer Tap:p15, the RNA adaptor Aly/Ref, and the ATP-dependent helicase Dbp5 are directly involved in 
the nuclear mRNA export at the nuclear pore complex, which is under debate for proteins of the EJC and TREX complex 
(figure from Köhler 2007). 
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Ultimately, various factors of the TREX complex ensure that only fully processed mRNA (5’ capping, 
splicing, polyadenylation) is being exported to the cytoplasm, or otherwise being degraded (Masuda 
2005, Erkmann 2004). The export occurs via direct transient interactions with factors of the nuclear 
pore complex (Braun 2002).  
In analogy to cellular protein folding, the maturation of mRNA is under such a precise quality control 
and regulation by its processing machinery, that these factors may be described as “mRNA 
chaperones”. They guard mRNAs on the way from nuclear processing to ribosomal translation, and at 
the same time protect them against detrimental interactions (premature export, degradation). The 
chronological dynamics, structure, and functions of most proteins involved in this highly coupled, 
complex process are still under intense investigation.    
Figure 21 | Current view of co-
transcriptional mRNA 
processing and export to the 
cytoplasm. Processing includes 
the assembly of messenger 
ribonucleic acid particles 
(mRNPs), mRNA capping, 
splicing, polyadenylation, and 
quality control. The TREX 
complex including THOC proteins 
bind early during mRNA 
synthesis and ensure a full 
maturation, before the mRNA 
can be exported to the 
cytoplasm. The mRNA quality 
control factors, such as the cap-
binding complex (CBC) or the 
cleavage and polyadenylation 
specificity factor 6 (CPSF6), 
become included into the mRNP 
complexes after individual 
maturation steps. After full 
processing, Thoc4 together with 
Thoc5 promote the binding of 
Nxf1 (Tap:p15), which reveals its 
interaction sites for mRNA and
the nuclear pores, initiating the 
export of mature mRNA to the 
cytoplasm. Here, most mRNA 
bound proteins are replaced by 
actively translating ribosomes, 
and the mRNA maturation 
factors are reimported into the 
nucleus (figure from Müller-
McNicoll 2013). 
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Designed β proteins as experimental model to investigate molecular 
mechanisms behind neurodegenerative diseases 
Amyloid fibrils were discovered as the hallmarks of dementia and other protein misfolding diseases 
(Alzheimer 1907). Amyloid-like aggregates assemble from diverse, disease-dependent proteins that 
misfolded from their native state into planar cross-β-sheet structures (Astbury 1959). Protein 
misfolding is accompanied by a functional loss of the respective protein, and potentially by a 
destructive functional gain originating from the misfolded structures that influence their cellular 
environment (Winklhofer 2008). Thus, a complex combination of multiple malfunctions may occur in 
cells, which complicates scientific analyses and hampers efforts in understanding dementia-related 
diseases. 
For focusing on the toxic gain-of-function, we utilized artificially designed proteins folding into 
fibrillary cross-β-sheet structures, comparable to amyloids appearing in neurodegenerative diseases. 
This allowed us to observe the toxic impact of amyloid-like structures on living cells without 
interference from loss-of-function effects that accompany the misfolding of every natural disease-
associated human protein. 
It is still a major challenge to design novel proteins with any desired, e.g. enzymatic function. 
However, utilizing knowledge about the geometry of secondary structures and the hydrophobic 
effect allows engineering certain protein conformations. Artificial proteins with α-helical or β-sheet 
structures have been achieved by positioning hydrophobic amino acids in such a way that they 
become buried upon folding. On the protein surface, mainly polar and charged residues remain.  
Libraries of such proteins were pioneered by Prof. Michael Hecht and his colleagues. Artificial β-sheet 
proteins were designed by alternating hydrophilic and hydrophobic side chains in a binary pattern 
(…①❷③❹⑤❻⑦…), since side chains in β-sheet structures are directed up and down in an 
alternating pattern. Serial strings of such β-strand building blocks were connected by flexible and 
typical strand braking residues, such as glycine, serine, or proline. Connecting several β-sheets of 
identical length by short turns resulted in the formation of stable, artificial β-sheet proteins (here: 7 
residues long β-strands, 4 residues long turns; 6 β-strands in series). However, proteins produced by 
this technique not only formed β-sheet structures, but independently of the exact sequence 
resembled amyloid cross-β-sheet fibrils comparable to those occurring in neurodegenerative 
disorders (West 1999). Nature actually strongly disfavors such binary patterns in native sequences, 
which already indicates potential difficulties of inherently amyloidogenic structures that appear in 
cells (Broome 2000). 
 
Figure 22 | Sequence design of artificial β proteins utilized for folding into amyloid-like structures. We utilized such  
β proteins to model the effects of protein misfolding, as it occurs in different forms of dementia. Short polypeptide 
stretches constructed by alternating patterns of polar (blue) and hydrophobic (yellow) side chains were connected by short 
linker sequences. These consist of strand breaking side chains, allowing β-turns (~) to form in between two β-sheets 
(arrows). The resulting β proteins comprising six potential β-sheets were fused to N-terminal tags. Tags facilitated detection 
(c-Myc) or targeted the proteins into cellular compartments, such as nucleus, cytoplasm, or mitochondria (adapted from 
West 1999). 
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The polar-hydrophobic pattern is primarily important for the formation of secondary structures in 
such designed proteins. Individual residues therefore can be varied in compliance with the polar-
hydrophobic pattern, allowing the creation of a large variety of sequences (West 1999). Sequence 
dependently, variations from the idealized β-sheet structure may certainly occur.  
 
Artificial α-helical proteins can be designed by a different distribution of polar and hydrophobic side 
chains (such as ○●○○●●○○●○○●●○). Following α-helical geometry in a polypeptide sequence, polar 
and hydrophobic surface regions can be created. Several helices can then assemble to e.g. a four-
helix-bundle, stabilizing the whole structure by orienting hydrophobic residues to the inside 
(Kamtekar 1993, Hecht 2004). In contrast to the β-sheet proteins, such designed soluble α-helical 
structures should be devoid of amyloid-like nature or tendencies to assemble into higher-molecular-
weight polymers. Therefore, α-helical proteins served us to control effects of expressing any artificial 
structures in cells.  
 
Figure 23 | Structural model of designed β-sheet proteins (left, monomer) and amyloid-like fibrils (right, fibril section 
with 3 monomers, assembling via open hydrophobic surfaces). The protein backbone (green) folds into planar β-strands of 
7 amino acids in length, interrupted by 4 amino acid turns (gray). Turns connect six antiparallel β-sheets within a monomer. 
Side chains project alternatingly up (polar residues, red) or down (hydrophobic residues, yellow). Interactions between 
open hydrophobic surfaces lead to the polymerization of β protein monomers into cross-β-sheet fibrils (amyloids), whereby 
the β-sheets run orthogonal to the fibril axis (from left to right; figure adapted from Wang 2002). While in native proteins 
β-sheet structures are rather twisted (Chothia 1981, Zandomeneghi 2004), short β-strands can be forced into planar 
conformations, allowing the assembly of long repetitive amyloid fibrils. 
Figure 24 | Geometry and design principle of an artificial α-helical four-helix-bundle protein, and solution structure of 
αS824, an artificial α-helical protein. (A) Helix wheel representing the geometry and periodicity of an amphiphilic α-helix 
with hydrophobic (yellow side chains) and polar (red side chains) surface regions (figure adapted from Kamtekar 1993). (B)
Structural model of a four-helix-bundle, burying its hydrophobic regions in the inner core of the bundle (figure adapted 
from Kamtekar 1993, Hecht 2004). (C) Solution structure of αS824, an artificial α-helical protein (figure adapted from Wei 
2003).  
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Aims of this study 
Fibrillar plaques and intracellular tangles were first described by Alois Alzheimer in a brain autopsy of his 
famous patient Auguste Deter (Alzheimer 1907/1995). Since then, proteinaceous aggregates became the 
hallmark not only of Alzheimer’s, but a wide range of neurodegenerative diseases, many of them 
comprising related symptoms and pathology.  
The proteins held responsible for initiating the process of aggregation in cells are usually not toxic per se, 
but perform specific biological functions in their native states. Nevertheless, proteins may turn harmful 
e.g. through conformational transitions, proteolytic fragmentations, or sequence mutations. 
Conformational transitions can also be influenced by “environmental” factors in the cell, including 
alterations in the proteostasis network as they may occur during aging processes. Certain non-native 
protein conformations may then accumulate, over long times or because they cannot be removed. If they 
are able to assemble into higher-molecular-weight structures and to interact with other cellular factors, 
they may gain toxic functions on cells. In this study, we aimed to focus on such emanating toxic functions 
that protein structures may acquire by misfolding, in contrast to the functional loss of individual misfolded 
proteins. Therefore, we utilized a set of artificial β proteins that were designed to adopt directly amyloid-
like oligomeric and fibrillary structures, without the background of evolutionary selection regarding their 
structure or biological function. Thus, with the designed β proteins we aimed to investigate the general 
toxic potential of misfolded amyloid-like protein conformations in cells. 
In the first part of this study, we tried to increase our knowledge about the structural origins of amyloid-
related toxicity. We therefore purified different β proteins and reconstituted their aggregation in vitro 
under physiological conditions. After demonstrating their amyloid-like nature, we analyzed their 
physicochemical properties to set them in correlation to their toxicity. Oligomerization and fibril 
formation was observed by electron microscopy and various spectroscopic and biochemical methods. 
Toxicity of the amyloid-like β proteins was assessed in different cellular systems to understand the 
fundamental biology behind the known neuronal vulnerability. In conjunction with properties of the 
cellular interactors of the β proteins, we hoped to gain a better understanding of the structural 
determinants of amyloid-related toxicity in cells. 
Numerous cellular malfunctions and defects were observed in model systems and patient’s tissues 
associated to protein aggregation and neurodegenerative diseases. Toxicity appears to spread in a 
complex manner through cells, its origins still remaining unclear. Protein aggregates and distributed 
oligomeric material occur dependent on the specific disease often simultaneously in different cellular 
compartments. To describe cellular mechanisms of toxicity we decided to direct the aggregation into 
individual compartments to observe arising localized toxicities, corresponding cellular malfunctions, as 
well as strengths and weaknesses of subcellular proteostasis networks. Cellular interactors should direct 
us towards affected cellular pathways with a special focus on the early events during the aggregation 
process. This strategy should help us to resolve the multifactorial nature of neurodegenerative disease 
mechanisms and to reveal previously unknown compartment-specific proteostasis functions and factors. 
Our observations on the β proteins as general misfolding model sequences should then be compared to 
human disease associated proteins and related animal models to evaluate the significance and disease 
relevance of our findings.  
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Results 
Designed β proteins  
The three β proteins utilized in our studies, β4, β17, and β23, were constructed using the same 
alternating polar-hydrophilic amino acid pattern. β4, β17, and β23 contain the same number of 
amino acids and proposed β-strands (6 strands of 7 amino acids length, connected by 4 amino acid 
long turns). They vary, however, in their individual amino acid sequence.  
Among the β proteins, β23 has the most negative net charge, the highest hydrophobic volume 
(volume occupied by aliphatic side chains), and the highest β-sheet propensity. The increased 
hydrophobic volume and β-sheet propensity of β23 were ascribed to its high isoleucine content 
(Tartaglia 2008).  
 Amino 
acids 
Molecular 
weight 
(kDa) 
Net 
charge 
at pH7 
Rel. hydrophobic 
Volume 
(a.u.) 
Isoleucine 
residues 
Hydrophobic 
aromatic 
side chains 
β4 80 8.94 -8.1 75 4 3xF, 1xY, 0xW 
β17 80 8.87 -8.6 75 5 3xF, 1xY, 0xW 
β23 80 9.05 * -11.6 * * 80 * * 11 * 3xF, 1xY, 0xW 
 
Table 1 | Sequence analysis summarizing basic physicochemical properties of the c-Myc tagged β proteins. The most toxic 
β23 (see below) stands out due to its high negative net charge and its increased hydrophobicity and isoleucine content 
(replacing alanines or valines in β4 and β17). The number of hydrophobic aromatic side chains was equal for the 3 
sequences (F, phenylalanine; Y, tyrosine; W, tryptophan). Properties calculated by ProtParam (Gasteiger 2005). 
To ascribe properties of the designed β proteins to their amyloid character and to distinguish them 
from features of non-amyloidogenic sequences, we made use of an artificial soluble α-helical protein 
(αS824). Overall, αS824 comprises a similar amino acid composition as the β proteins. A different 
order of the residues within the sequence causes αS824 to fold into a soluble 4-helix bundle with an 
inner hydrophobic core, as demonstrated by NMR (Wei 2003). 
 
Artificial β proteins are cytotoxic in E. coli  
The β proteins were shown to form amyloid-like fibrils in vitro (West 1999). Since amyloidogenic 
aggregation is observed with many proteins associated to neurodegenerative disease, we were 
wondering whether a general proteotoxic effect emanating from amyloid structures could be caused 
by the artificial β proteins in the different kingdoms of life. 
For analyzing potential toxicity in bacteria, E.coli cells (BL21) were transformed with inducible 
plasmids (trc promoter containing the lacO operator and the lacIq repressor) encoding the β proteins 
and grown overnight on selective LB agar. A single colony was picked and grown in liquid selective LB 
medium. On the next day, cultures were diluted to an equal cellular density (OD600nm of 0.15). When 
E.coli cultures initiated exponential growth after 90 min, protein expression was induced by addition 
of 0.5 mM IPTG. 
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E. coli cultures carrying an empty plasmid backbone (control) grew exponentially for around 3 hours 
before growth saturated into stationary phase. E. coli cells carrying plasmids encoding β4 and β17 
showed a similar exponential growth behavior, however, their division rates were significantly 
slowed down, and growth stopped at lower cell densities compared to wildtype E.coli cultures. 
Virtually no growth could be observed for cells expressing β23, entirely preventing cell division. 
Accurately, growth was inhibited even before chemical induction of β23 expression, most likely due 
to leaky expression within the pre-culture (low levels of β proteins were observed by immunoblotting 
of non-induced cells). β23 therefore proved to be highly toxic in E. coli cells even at low cellular 
levels.  
Structural modifications affect toxicity 
To analyze effects of structural alterations on cellular toxicity, the β proteins were modified. In one 
set, two positively charged lysine residues were introduced at the predicted hydrophobic interaction 
surfaces between β protein monomers (in the middle of the first and the last β strand, respectively). 
By weakening these hydrophobic contacts, aggregation into oligomers and fibrils should become less 
favorable. In vitro, β proteins carrying these two lysine mutations have been shown to be soluble and 
monomeric (Wang 2002).  
E. coli cultures expressing such “β17 Lys” or “β23 Lys“ mutants grew considerably faster than their 
non-mutated counterparts. “β17 Lys” grew as fast as β4. This suggests that indeed amyloid-like 
oligomers and fibrils are responsible for the observed growth impairment, and a destabilization of 
such structures positively affects cellular survival. Beyond polymerization prevention, the exchange 
of hydrophobic surface residues for charged amino acids might also reduce unspecific interactions 
with cellular factors. 
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Figure 25 | Growth curves of E. coli
cells expressing β proteins in 
comparison to wildtype cultures 
(transformed with empty vectors). 
E. coli cells expressing β proteins
exhibit a sequence dependent growth 
defect, varying from slightly delayed 
division rates in case of β4 to virtually 
no growth in case of β23. 
Representative growth curves of 3 
independent experiments.  
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In an opposing way, unpaired β strands could act as additional interaction surfaces, and increase 
interactions to cellular factors. To analyze effects on toxicity, a single β-strand either was added to 
(β17+4, β17+23) or was removed from (β23short) the standard β protein sequences. As expected, 
growth for the extended β proteins with seven β strands was furthermore decreased in comparison 
to β17 alone. β23short with only 5 β strands grew similar to the anyways highly toxic β23.  
 
In conclusion, when expressed in E. coli cells, the β proteins exhibited a sequence specific effect on 
growth. β proteins with an odd number of β strands exhibited an increased toxicity, whereas variants 
with diminished aggregation and hydrophobic surfaces proved to be less detrimental. The β proteins 
could therefore be modified in a rational manner, and they caused toxicity in an allegeable way.  
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Figure 26 | Growth curves of E. coli cells 
expressing β protein mutants with 
inhibited fibril assembly (continuous 
lines). The expressed mutants carry 
charged lysine residues on their 
polymerization surfaces, weakening the 
hydrophobic contacts that are necessary
for fibril growth. E. coli cells expressing 
these β proteins mutants markedly 
increased their growth rates, compared 
to the respective original sequences. 
Representative growth curves of 3 
independent experiments. 
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Figure 27 | Growth curves of E. coli
cells expressing β protein mutants 
with an odd number of β-sheets, 
potentially increasing interaction 
surfaces towards other cellular factors 
(continuous lines). E. coli cells 
expressing these β protein mutants 
further slowed down in growth, 
demonstrating their increased toxicity 
compared to the respective original 
sequences. β17+23 differed from 
β17+4 only by an isoleucine and a 
leucine side chain (replacing valine and 
phenylalanine). The residual sequences 
were identical. Already β23 stood out 
by its high frequency of isoleucine. 
Representative growth curves of 3 
independent experiments.  
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β proteins are purified from E. coli inclusion bodies 
The β proteins were expressed under the control of an IPTG inducible lac-promoter in E. coli cells, 
where they formed insoluble inclusion bodies. The c-Myc tagged proteins were isolated from 
inclusion bodies by denaturation in urea, followed by ion exchange and size exclusion 
chromatography (West 1999). However, since other cellular factors were apparently entrapped into 
the inclusion bodies, their color turned from typically white to yellowish-brown. To guarantee a high 
purity of the final isolate, additional purification steps (a denatured size exclusion chromatography) 
were included.   
αS824 was expressed as soluble hexa-histidine tagged protein and purified by Ni-NTA 
chromatography. After TEV cleavage of the His-tag, highly pure c-Myc tagged αS824 protein was 
obtained.  
The purity of the β proteins was confirmed by Coomassie Brilliant Blue stained SDS-PAGE, 
immunoblotting, UV/VIS spectroscopy, and amino acid analysis. The Coomassie Brilliant Blue stained 
SDS-PAGE showed monomeric β proteins and αS824. Due to their hydrophobic nature and their small 
size, the β proteins bound Coomassie Brilliant Blue rather weakly. Immunoblotting with an anti-c-
Myc antibody confirmed the identity of the proteins.  
The purified β proteins appear at an apparent size between 10-15 kDa, despite their arithmetical 
molar masses of close to 9 kDa. Reasons for their gradually decreased mobility might be a 
differentially preserved residual structure during PAGE, or a different affinity towards SDS molecules. 
The partial loss of this effect under denaturing conditions (4M Urea SDS-PAGE) supports this 
hypothesis. The differential mobility appears for the purified proteins as well as for whole cell lysates 
independently from organism (human or bacterial cells), lysis, or purification methods. αS824 
appeared as pure, monomeric protein at around 15 kDa (arithmetical mass of 13 kDa) on Coomassie 
Blue stained SDS PAGE and immunoblots. 
  
 
  
Figure 28 | Purified 
β proteins and αS824 
on (A) SDS-PAGE, (B)
corresponding anti-
c-Myc immunoblot, 
and (C) 4 M urea SDS-
PAGE. SDS-PAGEs 
were stained by 
Coomassie Brilliant 
Blue. β4 β17 β23 α β4 β17 β23 α 
130 
70 
55 
 
40 
 
35 
 
25 
 
15 
 
10 
kDa 
130 
70 
55 
 
40 
 
35 
 
25 
 
15 
 
10 
kDa 
130 
70 
55 
 
40 
 
35 
 
25 
 
15 
10 
kDa 
 
β4   β17  β23   α 
A B C 
 48  ∙  Results 
Concentration and purity of the β proteins 
Near and far UV spectroscopy can be applied to gain information about concentration and purity of 
protein solutions (Aitken 1996). Among the aromatic amino acids, especially tryptophan absorbs 
radiation around 280 nm, tyrosine and phenylalanine only to a much weaker extend (~20% and ~5% 
of tryptophan, respectively). The β proteins do not contain any tryptophan in their sequence, only a 
single tyrosine, each. αS824 contains one tryptophan and one tyrosine.  
The absorption spectra of the β proteins reflect this situation. All purified β proteins show a very low 
absorbance at 280 nm, indicating their high purity and the absence of other (tryptophan containing) 
proteins. αS824 in contrast shows a classical tryptophan peak with a maximum around 280 nm.  
Concentrations of proteins in solution are commonly determined by their absorbance at 280 nm. The 
absence of tryptophan residues in the β proteins required a different method for quantification. 
Peptide bonds absorb strongly in the far UV.  Here, the absorption coefficient depends linearly on the 
length (number of peptide bonds) of a protein. Therefore, the protein concentrations of the β 
proteins were determined at 210 nm with an absorption coefficient of 20 for 1 mg/mL of protein 
(Aitken 1996).  
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Figure 29 | Absorption spectra of purified β proteins and αS824. (A) Tryptophan absorption around 280 nm only occurred
for αS824 (black), not for the β proteins (colored). (B) The peptide bonds of the purified β proteins absorb in the far UV (β4 
in green, β17 in blue, β23 in red).  
  Results  ∙  49 
Structural properties of the β proteins 
Amyloid-like oligomers and fibrils revealed by transmission electron microscopy 
Purified β proteins in a physiological solution (150 mM KCl, 0.5 mM MgCl2, 25 mM HEPES, pH 7.5) 
were negatively stained on metal grids for transmission electron microscopy. The β proteins formed 
thin filaments with diameters of ~3 nm and lengths of 100-500 nm. The fibril diameters suggested a 
linear assembly of monomeric β proteins into fibrils, consisting of up to several hundred monomers 
(expected diameter of a β-sheet containing seven residues including terminal turns is ~2.7 nm).  
In addition, globular oligomers were found, particularly in case of β23. The diameter of the spherical 
oligomers ranged from 10-30 nm. The size variation indicated oligomers comprising a variable 
number of monomers in the population, not limited to a unique defined species. Globular oligomers 
made up a large fraction of the β23 species (up to 50% in physiological buffer). On the other hand, 
they were mostly absent in samples of β4 and β17, which were predominantly assembling into fibrils.    
Length and thickness of the fibrils increased on lowering the pH from 7.5 to 6. This observation 
seems rational, considering the high charge density of the β proteins (80 residues, net charges of -9 
to -13 at neutral pH). Negative net charges decrease due to protonation of acidic residues, lowering 
intra- and extramolecular repulsion. Longer fibrils of several hundred nanometers up to micrometers 
were found in 10 mM potassium phosphate at pH 6. The fibrils started to entangle each other, 
forming higher order fibrils (with diameters up to 10-12 nm under these conditions).  
 
 
 
Figure 30 | Transmission electron microscopy of aggregates formed by purified β proteins refolded in physiological buffer 
at pH 7.5. Proteins were negatively stained and observed at a magnification of 55,000 x. 
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Fibrils were forming in a time-dependent manner after dilution from denaturant (8 M guanidinium 
hydrochloride). Already after 5 min of refolding in physiological buffer, short fibrils of 10-30 nm 
became visible in case of β17 and β23. In addition, first globular β23 oligomers were present after 
5 min. During the next two hours, fibrils grew in size, reaching not yet the lengths present after 24 h. 
The kinetic electron microscopy data indicates, in consistency with the fluorescent amyloid stains 
(Thioflavin T, NIAD-4, see below), that the β proteins refold very rapidly into their fibrillary 
conformation. Fibril assembly initiates immediately without a (by the applied methods) detectable 
nucleation phase, but develops over hours to reach equilibrium conditions in vitro in a physiological 
buffer.  
 
 
  
Figure 31 | Transmission electron microscopy of aggregates formed by purified β proteins refolded at pH 6 for 24 h. 
Proteins were negatively stained and observed at a magnification of 55,000 x. 
Figure 32 | Transmission electron microscopy of aggregates formed by denatured β proteins refolded for 5 min or 2 h in 
physiological buffer at pH 7.5. Proteins were negatively stained and observed at a magnification of 55,000 x. 
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CD spectroscopy demonstrates β-sheet secondary structure 
To determine secondary structures of the β proteins, circular dichroism (CD) spectroscopy was 
applied after refolding the proteins in-vitro in a physiological buffer solution (150 mM KCl, 0.5 mM 
MgCl2, 25 mM HEPES, pH 7.5). To allow measurements in the far UV, the aggregated β proteins were 
diluted into a low salt buffer before the measurement (25 mM KCl, 6 mM HEPES, pH 7.5), assuming 
the aggregates and their secondary structures were mainly preserved. Measurements were 
performed at a protein concentration of 0.1 mg/mL. β protein fibrils and oligomers forming at this 
concentration stayed in solution and did not precipitate or sediment during the measurement.  
The CD spectra of β4, β17, and β23 resemble classical β-sheet protein spectra with a global minimum 
at 216 nm. Minor deviations occurred for β4. The spectrum of αS824 contains two minima at 208 and 
222 nm, characteristic for an α-helical protein.   
 
Relative contributions of different secondary structure elements were calculated by the CDSSTR 
algorithm (Johnson 1999, Sreerama 2000). This analysis considers a CD spectrum as a linear 
combination of spectra of individual secondary structure elements, and calculates the composition 
mathematically via singular value decomposition.  
Figure 33 | CD spectra of purified and refolded β proteins and αS824. The β proteins were refolded in physiological 
buffer and show typical spectra of β-sheet rich proteins. αS824 shows two minima and a stronger negative signal, as 
typical for α-helical proteins. 
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The analysis confirms that all three β proteins consist mainly of β-sheets as the main structural 
component (62-63%). However, a significant fraction of the polypeptide chains seems to contain 
unstructured regions (~32%) each. Such deviations from perfect β-sheet structures may be expected 
for artificially designed proteins. Moreover, these deviations may be crucial for the properties and 
interactions of the β proteins in cells. The residual 5-6% of α-helical content may be ascribed to the 
10 amino acid long N-terminal c-Myc sequence (EQKLISEEDL), which stems from an α-helical part of 
the c-Myc protein (Nair 2003).  
 
Noticeable is the high consensus between the secondary structures of the three β proteins. 
Conclusively, the differential toxicity cannot be explained by general differences in the secondary 
structural composition here. However, the three-dimensional arrangement within the β proteins may 
vary considerably. Especially the unstructured regions may significantly contribute to structural 
variation, with potentially crucial consequences for cellular toxicity.  
 
 
  
 
Figure 34 | Estimation of secondary structure content by singular value decomposition (CDSSTR) of the CD spectra of the 
β proteins and αS824. Analyses revealed mainly β-sheet structure and some unstructured regions for the β proteins, 
whereas αS824 was found to be mainly α-helical. 
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FTIR spectroscopy confirms amyloid-like nature  
Amyloid fibrils consist of cross β-sheet structures. These secondary structures differ generally from 
β-sheet folds of native proteins regarding their distribution of φ/ψ dihedral angles (Ramachandran 
plot), their number of strands per sheet, and their β-sheet twist (Zandomeneghi 2004). These 
differences are reflected in the amide I region of infrared spectra of proteins. Infrared signals 
originate primarily from stretching vibrations of main-chain carbonyl groups, which can be observed 
in the wavenumber range of 1600-1700 cm-1.  
As observed by Zandomeneghi et al., the maximum of the Amide I band of native globular β-sheet 
proteins occurs between 1630-1645 cm-1. Contrary, a multitude of amyloid fibers populates in the 
range of 1610-1630 cm-1, for example Aβ1-40 at 1625 cm
-1. This observation demonstrates that native, 
slightly twisted β-sheets differ in structural details from flat, cross-β-sheet conformations of amyloids 
(despite the exception of functional amyloids).    
The β proteins were dried under N2 as a thin film on a Germanium crystal, where H-D exchange was 
performed by flushing through D2O-saturated N2. The spectral region of the Amide I band (1705 to 
1595 cm-1) was extracted, corrected for the base line, and scaled such to obtain a constant integral 
value. Peak positions of spectral components were analyzed using Fourier-self deconvolution and the 
second derivative of the spectra. 
A B 
Figure 35 | Structural differences between native, slightly twisted β-sheet structures and flat cross-β-sheet 
conformations within amyloid fibrils can be observed by FTIR spectroscopy. (A) Transmission mode FTIR spectra of native 
transthyretin (TTR, above) and misfolded TTR in form of amyloid fibrils (below) in D2O. The global maximum of the Amide I 
band, originating from β-sheet secondary structures, prominently shifts from 1630 cm-1 (native TTR) to 1615 cm-1 (fibrillary 
TTR; Zandomeneghi 2004). (B) A literature survey revealed that native β-sheet proteins and amyloid fibrils absorb generally 
in distinct spectral regions of the Amide I band. Higher wave numbers in this region correspond to different dihedral angels 
(φ/ψ), reflected in larger twist angels of most native β-sheet proteins compared to flat, cross β-sheet amyloid fibrils 
(Zandomeneghi 2004). 
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All three β proteins displayed a global maximum at exactly 1624 cm-1. This verifies not only the 
amyloid nature of the β proteins, but also points towards their mutual similarity regarding their 
β-sheet structure (similarly flat β-sheets). Furthermore, all three β proteins show a small peak around 
1690 cm-1, which indicates an antiparallel orientation of the β-sheets.  
 
β4 shows a slightly decreased intensity at 1624cm-1. Therefore a small peak around 1650 cm-1 
appeared, a characteristic region for α-helices. Since the spectra were normalized by the surface 
beneath their curves, it can be estimated from these measurements that β4 contains around 5% 
more α-helical structure than β17 and β23. Slightly increased α-helical content is in agreement with 
the CD analysis of β4, although the CDSSTR algorithm did only find a minor increase of ~1% α-helical 
structure. However, this minor difference seems rather unlikely to reveal a major causal explanation 
of the significantly lower toxicity of β4 in comparison to β17 and β23 in vivo.  
The FTIR spectrum of αS824 showed a very symmetrical prominent peak with a global maximum at 
1647 cm-1, confirming its overall α-helical structure.  
 
 
Figure 36 | FTIR spectra of purified, refolded β proteins and αS824. The absorption at 1624 cm-1 is very characteristic for 
fibrillary β-sheet structures. The small peaks around 1690 cm-1 point toward an antiparallel orientation of the β-sheets. 
αS824 showed a very symmetrical peak and a prominent maximum of 1647 cm-1, confirming its α-helical structure.  
  Results  ∙  55 
Amyloid properties and aggregation kinetics 
β proteins bind classical and novel amyloid sensors – in correlation with toxicity  
Thioflavin T and Congo Red are dyes that have traditionally been used as amyloid sensors due to 
changes of their absorbance and fluorescence properties upon amyloid binding.  
Congo Red displays a green birefringence under polarized light when bound to amyloid fibrils. Its 
absorbance slightly increases in intensity, and a small redshift occurs (Eisert 2006). Thioflavin T was 
introduced 1959 by Vassar and Culling as a “fluorescent stain with special reference to amyloid and 
connective tissues” (Vassar 1959). Thioflavin T, an amphiphatic, positively charged small molecule, 
was found to form micelles at concentrations used in amyloid binding assays (10-20 µM) of 3 nm 
diameter (Khurana 2005) that bound along surface side-chain grooves running parallel to the long 
axis of β-sheet fibrils (Biancalana 2010). Upon amyloid binding, a new excitation peak at 450 nm 
appears, leading to an enhanced fluorescence emission at 482 nm (Khurana 2005). By this, the 
presence of amyloid fibrils as well as their kinetics of formation can be monitored.  
NIAD-4 is a recently discovered amyloid binding fluorophore with the ability to cross the blood-brain 
barrier. The dye is only weakly fluorescent in aqueous buffer, but its emission intensity greatly 
increases upon binding to Aβ or other amyloid fibrils (Nesterov 2005, Brandenburg 2012).  
Purified β protein fibrils bound all three tested amyloid sensors: Thioflavin T, NIAD-4, and Congo Red.  
  
β protein fibrils assembled after dilution from denaturant into physiological buffer (150 mM KCl, 
0.5 mM MgCl2, 25 mM HEPES, pH 7.5) for 24 h showed an increase in Thioflavin T fluorescence. The 
intensities of Thioflavin T fluorescence correlated to the cellular toxicity of the β proteins: β23 
showed the highest toxicity and Thioflavin T fluorescence, followed by β17 and β4.  
Under equal conditions, NIAD-4 bound to fibrils of the three β proteins, resulting in a similar increase 
in fluorescence from β4 over β17 to β23. Both fluorescent dyes bound the β proteins in a gradual 
manner, reflecting their toxic impact on living cells.  
-2
0
2
4
6
8
10
12
14
16
18
20
460 470 480 490 500 510 520 530 540
Re
l. 
flu
or
es
ce
nc
e 
(a
.u
.)
Wavelength (nm)
β4
β17
β23
αS824
Figure 37 | Thioflavin T 
fluorescence upon binding to 
β proteins or αS824. The 
fluorescence intensity 
significantly increases in 
presence of preformed 
β protein fibrils (refolded 
from guanidine), correlating 
to the toxicity of the 
β proteins. 3 µM of 
monomeric protein were 
diluted in physiological buffer 
with 20 µM Thioflavin T. 
Representative spectra of at 
least 4 experiments are 
shown. Thioflavin T 
background fluorescence was 
subtracted. 
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The α-helical protein αS824 showed only a marginal increase in Thioflavin T and NIAD-4 fluorescence, 
most likely due to unspecific low-level binding. In addition, equal mass concentrations of BSA and 
Maltose binding protein (MBP) were tested for their NIAD-4 binding. They showed an even lower 
fluorescence than αS824.  
Congo Red was also bound by the three β proteins. The binding leads to an increased absorbance at 
535 nm and to a small redshift of the absorbance maximum from 490 nm towards ~500 nm in 
comparison to Congo Red in physiological buffer solution. This behavior is characteristic for Congo 
Red binding to amyloid fibrils, as shown for e.g. lysozyme fibrils (Krebs 2000). Differences between 
the three β proteins were hardly visible. αS824 displayed no redshift and no increase in absorbance. 
Its absorbance at the 490 nm maximum was even a bit lowered.  
The amyloid-like structures of the β proteins were specifically recognized by the amyloid sensors 
Congo Red, Thioflavin T, and NIAD-4. Amyloid sensor binding correlated very well with the cellular 
toxicity of the β proteins. More knowledge about structural details of the dye binding sites may 
promise clearer insights into the hazardous potential of distinct amyloid conformations.  
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Figure 38 |NIAD-4 fluorescence upon binding to β proteins, αS824, BSA, or MBP. The NIAD-4 fluorescence increases strongly 
in presence of preformed β protein fibrils (refolded from guanidine), correlating to their toxicity. 3 µM of monomeric protein 
with 1 µM NIAD-4 were diluted in physiological buffer (25 mM HEPES, 150 mM KCl, 0.5 mM MgCl2, pH7.5). Representative 
spectra of at least 4 experiments are shown.  
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β proteins contain hydrophobic  surface patches – in correlation with toxicity 
ANS (8-Anilino-1-naphthalenesulfonic acid) is a fluorescent dye that was originally found to bind to 
non-polar environments on apomyoglobin (but not to myoglobin or hemoglobin), giving rise to a 
huge fluorescence blueshift in comparison to the dye in a polar or aqueous surrounding (Stryer 
1965). Since then, ANS was used in protein folding studies to characterize individual steps of protein 
folding, leading in general to an initial rise followed by rapid decline of ANS fluorescence. Rise and 
decline correspond to the formation of hydrophobic patches on molten globule states and the later 
burial of such hydrophobic patches in the core of a protein. Proteins with hydrophobic patches on 
their folded structure, as they are characteristic for interaction surfaces, retain their ability to bind 
ANS to some degree.  
The β proteins were tested for their ability to bind ANS after refolding from denaturant in a 
physiological buffer in equilibrium. All three β proteins show a significantly higher ANS fluorescence 
than control proteins, such as αS824, or maltose-binding protein (MBP wildtype).  
ANS binding correlated with the cytotoxicity of the β proteins. Similarly, the ANS fluorescence 
maximum exhibited a stronger blueshift for the more toxic β sequences, indicating an environment 
of higher hydrophobicity. The fluorescence maxima of αS824 and MBP of around 525 nm correspond 
approximately to the fluorescence maximum of ANS in water, demonstrating that these proteins are 
fully folded exposing a polar surface. The fluorescence maximum of ANS in presence of the β proteins 
is strongly blueshifted. The fluorescence maximum at 472 nm for β23 is comparable to an ANS 
spectrum in an organic solvent, such as DMSO (Hawe 2008), or ANS bound to misfolded protein 
structures.  
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Figure 39 | Congo Red 
absorption in presence of 
β proteins and αS824. 10 µM 
of β proteins were refolded 
from 8 M guanidine into 
physiological buffer with 7 µM 
Congo Red. Binding of Congo 
Red to the β protein fibrils can 
be recognized by an increased 
absorbance around 535 nm 
(arrow). Representative spectra 
of 3 experiments are shown. 
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Electrostatic attractions of ANS to the β proteins are not expected, since ANS and the three 
β proteins are negatively charged, β23 containing the highest negative net charge of -13. Beyond 
amyloid sensor binding (Thioflavin T, NIAD-4), the steadily accessible hydrophobic surfaces on the 
refolded β protein aggregates correlate to their toxicity and may constitute one of its major sources.   
β proteins refold rapidly and spontaneously – with highly similar kinetics  
ANS and Thioflavin T can be used to follow the kinetics of refolding and aggregation of the β proteins 
after dilution from the unfolded state in denaturant into a physiological buffer. The fluorescent 
sensors bind the assembling structures during the formation of accessible hydrophobic patches or 
the creation of amyloid binding sites.  
The three β proteins aggregated very rapidly. The Thioflavin T fluorescence rose instantly upon 
dilution of the β proteins from denaturant (8 M guanidinium). The kinetics of Thioflavin T binding 
were highly comparable among all three β proteins. Already after two minutes of refolding, the 
Thioflavin T signal reached 90% of its final intensity. Initial lag phases could not be observed.  
Figure 40 | ANS fluorescence upon binding to β proteins, αS824, MBP wildtype, or in physiological buffer. The 
fluorescence intensity significantly increased in presence of preformed β protein fibrils (refolded from guanidine), and the 
fluorescence maximum shifts towards shorter wavelength. In presence of αS824 or MBP, the ANS fluorescence changes 
only marginally. 3 µM of monomeric proteins were diluted in physiological buffer (25 mM HEPES, 150 mM KCl, 0.5 mM
MgCl2, pH7.5) containing 20 µM ANS. Representative spectra of at least 4 experiments are shown. 
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However, the relative intensity of Thioflavin T binding varied in correlation with cytotoxicity, as 
described above. αS824 did not show any changes in fluorescence over time.  
Kinetics of refolding and aggregation of the β proteins were furthermore monitored by ANS 
fluorescence. The formation of surface accessible hydrophobic patches rose exponentially within the 
first seconds of refolding. ANS fluorescence appeared even slightly faster than Thioflavin T binding.  
Most likely, ANS bound already to monomers or small oligomers during or after refolding.  
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Figure 41 | Thioflavin T binding 
kinetics of β proteins refolding 
from guanidine assemble within 
minutes into amyloid-like fibrils. 
20 µM of β proteins were diluted
from 8 M guanidine into
physiological buffer (150 mM KCl, 
0.5 mM MgCl2, 25 mM HEPES, 
pH 7.5). For comparison, αS824 is 
shown (diluted from folded 
state). Representative kinetics of 
at least 4 experiments are shown. 
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Figure 42 | ANS binding 
kinetics of β proteins, 
rhodanese, and MBP double 
mutant refolding from 
guanidine. 20 µM of β proteins 
or equal amounts (w/w) of 
rhodanese or MBP double 
mutant were diluted from 8 M 
guanidine into 10 mM 
potassium phosphate, pH 6.0 
(same conditions as for electron 
microscopy, second condition).  
The ANS fluorescence of the 
slowly folding MBP double 
mutant decreased further to 
lower values over time. All 
other proteins almost reached 
their equilibrium. For 
comparison, αS824 is shown 
(diluted from folded state).
Representative kinetics of at 
least 3 repetitions are shown. 
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Unlike for most native cellular proteins, the ANS fluorescence did not decrease during refolding after 
an initial burst, but remained persistently high in steady state. Hydrophobic patches therefore 
appeared during refolding and fibril assembly of the β proteins. The hydrophobicity did not fully 
become buried inside of the structures, but remained exposed on the surface of the assembled fibrils 
(Lindgren 2005). Hydrophobic exposure has been shown to be a characteristic determinant of toxicity 
on protein oligomers, especially in combination with structural flexibility (HypF-N oligomers; 
Campioni 2010).  
A very slowly refolding double mutant of the maltose binding protein (MBP DM) and the GroEL 
dependent rhodanese were diluted from 8 M guanidine into physiological buffer in absence of 
chaperonins (required for rapid native refolding of these proteins). ANS fluorescence of these 
“misfolded conformations” of natural proteins was similar to β4 and β17, clearly exceled by the ANS 
fluorescence of β23. Equal masses of proteins were applied for these experiments. High fluorescence 
intensities and strong fluorescence blueshift, both properties demonstrate the high surface 
hydrophobicity of the β proteins (Figure 42).  
Most aggregation prone proteins show an initial lag phase (nucleation) before they start to aggregate 
exponentially. During nucleation, a protein refolds from its native into a misfolded structure, which 
can happen either spontaneously or through interactions with e.g. other misfolded monomers. If this 
conformation is stable enough to persist, it may recruit more molecules into the thereby growing 
fibrils (Hortschansky 2005). Overall, sigmoidal aggregation kinetics finally become stationary, when 
the growth of fibrils saturates.   
This nucleation time appears to be absent for the β proteins, which likely assemble directly from 
their unfolded state into rapidly growing fibrils. Such a behavior seems plausible, since the artificial 
β proteins were not designed to fold into any native structure distinct from the β-sheet 
conformation. Moreover, they are of very small size, and thus rapidly fold into an amyloid-like 
β-sheet conformation. This creates a high concentration of “monomeric building blocks” that can 
immediately assemble into fibrils. A distinct “native state” as a form of kinetic trap, delaying the way 
to aggregation, does not exist (see discussion). 
Transmission electron micrographs of β17 and β23 were taken to achieve a better insight into fibril 
structures forming shortly after refolding from denaturant. Already after 5 min, short fibrils were 
visible. They continued to grow over the hours. In case of β23, small oligomers were visible after 
5 min, and they remained present in equilibrium with the growing fibrils (Figure 32).  
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ANS, Thioflavin T, and NIAD-4 differentiate between monomers, oligomers, and 
fibrils 
Formation of hydrophobic surface patches occurred even more rapidly than fibril formation (ANS vs. 
NIAD-4 or Thioflavin T kinetics), saturating in a multi-sigmoidal curve after 120 sec of refolding. ANS 
fluorescence kinetic curves were composed of two or more sigmoidal processes (Figure 43). The 
underlying reactions started together with the dilution of the β proteins from denaturant, but 
processed with different rates. Initial hydrophobic patches were presumably already forming on 
transient monomeric folding intermediates, giving rise to the first burst of ANS fluorescence 
(phase 1, refolding monomers, very fast rate, and early saturation). Conformational rearrangements 
caused a partial coverage of hydrophobic surfaces on the oligomerization sites, which is reflected in a 
slower second (and potentially third?) phase of ANS fluorescence (phase2, oligomerization and/or 
fibril growth, slower rate, later saturation; see bi-logistic growth, Meyer 1994).  
Similar to ANS, Thioflavin T fluorescence kinetics of refolding β23 deviated from a single logarithmic 
fit. The kinetics initially rose faster than expected, but saturated within 5 min. Thioflavin T is most 
likely not completely specific for amyloid fibrils, but also binds to intermediate oligomeric species or 
short protofibrils of high β-sheet content. These structures subsequently mainly fuse to form longer, 
mature fibrils, which is then not reflected in a fluorescent change any more (saturated signal).  
The NIAD-4 fluorescence is contrarily very well described by a single logarithmic function. There was 
no initial signal “overshoot”, and the fluorescence did never completely saturate, but continued to 
increase. This behavior indicates that NIAD-4 may be the most specific amyloid fibril sensor here, 
binding neither to monomers nor to early oligomerization intermediates. NIAD-4 fluorescence 
therefore increased with the maturation of fibrils over hours.  
The β proteins therefore behaved overall very similar to native proteins in the process of amyloid-like 
misfolding and aggregation. A very rapid nucleation phase, originating from a direct folding into the 
building blocks of oligomerization, is followed by exponential fibril growth. Eventually, fibril 
maturation processes over hours and days by growth and association of preformed (proto-)fibrils, 
which results in precipitating high-molecular-weight fibers (Dobson 2003).  
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Figure 43 | Refolding and aggregation kinetics of β23 diluted from denaturant (8M guanidine), observed by ANS, NIAD-4, 
and Thioflavin T binding. (A) Single logarithmic fit (black dashed curve) on the fluorescence of NIAD-4, binding to refolding 
β23. (B) Single logarithmic fits (black dashed curves) on the fluorescence of ANS and Thioflavin T, binding to refolding β23. 
In contrast to NIAD-4, the fluorescence of ANS and Thioflavin T initially rose faster than a single logarithm, but then 
remained constant (deviations within red dashed areas). (C) Residuals describing the deviation of the single logarithmic fits 
from the experimental fluorescence data. Whereas NIAD-4 residuals distribute evenly around zero (green, like noise), ANS 
and Thioflavin T residuals initially rose for ~2 min and then declined continuingly. Supposedly, the two dyes bound to 
refolding intermediates (monomers, oligomers), whereas NIAD-4 only recognized the β protein fibrils. (D) Theoretical 
“diverting bi-sigmoidal curve”, describing two sigmoidal processes beginning at the same time, but growing with different 
rates (such as refolding and fibrilization; top graph). “It is noteworthy that [diverting bi-sigmoidal curves] are S-shaped but 
asymmetric. They do not ‘look logistic’” (figure adapted from Meyer 1994). Since nucleation happened very fast for 
refolding β proteins, only the second part of the curve (dashed square in bottom graph) could be observed in (A) and (B).  
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β proteins bind anti-amyloid oligomer (A11) antibody 
The A11 anti-oligomer antibody was raised against a molecular mimic of soluble Aβ oligomers. 
Moreover, A11 recognizes oligomeric species from different neurodegenerative disease proteins, 
most likely forming a common epitope independent of specific sequences (Kayed 2003, Kayed 2006). 
In an earlier attempt, cell extracts prepared from HEK293T cells expressing β proteins were 
separated by gel filtration. The individual fractions showed an A11 reactivity overlapping with the 
anti-c-Myc recognition of the β proteins (Olzscha 2011). Here, equal amounts of purified β proteins 
were refolded in a physiological solution, directly blotted on a nitrocellulose membrane, and tested 
for their A11 reactivity. A11 recognized all three β proteins, as in case of the cellular lysates. 
Quantitatively there was no significant difference. αS824 showed minor A11 binding, which was not 
visible for MBP or BSA.  
 
 
Purified and refolded β proteins formed oligomeric species that are recognized by A11 in vitro. 
However, the equilibrium amount of different oligomeric species (monomers, small oligomers, 
aggregates) assembling in vivo and from purified protein in vitro may differ to some degree, as in vivo 
cellular factors likely influence or participate in oligomer formation. A11 indicated the presence of 
epitopes common to oligomeric forms of neurodegenerative disease proteins on all three β proteins, 
despite the absence of visible spherical oligomers on the electron microscopic recordings. However, 
A11 epitopes might also be present on the surface or the termini of shorter (proto-)fibrils.  
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Figure 44 | A11 anti-oligomer antibody reactivity of β proteins, purified αS824, MBP or BSA in vitro. (A) Native dot blot of 
β proteins (purified and refolded in physiological buffer), αS824, MPB and BSA. The proteins were directly blotted on 
nitrocellulose membranes tested for A11 reactivity. All three β proteins were recognized by A11. αS824 showed some 
minor, MPB and BSA did not show any A11 reactivity. (B) Quantification of A11 reactivity for the β proteins, normalized to 
the amount of protein blotted, as determined by the c-Myc antibody signal intensity (not shown here, equal amounts were 
blotted). There was no significant difference in A11 reactivity between the three β proteins in vitro.  
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β proteins interact directly with Hsp110 – quantitatively correlating with toxicity 
Hsp110, a heat shock protein structural related to and collaborating with Hsp70 (Polier 2008), was 
found to interact and to colocalize with all three β proteins in cells (Olzscha 2011). Overexpression of 
Hsp110 partially rescued the toxicity of β proteins in HEK293T cells (Olzscha 2011). A direct molecular 
interaction of Hsp110 and the β proteins was not shown so far.  
Equal amounts of purified β proteins and αS824 were incubated with anti-c-Myc antibodies coupled 
to magnetic beads in a physiological buffer including 0.5% BSA, blocking unspecific interactions. After 
washing away unbound β proteins, the beads were incubated with equal amounts of purified 
Hsp110, followed by intense washing. Bound proteins were eluted under denaturing conditions (SDS) 
and analyzed by SDS-PAGE and immunoblotting.  
 
A quantitative analysis of the eluate revealed that Hsp110 bound to β proteins in vitro in correlation 
to their toxicity. β23 bound 5 times more Hsp110 than equal amounts of β4, and 2 times more 
Hsp110 than equal amounts of β17. The data indicates a potential direct interaction between the 
β proteins and Hsp110 alone. Possibly, additional cellular factors (such as Hsp70 or other 
cochaperones) may further increase the interaction or render it functional towards a structural 
modification or disaggregation, which could not be observed under the applied in vitro conditions 
here.  
Meanwhile, Hsp110 was found to engage in disaggregation of misfolded substrates (luciferase and 
GFP), together with Hsp70/Hsp40, and independent of the AAA+ ATPase p97. Hsp110 was found to 
hydrolyze ATP, and to promote nucleotide exchange on Hsp70 for promoting disaggregation of 
disordered aggregates, though failing in case of amyloid forms of α-synuclein or the yeast prion 
protein Sup35 (Shorter 2011). Furthermore, human cytoplasmic Hsp110 ATP-dependently refolded 
misfolded luciferase in vitro in the absence of Hsp70, but together with Hsp40, demonstrating an 
own ATP-dependent chaperone function of Hsp110 (Mattoo 2013). Cofactors such as Hsp40s and 
Hsp70s might still enhance a disaggregation function of Hsp110 in cells.   
Figure 45 | Analytical affinity chromatography of Hsp110 by β proteins bound to anti-c-Myc antibodies coupled to 
magnetic beads. (A) Purified β proteins or αS824 (input) binding to magnetic anti-c-Myc beads were incubated with Hsp110 
(input). Proteins eluted from the beads were separated (eluat) by gradient SDS PAGE stained with Coomassie Brilliant Blue. 
(B) For quantification, input and eluat were immunoblotted and labeled with anti-Hsp110 antibodies. (C) Quantification of 
Hsp110 binding to the β proteins from (B). Result from three independent experiments. Background binding (control) was 
substracted, Hsp110 binding was normalized to the amount of β protein in the eluat (anti-c-Myc signal).  
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Purified β proteins are cytotoxic on addition to human cells 
Similar to prion proteins, misfolded protein structures might be released e.g. through exocytosis or 
during cell death and be distributed locally, over organs or the human body. Misfolded structures 
may damage cells from the extracellular site, or they may become internalized again, with the 
potential of propagating their detrimental effects. Large Aβ deposits accumulate mainly in the 
extraneuronal space, but their role in the pathogenesis of Alzheimer’s disease remains still unclear.   
To analyze these phenomena, purified β proteins were added into the culture medium of HEK293T 
cells to study their toxicity on cells from the extracellular side. β proteins were refolded from 
guanidine and assembled into oligomers and fibrils (non-precipitating at these concentrations). 
Added to the culture medium, the β proteins did not show any detrimental impact on cell survival 
(tested in different concentrations, with or without fetal bovine serum in the culture medium).  
Interestingly, toxicity appeared after sonication of the refolded β protein oligomers. The samples 
were sonicated in a physiological buffer solution for a few seconds with a tip sonicator. Directly 
afterwards, the β proteins were diluted into culture medium, which was then added to HEK293T 
cells. Here, the β proteins had a concentration dependent toxic impact, as determined by MTT assay 
(see below). Toxicity was even observed at very low concentrations (β23 at 20 nM).  
 
 
 
 
Sonication most likely brakes down aggregates into smaller particles and exposes previously buried 
hydrophobicity to the surface. As we see below, the β proteins indeed converted into conformations 
with increased surface hydrophobicity. 
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Figure 46 | Viability of HEK293T cells treated 
with purified and in vitro refolded β proteins. 
The viability of HEK293T cells after treatment 
with different concentrations of β23 for 24 h 
was determined based on MTT reduction. In 
one set (red), the β proteins were treated for 
5 sec with a tip sonicator in physiological buffer, 
before diluting them into culture medium that 
was added to the cells. Averages and SD from 3 
experiments. 
 66  ∙  Results 
Sonicated β proteins are more hydrophobic  
To examine structural changes before and after sonication, equal concentrations of purified 
β proteins, refolded from guanidine, were compared regarding their ability to bind ANS. For all three 
β proteins, the intensity of ANS fluorescence doubled after sonication, indicating that their exposed 
hydrophobic surfaces increased strongly. Increased surface hydrophobicity likely appeared due to a 
fragmentation of particles into smaller oligomers. Additionally, conformational changes may expose 
hydrophobic residues previously buried within preformed aggregate structures in equilibrium.  
 
 
The purified β proteins shown to be toxic in the medium on HEK293T cells exposed an increased 
hydrophobicity on their surface and presumably decreased in average molecular weight. Such 
conformations might be more reactive on cells, coming into contact with membrane proteins or the 
lipid bilayer. Whether the β proteins were able to cross the bilayer directly or by endocytosis and to 
reach the cellular interior is an interesting question worthwhile to study. However, HEK293T cells 
were rather resistant towards preassembled (non-sonicated) β protein aggregates, which did not to 
cause immediate toxicity on cultures. 
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Figure 47 | Hydrophobic surface patches of β protein aggregates increase after sonication. ANS spectra of purified and 
refolded β proteins, before (continuous spectra) and after (dashed spectra) sonication with a tip sonicator in physiological 
buffer solution. 
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Extracellular β proteins induce neurotoxic signaling by the cellular prion protein  
In a different attempt, cells became sensitized towards extracellular β proteins and other amyloid 
structures (such as Aβ and the infectious prion proteins PrPSc and Sup35) by overexpression of the 
cellular prion protein (PrPC). As an integral membrane receptor, PrPC might be a critical cellular target 
of extracellular misfolding and aggregation and an important signaling factor initiating cellular 
responses.  
The experiments with extracellular oligomeric and fibrillary β proteins on cells overexpressing 
membrane anchored PrPC were mainly planned and accomplished by Dr. Ulrike K. Resenberger and 
Prof. Dr. Jörg Tatzelt (at the Adolf-Butenandt-Institute, Ludwig-Maximilians-University Munich, 
Germany, now Ruhr-Universität Bochum, Germany). 
SH-SY5Y cells expressing GPI anchored PrPC were treated with 200 nM β proteins (β17) or αS824 in 
the medium for 12 h. Only the (here non-sonicated) β proteins caused an increase in cell death.  
Beyond the β proteins, PrPC mediated toxic signaling of homologous and heterologous PrPSc, 
oligomeric but not high-molecular-weight forms of Aβ (secreted from co-cultured CHO-7PA2 cells 
stably expressing Aβ V717F), as well as β-sheet rich conformers of the yeast prion protein Sup35 
(prepared as β-sheet rich low-molecular-weight oligomers formed by the middle and N-terminal 
region; Resenberger 2011). PrPC therefore recognized and responded to very different amyloid and 
prion proteins, suggesting common structural features determine a binding site on PrPC for activation 
(Resenberger 2011). For mediating toxic effects, both the intrinsically disordered N-terminal domain 
and the C-terminal GPI anchor of PrPC were required (Resenberger 2011).  
The toxic signaling by the cellular prion protein was inhibited by expressing a secreted soluble version 
of the intrinsically disordered N-terminal domain of PrP devoid of the GPI anchor. Co-
immunoprecipitation demonstrated an efficient capturing of extracellular β proteins by secreted N-
terminal PrP domains (fused to Fc portions of human IgG1 allowed expression and secretion of the 
construct in SH-SY5Y cells). Expression and secretion of these soluble PrP constructs reduced toxic 
signaling of extracellular β proteins (50 nM) or Aβ (Resenberger 2011). 
In primary cortical neurons, the purified β proteins only caused toxicity in cultures isolated from 
PrP+/+, not from knockout mice (PrP0/0). The β proteins were added on day 4 and 5 at 2 or 5 µM, and 
the neurons were fixed at day 6. Cellular growth and morphology was examined by 
immunofluorescence using an anti-β3 tubulin antibody. The β proteins caused significant dendritic 
damage and neuronal loss in PrP+/+ neurons, while no toxicity occurred in neuronal cultures from 
PrP0/0 mice (Resenberger 2011). 
Toxic signaling of the β proteins or Aβ could moreover be reduced by the A11 antibody, recognizing 
and binding toxic oligomers in the medium of SH-SY5Y cells. Furthermore, pre-treatment of cells with 
the NMDA receptor antagonist memantine reduced the toxic signaling, as NMDA receptor and PrPC 
signaling interfere with each other regarding excitotoxicity and neurotoxic signaling (Khosravani 
2008, Ondrejcak 2010, Resenberger 2011). These experiments revealed that the β proteins – in an 
equivalent way to natural amyloid and prion proteins – were able to induce a cellular response in 
form of neurotoxic PrP signaling. PrPC sensitized cells toward neurotoxic signaling independently 
from its own misfolding and prion replication (Resenberger 2011). Neurotoxic PrP signaling initiated 
by extracellular protein aggregation demonstrated that the presence of signaling pathways enables 
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cells to respond to local misfolding e.g. by apoptosis. Induced cell death may prevent further 
“infection” and distribution of misfolded proteins in an attempt of local restriction of aggregate 
burdens.  
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Figure 48 | The cellular prion protein (PrP
C
) mediates neurotoxic signaling induced by β proteins, amyloid beta (Aβ), and 
prion proteins. (A) Extracellular β proteins (here namend β-peptides, 200 nM) cause neurotoxic signaling and induce 
apoptosis, but only in cells expressing the membrane bound cellular prion protein PrPC (full length). Deleting the 
intrinsically disordered N-terminal domain or the C-terminal GPI anchor abolished apoptosis induction. (B) β proteins 
caused neuronal toxicity and cell death only in PrP +/+ neurons , whereas PrP0/0 neurons were resistant. (C) Putative model 
of neurotoxic signaling induced by oligomeric amyloid structures via PrPC. β-sheet rich structures of misfolded proteins bind 
to PrPC sitting in the plasma membrane. Neurotoxic signaling can be inhibited by trapping misfolded structures by e.g. A11 
antibodies or soluble PrP domains in the extracellular environment, or by signaling of the NMDA receptor antagonist 
memantine. Different intracellular factors might be involved in transmitting neurotoxic signals inside of cells, finally 
influencing apoptotic pathways (Resenberger 2011).  
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β proteins are highly toxic in the human cytoplasm 
The c-Myc labeled β proteins were expressed in HEK293T cells for three days, where they exhibit a 
gradual toxicity (Olzscha 2010, Olzscha 2011).  
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is a water soluble dye that 
readily enters the cells across the membranes and becomes reduced by cellular enzymes. Thereby 
MTT changes its color and fluorescence properties (Mosmann 1983, Shearman 1995). Reduced MTT 
in a colorimetric cell survival assay reflects the redox state of a cell population. It depends on the 
cellular reduction potential (NADH content and cellular oxidoreductases), including the number of 
cells in a population.  
Viability was increasingly reduced for HEK293T cells expressing β4, β17, or β23; the soluble αS824 
protein was not toxic (Olzscha 2011). The relative cytotoxicity of the three β proteins is equal to that 
observed in E. coli cells (growth inhibition). The sequence-dependent proteotoxicity of the β proteins 
was therefore independent from the species being affected. 
 
β proteins are highly toxic in the cytoplasm, and less toxic in the nucleus 
Mammalian cytoplasm and nucleus strongly differ in their basic proteostasis machineries, including 
their chaperone content and degradation systems (Nielsen 2014). During cellular stress, many 
components of the proteostasis machineries are specifically expressed and become localized to 
distinct cellular sites. For example, chaperones are increasingly imported into the mammalian 
nucleus (Miyamoto 2014, Kose 2012, Park SH 2013). Many human neurodegenerative disease 
proteins form insoluble inclusions in the cytoplasm (tau, TDP-43, α-synuclein), whereas especially 
fragments of polyglutamine repeat proteins accumulate in the nucleus, or spread between both 
compartments (huntingtin, ataxin; Soto 2003, Woulfe 2007, Miller 2011).  
To examine how different compartments handle misfolded protein structures and to reveal 
compartment-specific vulnerabilities towards protein aggregation, we fused β proteins to nuclear 
export signals (NES) and nuclear localization sequences (NLS). We expressed these constructs in 
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Figure 49 | Viability of HEK293T cells 
expressing β proteins or αS824, 
compared to cells transfected with 
empty plasmid backbones. The β proteins 
affect the cellular viability in a sequence 
dependent manner. Cytotoxicity rose 
from weak (β4) over intermediate (β17) to 
strong (β23). Cells expressing the soluble 
αS824 showed no toxicity. Cellular 
viability was determined by the cellular 
capability of reducing MTT. Averages and 
SD from at least 5 independent 
experiments (compare to Olzscha 2011). 
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HEK293T cells, utilizing cellular transport systems to direct the β proteins to cytoplasm or nucleus, 
respectively. Toxicities of cells expressing these β proteins for 3 days were determined by MTT 
assays. Expressing the β proteins targeted to the cytoplasm resulted in toxicities comparable to 
β proteins carrying no localization sequence, which were distributed over cytoplasm and nucleus. 
Surprisingly, all β proteins directed to the nucleus showed a significantly lowered cytotoxicity. The 
relative, sequence-dependent toxicities among the β proteins were maintained for the constructs 
targeted to distinct compartments (β4<β17<β23). 
 
 
Cellular targeting sequences fused to the β proteins might alter their biophysical properties, and 
thereby influence their conformations and behavior in cells. Therefore, we introduced a point 
mutation within the nuclear targeting signal. NLS-β23(K7T, K15T) carries two single K to T mutation 
within the NLS repeat (DPKKKRKV mutated to DPKTKRKV), which renders nuclear localization 
inefficient (Kalderon 1984, Makkerh 1996, Hodel 2001). Thus, aggregates of NLS-β23(K7T, K15T) were 
distributed over cytoplasm and nucleus, similar to β23, despite of the additional N-terminal tag. The 
toxicity rose again to levels comparable to non-targeted or cytoplasmic β proteins. It seems therefore 
unlikely that the addition of the NLS itself was mainly responsible for the observed decrease in 
toxicity. 
 
Figure 50 | Viability of HEK293T cells expressing β proteins directed to cytoplasm (NES) or nucleus (NLS) in comparison to 
cells transfected with the non-targeted β proteins (c-Myc tag only), different versions of αS824, or empty plasmid 
backbones (control). Surprisingly, the detrimental impact of the β proteins as misfolding model proteins was strongly 
decreased for all β proteins targeted to the nucleus. The toxicity of cytoplasmic β proteins remained at a high level similar 
to the original, non-targeted β proteins distributing over cytoplasm and nucleus. Cells expressing different versions of 
αS824 showed no significant toxicity. Cellular viability was determined by the cellular capability of reducing MTT. Averages 
and SD from at least 4 independent experiments. Significances according to Students T-test.  
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β protein-EGFP fusions remain toxic 
The β proteins were fused via a flexible 16 amino acids long linker sequence (TSGSAASAAGAGEAAA; 
Chang 2005) N-terminal to EGFP, enabling e.g. fluorescent life-cell imaging applications. MTT assays 
demonstrated toxicities comparable to constructs lacking EGFP, indicating that the toxic function of 
the β proteins was essentially retained after fusion to the soluble fluorescent protein.  
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Figure 51 | Viability of NLS-β23(K7T, K15T), 
carrying an inefficient NLS, in comparison to 
different β23 variants. NLS-β23(K7T, K15T) 
carries a point mutation in each of its two 
SV40 derived NLS repeats. The protein 
aggregates in cytoplasm and nucleus 
simultaneously. Toxicity was found to be 
comparable to β23 and NES-β23 (MTT assay).
Averages and SD from at least 3 independent 
experiments. 
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Figure 52 | Viability of HEK293T cells 
expressing c-Myc tagged β protein-EGFP 
fusions in comparison to cells transfected 
with αS824-EGFP or empty plasmid 
backbones. Toxicities are highly comparable 
to the β proteins lacking EGFP, indicating a 
dominant effect of the β sequences 
regarding their toxic functions. Cellular 
viability was determined by the cellular 
capability of reducing MTT. Averages and SD 
from 3 independent experiments. 
Significances according to Students T-test. 
* 
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Nuclear β protein levels are slightly higher than cytoplasmic 
Toxicity occurs usually in a concentration dependent manner. Expression levels of the cytoplasmic 
and nuclear β proteins were detected by immunoblotting against the N-terminal c-Myc epitope. Cell 
lysates were by separated by SDS-PAGE and blotted on Nitrocellulose or PVDF membranes. The two 
types of membrane non-covalently bind proteins due to different physical properties (electrostatic 
and hydrophobic interactions, respectively) and show different binding capacities. Binding affinities 
can therefore vary for the different β protein sequences. 
The cellular levels of the β proteins targeted to the cytoplasm were slightly highly comparable to the 
non-targeted β proteins and showed in generel an inverse correlation to cytotoxicity – with lowest 
protein levels for β23 and NES-β23.  
Nuclear β proteins, however, were expressed at higher cellular levels. Thus, the decreased toxicity of 
nuclear β proteins was not caused by decreased β proteins levels. Under equal β protein 
concentrations, the toxic impact of cytoplasmic β proteins may even be higher than observed under 
the given conditions.  
 
 
 
 
  
Figure 53 | β protein levels detected by immunoblotting with anti-c-Myc antibodies. Levels of non-targeted β proteins 
(only c-Myc tagged) and β proteins targeted to the cytoplasm (NES/c-Myc) showed comparable protein levels. The 
β proteins reached slightly higher levels in the nucleus (NLS/c-Myc), as observed on nitrocellulose and PVDF membranes.  
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Diverse cytoplasmic aggregates distort the nuclear pore complex 
In HEK293T cells, β proteins targeted to the cytoplasm or nucleus were expressed for 24 h. Cells were 
fixed and stained for the β proteins by anti-c-Myc antibodies. To discriminate the localization and 
aggregation behavior of the β proteins, cells were additionally stained for nuclear pore complex 
(NPC) proteins. Therefore, an antibody recognizing FG-repeat domains in nucleoporins (such as 
Nup62, Nup152, or Nup90) residing within the nuclear envelope was applied. The nuclear DNA was 
stained by DAPI (4',6-diamidino-2-phenylindole). Cells expressing NES-β proteins directed to the 
cytoplasm formed large perinuclear inclusions, mostly of spherical shape, which were accompanied 
by β proteins distributed over the whole cytoplasm. NLS-β proteins targeted to the nucleus formed 
several intranuclear inclusions of rather asymmetric shapes. In addition, tiny punctuated aggregates 
were visible around the inner side of the nuclear envelope.  
To assess our analyses on the designed β proteins, we utilized several human proteins associated to 
neurodegenerative diseases for comparison: c-Myc tagged, polyglutamine expanded Huntingtin exon 
1 (Htt96Q), forming mostly cytoplasmic, aggresome-like inclusions (Schaffar 2004); TDP-43 fragment 
4 EGFP (TDP-F4), driving the coaggregation of endogenous full-length TDP-43 into cytoplasmic 
aggregates similar to the disease case in ALS/FTLD patients (Pesiridis 2009, Yang 2014); and a Parkin 
mutant lacking Parkins last 13 amino acids, causing the mutant to aggregate in the cytoplasm 
(Winklhofer 2003). The specified aggregate locations reflect the situation in neurons of human 
patients. Fragments of polyglutamine-expanded huntingtin, however, accumulates in nuclear 
inclusions in co-occurrence with cytoplasmic aggregates. The relative distribution depends on cell 
types, polyglutamine extension length, organism, and age (Hackam 1999 1/2, DiFiglia 1997, Woulfe 
2007, Miller 2011, and others).  
The large perinuclear β protein aggregates in the cytoplasm were co-stained by the antibodies 
against nuclear pore proteins. Thus, FG-repeat proteins that usually reside at the nuclear pores were 
recruited into the cytoplasmic β protein aggregates. At the same time, the fluorescence intensity 
around the nuclear envelope decreased, indicating a real local loss of NPC proteins. The shape of the 
nucleus was often irregular, and the chromatin structure appeared rather disturbed 
(inhomogeneous, speckled DAPI staining). β proteins aggregates were not found at the nuclear 
pores, where they likewise could interact with FG-repeat proteins (e.g. due to their similar polar-
hydrophobic side-chain pattern) or become stuck during transport in or out of the nucleus.  
Strikingly, also the human disease related proteins distorted NPCs, especially Htt96Q and TDP-F4 (see 
also Liu 2015). NPC protein aggregates appeared in the cytoplasm often separated from the 
transgenic proteins (in contrast to the coaggregation with cytoplasmic β proteins). Again, the 
fluorescence intensity around the nuclear envelope decreased in cells expressing cytoplasmic, 
disease-associated proteins. 
Contrary to proteins aggregating in the cytoplasm, β proteins directed to the nucleus did neither 
interfere with NPC structures, nor disturb the distribution of nuclear DNA (DAPI staining). Cellular 
and nuclear morphology were well preserved. The DNA was distributed homogenously within the 
nuclear matrix (surrounding nucleoli and β protein aggregates), apparently highly similar to wildtype 
cells. Low toxicity was accompanied by a healthy morphology in absence of any NPC protein 
coaggregation. 
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Figure 54 | HEK293T cells 
expressing β proteins or αS824 
targeted to cytoplasm or nucleus, 
Htt96Q, TDP-F4, or ParkinΔC (red) 
were immunolabeled with 
antibodies recognizing FG-repeat 
proteins of the NPC (green) 24 h 
after transfection. In control cells 
transfected with empty vectors, 
the signal of the nuclear pore 
proteins encircles the nuclear 
envelope, indicating the border 
between cytoplasm and nucleus. 
DAPI binds nuclear DNA and stains 
the nuclear matrix, surrounding 
the protein-dense nucleoli (blue). 
Cells transiently transfected with 
β proteins targeted to the 
cytoplasm (NES) formed β protein 
aggregates outside of the nucleus. 
Perinuclear aggregates 
occasionally appeared to penetrate 
the nuclear envelope from the 
cytoplasmic side, but remained 
cytoplasmic. Nuclear pore proteins 
became recruited into cytoplasmic 
β protein aggregates. Nuclei were 
often shaped irregularly, and the 
intranuclear distribution of DNA 
was rather inhomogeneous (DAPI). 
Cells expressing β proteins directed 
to the nucleus formed several 
larger aggregates within the 
nuclear matrix. Here, no distortion 
of the nuclear membrane was 
observed. Cells had a wildtype-like 
morphology. In cells expressing 
Htt96Q, TDP-F4, or ParkinΔC, 
however, a fraction of nuclear pore 
proteins was found to sequester in
cytoplasmic inclusions, distinct 
from the transgenic proteins. As in 
cells expressing cytoplasmic 
β proteins, the fluorescence 
around the nuclear envelope was 
regularly reduced, indicating a loss 
of functional proteins at the 
nuclear pores. The soluble, 
distributed αS824 did not cause 
any irregularities, neither in the 
cytoplasm, nor in the nucleus. 
Representative images of 3 
independent experiments are 
shown. Scale bar length 10 µM. 
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Cells transfected with non-targeted, c-Myc tagged β proteins showed all detrimental features 
described for cells expressing β proteins directed to the cytoplasm, and they caused a similar toxicity 
(MTT assay). Apparently, β proteins in the cytoplasm exhibited strong dominant effects over nuclear 
β proteins on cells and their phenotypes.  
In cells expressing NLS-β23(K7T, K15T) with inefficient nuclear targeting, nuclear pore proteins were 
only trapped into the cytoplasmic aggregates, but were absent from the nuclear ones. This 
observation demonstrates that it very unlikely were solely the compartmental targeting signals, but 
rather the cellular localization of the β proteins that mainly caused the distinct phenomena (toxicity, 
coaggregation, and cellular morphology).  
The observed interactions with nuclear pore proteins and the distorted nuclear envelopes made us 
interested in the efficiency of nucleo-cytoplasmic transport processes in cells harboring protein 
aggregates in these two compartments. Furthermore, compartment-specific differences regarding 
cellular interactions of such misfolding structures and their handling by the compartment specific 
proteostasis machinery may explain our observations. 
Figure 55 | Distribution of β23 proteins with different cellular targeting sequences in HEK293T cells 24 h after 
transfection. Non-targeted β23 proteins form aggregates in cytoplasm and nucleus. β23 can also be specifically directed to 
the cytoplasm by a nuclear export signal (NES), or to the nucleus by a nuclear localization sequence (NLS).  A mutation of a 
single lysine residue in the (2 repeats long) NLS to threonine rendered the nuclear targeting of the β proteins inefficient, 
keeping the rest of the positively charged NLS unchanged. The mutation resulted in a distribution of NLS-β23(K7T, K15T)
aggregates over cytoplasm and nucleus again. Representative images of 3 independent experiments are shown. Scale bar 
length 10 µM. 
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Nuclear β proteins associate with nucleoli and scatter around the 
nuclear envelope 
For cells expressing β proteins directed to the nucleus, the morphology of the nucleus and of the 
nuclear envelope were highly preserved in comparison to wildtype cells. Immunofluorescence 
microscopy brought no indications for any interactions between the nuclear β proteins and 
chromatin (DNA, DAPI staining). Nuclear β proteins formed several distinct bodies in the nuclear 
matrix, from which macro-fibrillary structures appeared to grow out. In addition, very small particles 
encompassed the nuclear envelope. As the nuclear β proteins seemed to be separated from the DNA 
in the nuclear matrix, we wondered whether they were localizing at the nucleoli. 
Nucleoli are sub-compartments in the nuclear matrix forming around ribosomal gene clusters. They 
are responsible for transcription and local pre-assembly of ribosomal subunits and other 
ribonucleoprotein particles. Beyond that, nucleoli are involved in cell-cycle progression and in many 
forms of stress response. Additional functions are still being uncovered (Boisvert 2007, Boulon 2010).  
NPM-1 (nucleophosmin, or B23) is a nucleolar protein involved in diverse cellular processes, such as 
ribosome biogenesis and tumor suppressor regulation (through p53 and ARF). NPM-1 interacts with 
rRNAs and directs the nuclear export of the 40S and 60S subunits (Maggi 2008). NPM-1 contains 
several NESs and NLSs and is capable of shuttling between cytoplasm and nucleus. In vitro, NPM-1 
was shown to prevent the aggregation of several denatured proteins (Szebeni 1999). The 
phosphoprotein of 294 amino acids is charged highly negatively (net charge of -24, which is increased 
by multiple posttranslational phosphorylations). The C-terminal half of NPM-1 contains mainly low-
complexity regions predicted to be disordered (by IUPRed; Meszaros 2009).  
HEK293T cells expressing nuclear β proteins for 24 h were co-labeled for NPM-1 as a nucleolar 
marker. NPM-1 closely associated to the β protein inclusions in the nuclear matrix. Thereby, NPM-1 
mainly surrounded the nuclear β protein aggregates, rather than to overlap with them completely. 
Moreover, the nucleolar (but not the nuclear) morphology appeared slightly disturbed in presence of 
nuclear β proteins. The typical smooth and spherical bodies observed in wildtype cells were 
transformed into rather irregular, angular structures.  
NPM-1 furthermore colocalized to the small β protein aggregates locating at the inner side of the 
nuclear membrane, demonstrating an interaction beyond the nucleoli itself. However, these small 
inclusions were too small to distinguish between a direct overlapping and a neighboring association 
of the β proteins and NPM-1, so that mutual interferences could be of a different nature here.  
Observations of nucleoli and the nuclear envelope demonstrated that the nuclear β proteins do 
interact with cellular structures, and the β proteins are able to disturb the wildtype morphology in 
the nucleus (nucleoli). Whether the packing of β proteins into nucleolar structures has primarily 
protective functions, such as shielding the aggregates from more harmful cellular interactions, or 
whether this nucleolar clustering is accompanied by detrimental effects, such as on nucleolar 
dysfunctions, remains to be elucidated.  
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Figure 56 | Nucleolar association of β protein aggregates in the nucleus, as visualized by Nucleophosmin staining (NPM-
1). HEK293T (A) or SH-SY5Y cells (B) were transfected with β proteins (red) and, after 24 h, stained for endogenous 
Nucleophosmin (by antibodies, green), a nucleolar protein and chaperon. Nuclear DNA was stained by DAPI (blue). 
Nucleophosmin surrounded the nucleolar structures, which, upon expression of nuclear β proteins, seemed to break up and 
cluster the β protein aggregates at their center. Representative images of 3 independent experiments are shown. Scale bar 
length 10 µM. 
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However, no decline of protein biosynthesis could be observed (see below), as it might be expected 
in case of a dysfunctional nucleolar ribosome biogenesis.  
Although nuclear DNAs and RNAs are strongly covered in proteins, which additionally are often rich 
in extended disordered regions, interactions with the nuclear β proteins were not apparent by 
confocal microscopy. Detrimental interactions therefore seem to be markedly limited in the nucleus, 
especially in comparison to the influence of cytoplasmic β proteins on nuclear morphology.  
Nuclear β protein aggregates remain intact during cell division 
In higher eukaryotic cells, the nuclear envelope almost completely disassembles during initial cell 
division (“open mitosis”; Güttinger 2009). Likewise, nucleolar structures fall apart. While certain 
nucleolar factors become distributed over the surrounding cytoplasm (such as phosphorylated NPM-
1), a distinct machinery remains in an inactivated nucleolar complex (transcription and RNP 
processing factors), which is distributed among the separating cells for new nucleolar assembly 
(Hernandez-Verdun 2011). 
Most cerebral neurons are highly differentiated and do not enter into mitosis any more. Neuronal 
progenitors and other somatic cells however may divide in the presence of nucleolar associated 
protein aggregates. Thereby, either the aggregates may stay associated with nucleolar core particles 
that remain localized within the nuclei, or the aggregates may distribute over the whole cell in form 
of aggregated or dissociated structures. Moreover, they may keep their nuclear properties (regarding 
structure, reactivity, and toxicity), or they may transform into aggregates with cytoplasmic or mixed 
properties with harmful consequences for the cells.  
To elucidate the fate of nucleolar aggregates during mitosis, we searched for mitotic cells that were 
expressing β proteins. Mitotic cells were identified by their condensation and appearance of 
chromosomes (DAPI staining), as they are characteristic for the different states during nuclear and 
cell division. Thereby it became obvious that the nucleolar localized β protein aggregates remained at 
the center of the cells in close proximity to the condensed chromosomes during the whole process. 
At later states of mitosis, the “nuclear aggregates” were segregated with the chromatids, whereby 
they were distributed between the two separated cells. Also here they remained nuclear, after the 
nuclear envelope reassembled.  
In control cells, the nucleolar NPM-1 was distributed over the whole cytoplasm and excluded from 
the chromosomal DNA. In contrast to that, a fraction of NPM-1 remained colocalizing with the 
β protein aggregates and most likely other nucleolar factors. Residual nucleolar particles are actively 
separated during chromosomal segregation and responsible for an equal distribution among the 
separating cells (Hernandez-Verdun 2011). In some cells, low amounts of residual “non-aggregated” 
NLS-β17 was distributed over the cell during mitosis. Similar to NPM-1 and other nuclear proteins, it 
can most likely be reimported into the nucleus, once the nuclear envelope is reassembled. However, 
this does not exclude that damage may be caused by distributed oligomers or aggregates that may 
be seeded in the cytoplasm during cell division. Overall, the nucleolar aggregates remained secluded 
during mitosis.  
Mitotic-like cells harboring cytoplasmic aggregates of NES-β17 were extremely rare. The high toxicity 
of cytoplasmic β proteins prevented further cell divisions. Missing growth was also observed for the 
untargeted β proteins (see Olzscha 2010).  
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Figure 57 |Nuclear β protein aggregates remain nuclear during and after cell division. HEK293T cells transfected with NLS-
β17 at different states of mitosis and cytokinesis demonstrated a continuance of nucleolar deposition. The aggregates were 
distributed between the two newly forming cells. A fraction of the cellular NPM-1 remained bound to the aggregates during 
the whole process, while residual NPM-1 was distributed over the cytoplasm, similar to control cells. Representative images 
of 3 independent experiments are shown. 
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Increased solubility of β proteins in the cytoplasm 
Labeling the β proteins in HEK293T or SH-SY5Y cells with fluorescent antibodies, a visual analysis of 
fluorescence microscopy images already suggested a stronger distribution of lower-molecular-weight 
species over the cytoplasm. Contrary in the nucleus, β protein aggregates formed very compact 
nucleolar structures, fairly confined from their surroundings.  
The solubility of β protein aggregates in cytoplasm and nucleus was analyzed by sedimentation. To 
promote an efficient lysis of cell membranes and nuclear envelopes, cells were lysed in phosphate 
buffer supplemented with 1% Triton X-100, 420 mM NaCl, 10 mM MgCl2, protease inhibitors, and 
benzonase (nuclease). 24 h after transfection, HEK293T cells were lysed at 4 °C, and aggregates were 
sedimented at 20,000 x g for 5 min. The supernatant was separated, the pellet was resuspended in 
an equal amount of lysis buffer, and both samples were denatured in SDS loading buffer. 
Beforehand, a fraction was kept without centrifugation (total lysate). Samples were run on SDS PAGE 
and immunoblotted against c-Myc, GAPDH, and nuclear Histone-H3.  
 
 
 
 
 
Figure 58 | Immunoblot of a solubility analysis of β proteins directed to cytoplasm and nucleus. HEK293T cells transfected 
with β proteins were lyzed after 24 h, and insoluble aggregates were sedimented by centrifugation (20,000 x g for 10 min). 
Total (T), supernatant (S), and pellet (P) fractions were separated by SDS-PAGE and blotted on PVDF membranes. These 
were immunostained to quantify β protein levels (c-Myc signals). Histone-H3 levels demonstrated an efficient lysis of the 
nuclear envelope and, together with GAPDH levels, an equal loading of lysates. A representative immunoblot of more than 
3 experiments is shown. 
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All three nuclear β proteins were efficiently sedimented to a degree of 65-78%, corresponding to 
soluble fractions of 22-35%, demonstrating low solubility and high compactness. In contrast, a 
significantly higher fraction of cytoplasmic β proteins were found not to sediment at 20,000 x g, 
especially in case of β4 and β17 (soluble fractions of 47% and 63%). As indicated by 
immunofluorescence microscopy, cytoplasmic β proteins seem to form increased amounts of lower-
molecular-weight assemblies, such as oligomers and smaller aggregates, which distribute over the 
whole cytoplasm. Similarly, β23 showed a significant higher solubility in the cytoplasm, although the 
difference was less pronounced (45% in cytoplasm versus 35% in nucleus).  
 
 
Compared to physiological conditions, an increased amount of sodium chloride (420 mM NaCl) in the 
lysis buffer was necessary to enable an efficient nuclear lysis, which does not occur in PBS with 1% 
TritonX-100 and 137 mM NaCl (standard concentration). However, the higher salt content might 
influence the stability of the β protein aggregates, especially by weakening protein-protein 
interactions. This may increase the soluble fractions and thereby diminish the real differences. 
Nevertheless, the analysis allows concluding about the relative soluble material within the two 
compartments.  
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Figure 59 | Quantification of soluble fractions of cell lysates with β proteins in cytoplasm and nucleus. Averages and 
standard deviations from 3 independent experiments are shown. Significance levels as determined by unpaired Student’s 
t-test. 
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Oligomers of intermediate-molecular-weight in the cytoplasm 
Lysates of HEK293T cells expressing NES-β17 or NLS-β17 for 24 h were subjected to size-exclusion 
chromatography to analyze the presence and size-distribution of oligomeric β protein species in the 
two compartments.  
To do so, HEK293T cells were lysed in a nuclear extraction buffer (PBS including 420 mM NaCl, 1% 
TritonX-100, Complete Protease Inhibitor Cocktail (Roche), and benzonase). This procedure ensured 
nuclear lysis and digestion of cellular DNA (short vortexing followed by slow shaking at 4 °C for 
20 min). Lysates were centrifuged at 2,000 x g to remove large insoluble debris. The supernatants 
were applied to a Superose 6 size exclusion column (30 mL column volume) in PBS at 4 °C. 14 
fractions over a size range from 5 MDa to 5 kDa were collected. Fractions, pellets, and supernatants 
were analyzed for their β protein content. 
While the cytoplasmic β proteins of NES-β17 could mainly be applied to the Superose 6 column, a 
significant part of the nuclear NLS-β17 was already removed by centrifugation at 2,000 x g. The 
solubility analysis (above) already indicated a greater insoluble content for the nuclear aggregates. As 
expected, condensed accumulations of β proteins associated to nucleoli sedimented at such 
centrifugation speeds.  
Running a size exclusion chromatograpy, both, the cytoplasmic and nuclear β proteins started eluting 
at maximal particle sizes of several megadaltons (up to 5 MDa). While the signal of the nuclear 
β proteins quickly declined in fractions below megadalton sizes, oligomers formed by the cytoplasmic 
β proteins appeared in the range of 200-50 kDa. A small signal was observed around the potentially 
monomeric form of the β proteins (~10 kDa). Similar to the solubility analysis by centrifugation at 
20,000 x g, this results suggested that the vast majority of the β proteins aggregate into very high-
molecular-weight forms in the nucleus.  
A hyperphysiological salt concentration was only necessary for nuclear lysis, but not for sole lysis of 
the cell membrane surrounding the cytoplasm. Therefore, a sample of NES-β17 expressing cells was 
subjected to rather physiological salt conditions in the lysis solution (137 mM NaCl) followed by size 
exclusion. The NES-β17 signal now spread over an even larger size range from above 1 MDa to 100 
kDa. Apparently, the increased ionic strength caused a partial disintegration of oligomeric structures 
of several 100 kDa, suggesting that under more physiological conditions a heterogeneous population 
of oligomeric species formed in the cytoplasm. Thus with a size of around 10 kDa per monomer, 
cytoplasmic oligomers may include variable assemblies comprising 10-100 β protein molecules. 
Assemblies of the purified β proteins as observed by electron microscopy may correspond to such 
size ranges (spherical and fibrillary oligomers of 10-100 molecules).  
However, the size exclusion chromatography was performed from in vivo lysates, so that the 
β protein oligomers presumable bound various cellular factors of different sizes. As long as they 
remain bound, these interactors contribute to the overall mass and running behavior observed here. 
Thus, a range of small- to intermediate-size oligomers appeared in vivo. Since they were formed by 
unspecific, non-natural interactions, such oligomers easily fell apart at higher ionic strength. 
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Figure 60 | Size exclusion chromatography of HEK293T lysates. (A) Centrifugation of the lysates at 2,000 x g removed the 
cellular debris and a substantial fraction of the nuclear aggregates, which were too large to be analyzed on a Superpose 6 
column. The cytoplasmic aggregates remained almost completely in the supernatant, which was subjected directly to size 
exclusion chromatography. (B) Analysis of the fractions revealed huge megadalton-sized structures formed by the 
β proteins in cytoplasm and nucleus. These large aggregates were accompanied by molecular assemblies of several hundred 
kilodaltons of size in the cytoplasm. They may also contain cellular interactors of the β proteins contributing to their final 
mass. Assemblies below 1 MDa were almost absent in the nucleus. Representative anti-c-Myc immunoblots from 2-3 
independent experiments. 
A 
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Major aggregates are stable and immobile in cytoplasm and nucleus (FRAP) 
Fluorescence recovery after photo bleaching (FRAP) was applied to determine the structural 
dynamics of the major aggregates of cells transfected with NES-β17-EGFP or NLS-β17-EGFP. FRAP 
allows to bleach a region of interest (ROI) of a fluorescent protein within a living cell, and to follow 
the fluorescence recovery within that region over time. The faster the fluorescence recovers, the 
higher the mobility and the exchange of particles between a bleached region and its surrounding. 
The recovery depends on the size of the fluorescent particles, e.g. due to binding to cellular 
structures such as cytoskeleton, membranes, or nucleic acids, and on the aggregates internal 
dynamics (mobility of molecules within).  
HEK293T cells expressing NES-β17-EGFP, NLS-β17-EGFP, or EGFP alone for 24 hours were objected to 
FRAP measurements at 37 °C. A ROI was bleached by laser light at 405 and 480 nm for ~1 sec, and 
fluorescence recovery was followed over 120 sec.  
The bleached regions only marginally recovered in fluorescence over almost 2 min, and the bleached 
spots could still be identified over 1 h after bleaching (not shown). Both, the aggregates of 
cytoplasmic and nuclear β proteins fused to EGFP were highly immobile and did not exchange with 
surrounding fluorescent β protein molecules. A difference in mobility between the two 
compartments could not be observed. Soluble EGFP, in contrast, was highly mobile and immediately 
returned to equilibrium.  
 
However, a difference in mobility may be found in the rather distributed, oligomeric particles (see 
solubility analysis, size exclusion chromatography). However, as the β proteins-EGFP fusions not fully 
represent the properties of the c-Myc tagged β proteins, the analyses were restricted here to the 
major inclusions forming in the two compartments. The β protein-EGFP fusions may display an 
altered solubility as they expressed at higher levels, formed extended aggregates with often rather 
amorpheous-like morphology, and showed no NIAD-4 binding (see below).  
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Figure 61 | The major aggregates in cytoplasm and nucleus are highly immobile and do not exchange molecules within 
their structures, as they show no fluorescence recovery after bleaching a small spot within their boundaries. Recovery 
curves are averages of 3 independent experiments; standard deviations are shown.  
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Structural differences of β protein assemblies forming in cytoplasm or nucleus 
Targeting β proteins to the cytoplasm or the nucleus resulted in striking differences regarding their 
toxicity and their structural properties. Distinct β protein conformations may also be differentially 
recognized by fluorescent amyloid sensors in vivo. NIAD-4 is a fluorescent sensor developed for 
specifically binding to Aβ fibrils and other amyloid structures (Nesterov 2005, Brandenburg 2012). Its 
chemical structure (aromatic rings, aliphatic hydrocarbons) and its ability to cross the blood-brain 
barrier suggests that hydrophobic interactions may also influence binding and fluorescence 
properties of NIAD-4, beyond its general selectivity for amyloid structures (see in vitro binding of 
NIAD-4 and ANS, Figure 38 and following).  
 
 
Probing structural properties of the β proteins in cytoplasm and nucleus with NIAD-4, the nuclear 
aggregates bound the amyloid sensor only weakly, compared to the large juxtanuclear inclusions in 
the cytoplasm. This differential binding of NIAD-4 suggests conformational alterations or a different 
molecular shielding of the β proteins in the two compartments. Differences may originate from a 
different degree of order of the β-sheets within the amyloid core, or different amounts of 
hydrophobicity being exposed to the surface of the fibrils. The surface of cytoplasmic β proteins 
amyloids presented more structurally complementary “epitopes” for NIAD-4 binding. Additionally, 
cytoplasmic aggregates might expose a higher surface hydrophobicity. Molecular shielding through 
nuclear factors such as NPM-1 (nucleophosmin, see above) might further influence the 
oligomerization and aggregation process, or cover the NIAD-4 binding sites of the nucleolar amyloids. 
Such a molecular shielding might prevent many other cellular interactions, too.  
NIAD-4 staining, together with the size and solubility analyses, indicates significant structural 
differences between oligomers and aggregates forming in cytoplasm or nucleus. 
Figure 62 | Structural differences of 
β protein aggregates in cytoplasm 
and nucleus. The β proteins were 
expressed in HEK293T cells and 
stained by anti-c-Myc-antibodies (red) 
and the amyloid sensor NIAD-4 
(green). A white dashed line labels the 
nuclear envelope in case of β17. 
Merge I is a superposition of anti-
c-Myc antibody and NIAD-4 staining; 
here, red indicates a low NIAD-4 
fluorescence, but high c-Myc signal, 
while yellow indicates high antibody 
and high NIAD-4 staining. In the 
cytoplasm, anti-c-Myc and NIAD-4 
staining were distributed and localized 
to spherical inclusions. The β proteins 
in the nucleus formed irregular, 
compact structures. In “Merge DAPI”, 
nuclear DNA staining was included 
(blue). Representative images of 3 
independent experiments. Scale bar 
length 10 µM. 
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Cytoplasmic β proteins suppress induction of the cytosolic stress 
response – nuclear β proteins (partially) induce a response 
β proteins (without cellular targeting sequences) were shown to inhibit cellular stress response 
pathways (Olzscha 2011) that react upon misfolding, chemical, or heat stress. A functional heat shock 
response reacts e.g. with increasing cellular chaperone levels, such as Hsp27, Hsp70, or Hsp90.  
One reason for a decreased cytotoxicity of nuclear β proteins might be an improved cellular response 
towards internal or external stresses. Therefore, a luciferase reporter protein under the control of 
the Hsp70 promoter was coexpressed in HEK293T cells with the compartmentally targeted 
β proteins. As readout of Hsp70 promotor activation, the luciferase activity was detected and 
compared between cells expressing different β proteins.  
Without external stress, cells expressing non-targeted or cytoplasmic β proteins showed an activity 
similar to wildtype cells (blue bars, Figure 63). Quite surprisingly, expression of β proteins targeted to 
the nucleus caused an increase of luciferase activity, even in the absence of additinal stress (such as 
heat shock). This Hsp70 promoter induction of the β proteins was inversely correlated to their 
toxicity: NLS-β4 caused a 5-fold and NLS-β17 a 2.5-fold induction of luciferase activity, compared to 
wildtype cells. 
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Figure 63 | Induction of the Hsp70 promotor controlling luciferase expression in HEK293T cells with or without additional 
heat shock. Cells were cotransfected with β proteins, αS824, nuclear EGFP, or empty vectors. Averages and standard 
deviations from 3 independent experiments are shown. Values of individual experiments were normalized to control cells 
after heat shock, which were set to 100. 
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Cells were now tested for their stress reaction upon heat shock at 43 °C for 2 h, followed by a 
recovery period at 37 °C for 2 h. Afterwards, the luciferase activity was determined. The heat stress 
led to a strong (10-fold) induction of the Hsp70 promoter in control cells, as in cells expressing 
αS824. Luciferase levels of cells expressing non-targeted or cytoplasmic β proteins only rose 
marginally, indicating a defective stress response in these cells.  
Cells with nuclear β proteins, in contrast, showed a clear induction of the Hsp70 promoter. Luciferase 
activity was increased more than 10-fold in case of β4 and 8-fold in case of β17, compared to 
untreated wildtype cells. Solely cells expressing NLS-β23 did respond neither to protein aggregation, 
nor to heat shock.  
This observation may have different origins, since β23 is in general the most toxic sequence among 
the β proteins. Also in the nucleus, β23 caused a distinct toxicity, even if it was significantly lower 
than in the cytoplasm (MTT viability of 68% for NLS-β23 vs. 39% for NES-β23). Malfunctions of 
cellular responsiveness towards stress might either arise due to a disturbance of typical nuclear 
processes (transcription factor signaling, transcription, RNA processing) specifically by NLS-β23, or of 
luciferase synthesis and folding. A quantification of luciferase mRNA and protein levels might be 
helpful here. Otherwise, minor levels of NLS-β23 mislocalized to the cytoplasm might already be 
enough to cause a stress response deactivation. As we observed later, neither the general protein 
synthesis, nor the cytoplasmic-nuclear transport of proteins and RNA were significantly inhibited by 
NLS-β23. Thus, the inhibition of the Hsp70 promoter induction appears to represent a specific defect 
caused by β23 in the nucleus.  
In summary, β proteins in cytoplasm caused a strong suppression of the cellular response to 
misfolding or heat shock. On the contrary, cells expressing the less toxic nuclear β proteins were 
capable of sensing misfolding and heat shock stresses. However, also nuclear β proteins partially 
suppressed the stress response induction. Especially NLS-β23 did not show any reaction to the Hsp70 
promoter controlled luciferase.  
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Interactions between proteostasis sensors and β proteins in the 
cytoplasm, molecular exclusion in the nucleus  
The β proteins and many other misfolded structures engage in a variety of aberrant cellular 
interactions (Olzscha 2011). It is still a major question, however, how many and which of those 
interactions are ultimately harmful for cells, putting their survival at risk.  
Misolded structures might directly interact with individual cellular proteins and deactivate them 
through recruitment into aggregates. However, misfolded structures might also promote further 
misfolding and aggregation through a disturbance of the protein folding homoeostasis (proteostasis). 
An excessive occupancy of molecular chaperones might lower the cellular folding capacity, so that 
newly synthesized or structurally unstable proteins start to aggregate. Degradation pathways might 
become overloaded, disturbed, or confronted with non-degradable substrates. Misfolded structures 
may then accumulate and themselves take part in aberrant interactions. Reaching a certain threshold 
in the disturbance of cellular proteostasis might thus cause the final cellular collapse. 
 
 
Figure 64 | Cytoplasmic luciferase-EGFP proteostasis sensors coexpressed with β proteins targeted to cytoplasm or 
nucleus. HEK293T cells were cotransfected with NES-LucWT-EGFP (green) and empty control vectors, β proteins, or αS824. 
Cells were fixed 24 h after transfection and labeled with anti-c-Myc antibodies (red) and for nuclear DNA (DAPI, blue). 
Representative images of 3 independent experiments are shown. Scale bar length 10 µM. 
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To evaluate compartment-specific attributes of proteostasis, β proteins were coexpressed with 
proteins designed for sensing proteostasis stress. Firefly luciferase, a protein strongly dependent on 
molecular chaperones for folding and refolding, was fused to EGFP (Rajat Gupta 2011). In addition, 
similar targeting sequences that directed the β proteins to cytoplasm and nucleus (NES, NLS, now 
without a c-Myc tag) were added. With these localized proteostasis sensors we intended to monitor 
compartmental proteostasis states as well as aberrant interactions in the presence of β proteins.  
Wildtype (WT) and a destabilized double mutant (DM) of luciferase-EGFP (Rajat Gupta 2011) were 
directed to cytoplasm or nucleus (NES/NLS-LucWT/DM-EGPF). The sensor proteins were in general 
soluble and homogeneously distributed over the respective compartment. Expressed at higher levels 
(transfection of the 5-fold amount of DNA), the double mutants started to form inclusion on their 
own in cytoplasm or nucleus, demonstrating they were at risk of aggregation and have the potential 
to sense increased stress levels.  
 
 
β proteins targeted to cytoplasm and nucleus were then combined with the compartment-specific 
luciferase sensors. Targeting both proteins to the cytoplasm, the luciferase sensors were partially 
sequestered by cytoplasmic NES-β17 inclusions, surrounded by distributed NES-LucWT-EGFP. 
Figure 65 | Nuclear luciferase-EGFP proteostasis sensors coexpressed with β proteins targeted to cytoplasm or nucleus. 
HEK293T cells were cotransfected with NLS-LucWT-EGFP (green) and empty control vectors, β proteins, or αS824. Cells 
were fixed 24 h after transfection and labeled with anti-c-Myc antibodies (red) and for nuclear DNA (DAPI, blue). 
Representative images of 3 independent experiments. Scale bar length 10 µM. 
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However, the sensors remained completely homogenously distributed over the cytoplasm, when 
NLS-β17 or αS824 were coexpressed (Figure 64). 
Directing luciferase sensors to the nucleus did not show any disturbance in presence of NLS-β17. In 
the majority of the cells, the sensors where homogenously distributed over the nuclear matrix, even 
being excluded from the β protein aggregates (Figure 66). Only in a minor fraction (5-10 %) of cells, 
some nuclear luciferase sensors aggregated and got sequestered into the NLS-β17 aggregates. Very 
differently, the same sensors targeted to the nucleus were strongly recruited into NES-β17 
aggregates in the cytoplasm (Figure 65). Most likely this happened directly after ribosomal synthesis, 
before the cells were able to deliver the luciferase sensors actively into the nucleus. 
Very similar observations were made coexpressing NES-β23 or NLS-β23 with compartmental 
luciferase sensors. β23 caused coaggregation with the sensors in the cytoplasm, whereas they were 
excluded from nuclear β23 aggregates. Similar results were furthermore obtained combining the 
β proteins with the destabilized double mutants of the luciferase sensors. These occurred at lower 
cellular levels than the wildtype sensors in both compartments, indicating a potentially faster 
degradation.  
 
Aberrant interactions between structurally unstable and misfolded proteins therefore occurred more 
prominently in the cytoplasm. Here we observed (co-)aggregation of both luciferase sensors, 
directed to cytoplasm or nucleus. In addition, as we will see later, cytoplasmic β proteins may inhibit 
the molecular machinery responsible for nuclear protein import, and therefore additionally decrease 
the efficiency of nuclear luciferase translocation. Interference with nucleo-cytoplasmic transport 
further increases the likelihood of aberrant interactions with NLS-Luc-EGFP in the cytoplasm.  
The nuclear environment, and potentially the structural properties of the nuclear β proteins 
appeared in contrast to prevent aberrant interactions. Luciferase sensors and β proteins were left 
apparently unaffected from mutual interactions. Thus, cytoplasmic and nuclear aggregation and their 
aberrant interactions indicate elementary differences in the cytoplasmic and nuclear proteostasis 
with potentially severe consequences for the local misfolding and aggregation behavior. 
  
Figure 66 | Exclusion of proteostasis sensor NLS-LucDM-EGFP (green) from nuclear β protein aggregates (red). The 
proteostasis sensor was distributed over the nuclear matrix. The luciferase sensor did not overlap with, but surrounded 
nuclear β17 aggregates. 
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Inhibition of the proteasome causes a collapse of nuclear proteostasis 
Levels and fluorescence of luciferase-EGFP double mutants (LucDM-EGFP) were significantly lower 
compared to the wildtype. An accelerated degradation of LucDM-EGFP due to conformational 
instability seemed plausible. Henceforth, we were interested in the fate of misfolded species under 
proteasomal inhibition. The proteasome is the main cytoplasmic and especially nuclear degradation 
machinery for the removal of monomeric proteins.  
 
 
MG132 is a potent and selective inhibitor of the proteasome, which causes a large reduction in the 
rates of cellular protein degradation (Kisselev 2011). Here we applied MG132 to HEK293T cells 
expressing LucDM-EGFP targeted to cytoplasm or nucleus. After 5 h of treatment, most cells 
transfected with NES-LucDM-EGPF showed a homogenous distribution of the sensor in the 
cytoplasm, while around 10% of cells contained a single cytoplasmic inclusion. Very differently, in 
cells expressing NLS-LucDM-EGPF multiple smaller aggregates appeared in the nucleus, overlapping 
with nucleolar structures (see also Gupta 2012, Thesis). Apparently, the nuclear proteostasis made 
Figure 67 | Proteasomal inhibition by MG132 and its influences on cytoplasmic and nuclear proteostasis and aggregation. 
24 h after cotransfection of LucDM-EGFP (green) targeted to cytoplasm or nucleus and β proteins or control vectors, the 
proteasome was inhibited for 5 h by MG132. Cells were fixed and stained with anti-c-Myc antibodies (red) and for nuclear 
DNA (DAPI, blue). Proteasomal inhibition caused an aggregation of the nuclear luciferase proteins, which accumulated in 
nuclear inclusions associated to, but not completely overlapping with nuclear β proteins aggregates. Cytoplasmic LucDM-
EGFP was hardly influenced by proteasomal inhibition, rarely small aggregates were observed. Scale bar length 10 µM. 
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strong use of proteasomes to remove instable or misfolded proteins, which otherwise accumulated 
upon proteasomal inhibition.  
The nuclear β proteins still accumulated in form of aggregates upon proteasomal inhibition. 
However, β proteins seemed in general not to be degraded by the proteasome, as they did not show 
any ubiquitination and did not accumulate further upon MG132 treatment (see also Olzscha 2010). 
When coexpressed with NES-β17, the luciferase sensors behaved very similar with or without 
inhibition of the proteasome. In all cells expressing luciferase sensors and NES-β17, the luciferase 
sensors accumulated in perinuclear aggregates surrounded by homogenously distributed sensor 
protein.  
As in absence of MG132 treatment, NLS-LucDM-EGFP was strongly recruited to NES-β17 aggregates. 
Nuclear luciferase aggregates were only seen in a minority of cells. The direct entrapment of 
luciferase sensors in the cytoplasm reduced the nuclear concentration of NLS-LucDM-EGFP, which 
presumably was a reason for the absence of nuclear aggregation in these cells. Another possibility 
might be that NES-β17 influenced the nuclear or overall proteostasis by additional means to prevent 
nuclear aggregation. Possible mechanisms could include e.g. an upregulation or nuclear localization 
of chaperones, or an inhibition of nuclear NLS-LucDM-EGFP import. 
Proteasomal inhibition did not increase the aggregation of NES-LucDM-EGFP in presence of NLS-β17. 
As in the majority of cells before, the luciferase double mutant was homogeneously distributed over 
the cytoplasm. Only in rare cases, small cytoplasmic NES-LucDM-EGFP aggregates appeared. 
Proteasomal inhibition therefore does not seem to have a strong impact on the cytoplasmic 
proteostasis directly. Even in the presence of β proteins, NES-LucDM-EGFP remained soluble, rather 
indicating a strong stabilization by cytoplasmic chaperones. Therefore, misfolded species may rather 
be stabilized (at least temporarily) in the cytoplasm. 
In contrast, NLS-LucDM-EGFP aggregated in presence as in absence of NLS-β17 aggregates under 
proteasomal inhibiton. Both transfected proteins apparently were associated to the nucleoli. Despite 
not completely overlapping, they formed substructures very close to each other. Hence, the nuclear 
proteostasis appeared to be critically disturbed, when protein degradation through the proteasome 
was inhibited. These results demonstrate that aggregation at secure locations (such as the nucleoli) 
may offer an alternative to handle misfolded structures at least temporatily in case they cannot be 
directly degraded. 
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Cytoplasmic β proteins, Htt96Q, TDP-F4, and ParkinΔC inhibit nuclear 
translocation of NF-κB  
NF-κB is a ubiquitous transcription factor regulating cell type- and context-specific responses.  NF-κB 
is also active in neurons and glial cells (O’Neill 1997, Salles 2014, Kaltschmidt 2009), but best 
understood for its regulatory functions in B lymphocytes and in inflammation (Sen 2011, 
Oeckinghaus 2011). The highly complex regulation of NF-κB integrates cross-signaling among 
numerous pathways and translates it into pro-survival or pro-apoptosis signals, which can finally 
decide about life and development or death of a cell (Oeckinghaus 2011).  
NF-κB (a heterodimer of p50/p65) is directly controlled by binding to its inhibitor (IκB), which is 
phosphorylated by the IκB kinase (IKK), comprising IKKα, IKKβ, and its regulatory subunit NEMO (or 
IKKγ). Activation of NF-κB e.g. through TNF (tumor necrosis factor) receptor 1 mediated TNFα 
signaling induces phosphorylation and ubiquitination of IκB. This releases NF-κB into the cytoplasm 
and reveals its nuclear localization sequence (NLS). Recognized by importins, NF-κB is then actively 
translocated into the nucleus, where it binds to specific promoters and regulates gene transcription 
(Oeckinghaus 2011). 
Intrigued by a defective stress signaling and distorted nuclear pore complexes, we became interested 
in assessing the functional activation and nucleo-cytoplasmic translocation of central signaling 
factors in cells challenged by misfolding and aggregation. Therefore, HEK293T cells were transfected 
with β proteins targeted to cytoplasm or nucleus, with Htt96Q, TDP-F4, ParkinΔC, αS824, or empty 
control vectors. After 40 h, NF-κB signaling was activated by TNFα treatment at 20 ng/mL for 30 min, 
and cells were fixed and immunostained for fluorescence microscopy.  
Control cells demonstrated NF-κB translocation to the nucleus. Similarly, NF-κB translocated to the 
nucleus of cells expressing NLS-β17, NLS-β23, or αS824. Therefore, activation and nuclear import 
were fully functional in the presence of nuclear β protein aggregates. Molecular signaling from the 
extracellular medium was recognized and processed within these cells.  
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Figure 68 | Protein aggregation in the cytoplasm interferes with nuclear NF-κB import after activation by TNFα. 40 h after 
transfection of HEK293T cells with the indicated constructs, TNFα was applied for 30 min to activate NF-κB signaling. Cells 
were fixed and stained for protein aggregates (red), NF-κB (subunit p65, green), and nuclear DNA (DAPI, blue). 
Representative images from at least three independent experiments. Scale bar length 10 µM. 
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NES-β17, NES-β23, Htt96Q, TDP-F4, and ParkinΔC conversely prevented the nuclear import of NF-κB, 
which remained cytoplasmic. Partially, coaggregation between NF-κB and cytoplasmic β proteins 
occurred (especially for β23), but residual NF-κB was distributed over the cytoplasm. Thus, all tested 
cytoplasmic protein aggregates rendered the NF-κB activation dysfunctional. Almost all cells 
expressing cytoplasmic β proteins and around 70-80% of cells containing Htt96Q, TDP-F4, or 
ParkinΔC aggregates were affected by this translocation defect. 
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Figure 69 | HEK293T cells examined for nuclear NF-κB (p65) after activation by TNFα, or without treatment (-TNFα). Cells 
were analyzed and quantified for NF-κB translocation to the nucleus. Averages and SD from 3 independent experiments are 
shown; at least 100 cells were examined for every condition.  
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Processing upstream of NF-κB is functional in cells expressing β proteins 
Before NF-κB is transported into the nucleus by cellular importins, a number of processing steps have 
to be completed. These include phosphorylation of NF-κB and IκB, followed by IκB ubiquitination and 
degradation. Only then, the p50/p65 dimer of NF-κB exposes its NLS, which is recognized by nuclear 
importins (Karin 2004). 
Cells expressing β proteins were tested for NF-κB phosphorylation and IκB degradation. A 
phosphorylation specific antibody was applied (phospho-p65, Ser 536, Cell Signaling Technologies) to 
analyze HEK293T cells expressing β proteins, αS824, or cells transfected with an empty vector. After 
expression for 40 h, followed by TNFα treatment for 15 min (optimal for p65 phosphorylation and IκB 
degradation), lysates were analyzed by SDS PAGE and immunoblotting, stained for phosphorylated 
NF-κB (p65), IκB, and GAPDH.  
 
 
NF-κB (p65) was phosphorylated and IκB was degraded in cells expressing cytoplasmic or nuclear 
β proteins. This occurred even when β proteins were aggregating in the cytoplasm and NF-κB 
translocation was inhibited. These results demonstrate that NF-κB was fully processed upon TNFα 
signaling, and in a competent state to be actively imported into the nucleus. All upstream processing 
in the NF-κB signaling pathway occurred efficiently, however, NF-κB failed to translocate to the 
nucleus, when cytoplasmic aggregates were present.   
This observation indicates either a direct interference of cytoplasmic aggregation with the nucleo-
cytoplasmic transport of proteins, or a novel mechanism of NF-κB regulation. Cytoplasmic misfolding 
and aggregation may prevent NF-κB activation through an inhibition of its nuclear import. At the 
current state of knowledge, such an inhibition would, however, likely occur rather upstream in the 
signaling pathway, e.g. through an influence on IKK or deactivated IκB release. 
 
  
Figure 70 | Immunoblot examining the phosphorylation of NF-κB (p65) and degradation of IκB before and after activation 
by TNFα. Phosphorylation of p65 and degradation of IκB are prerequisites for the nuclear import of NF-κB. GAPDH levels 
demonstrate equal loading. Blots with the same antibody were generated with equal amounts of lysate and developed 
together to allow a comparative quantification. 
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Cytoplasmic β proteins, Huntingtin96Q, and ParkinΔC interfere with 
general nucleo-cytoplasmic protein transport  
Expression of cytoplasmic β proteins, Huntingtin96Q, and TDP-F4 disturbed the nuclear envelope 
morphology and chromatin structure, and caused aggregation of FG-repeat proteins of the NPC. 
TNFα mediated NF-κB signaling and other stress response pathways (Hsf1/Hsp70 promoter 
activation) were abolished by cytoplasmic aggregates.  
Disruption of the native localization and the active transport of essential cellular factors between 
nucleus and cytoplasm could lead to serious disturbances in cellular homoeostasis and signaling in 
general. Consequently, we established an assay that allowed us to quantitatively analyze nucleo-
cytoplasmic protein transport.  Therefore, we fused EGFP (eukaryotic green fluorescent protein) to a 
nuclear localization sequence (NLS) followed by a nuclear export signal (NES). Due to the two 
targeting signals, the model protein is continuously being shuttled by active protein transporters 
between cytoplasm and nucleus. Thus we termed the resulting protein S-GFP (shuttling GFP, see 
Figure 71 A). Disturbances in the distribution of S-GFP could thus be quantified by its fluorescence in 
the respective compartment.  
In cellular equilibrium, S-GFP was mainly cytoplasmic, indicating that the rate of nuclear export was 
higher than the rate of nuclear import. This circumstance allowed us to analyze the efficiency of 
general nuclear protein export in presence of misfolded proteins.  
NES-mediated nuclear protein export by CRM1 can be inhibited by the small molecule drug 
Leptomycin B (LMB; Kudo 1998). In wildtype cells, addition of LMB causes a redistribution of S-GFP 
from cytoplasm to nucleus within minutes. Thus, under LMB conditions the active nuclear import can 
be examined and be compared to cells expressing aggregating proteins.  
The relative concentrations of distributed S-GFP in the cytoplasm and nucleus were quantified by the 
fluorescence intensity of the protein in the respective compartment. The ratio of cytoplasmic to 
nuclear fluorescence describes the relative concentration of S-GFP in the two compartments.  
S-GFP was cotransfected with β proteins, Htt96Q and ParkinΔC in HEK293T cells. In control cells, S-
GFP was strongly enriched in the cytoplasm (7.7-fold compared to nucleus). The efficiency of nuclear 
export decreased only marginally in the presence of NLS-β17 (5.8-fold cytoplasmic /nuclear gradient; 
see Figure 72). The effect of nuclear β proteins on the nuclear protein export was insignificant.  
LMB treatment caused an inhibition of nuclear S-GFP export. 15 min were enough to redistribute the 
majority of the fluorescent protein to the nucleus. Control cells and cells expressing NLS-β17, both 
had a 6 fold concentration gradient of S-GFP between nucleus and cytoplasm. Nuclear import was 
completely undisturbed in presence of nuclear β proteins.  
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Figure 71 | Cellular distribution of 
S-GFP in HEK293T cells, co-expressed 
with β proteins, Htt96Q, ParkinΔC, or 
αS824. EGFP was fused to a nuclear 
localization sequence (NLS) and a 
nuclear export signal (NES), resulting 
in an EGFP permanently shuttling 
between cytoplasm and nucleus. (A) 
Construction of S-GFP. (B) In wildtype 
cells, S-GFP accumulated in the 
cytoplasm, most likely due to a higher 
nuclear export rate. This gradient is 
decreased in the presence of 
cytoplasmic β proteins, Htt96Q, or 
ParkinΔC. Nuclear β proteins did not 
disturb the distribution of S-GFP, nor 
did αS824. The small molecule drug 
Leptomycin B (LMB) inhibits the 
nuclear export of proteins, so that 
S-GFP redistributed to the nucleus 
within minutes. The efficiency of 
nuclear S-GFP import was significantly 
decreased in presence of cytoplasmic 
β proteins, Htt96Q, or ParkinΔC, but 
not by nuclear β proteins or αS824. 
Representative images of 3 
independent experiments. Scale bar 
length 10 µM. 
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This situation changed when cytoplasmic β proteins, Htt96Q, or ParkinΔC were coexpressed with 
S-GFP. The cellular localization of S-GFP generally drifted towards an equilibrated distribution 
between cytoplasm and nucleus. In other words, the concentration gradient between both 
compartments collapsed, the high import and export efficiencies achieved in control cells could not 
be reached any more. This was true for both transport directions, and occurred before and after 
inhibition of nuclear export by LMB.  
In case of NES-β17, the cytoplasmic-nuclear concentration gradient of S-GFP fell below 2, 
corresponding to an export capacity of 25% compared to control cells. Moreover, the overall 
distribution of nuclear localization of S-GFP in this population of cells became much broader than in 
control cells, most likely due to differences in the progression and the probabilistic nature of protein 
aggregation. Whereas the majority of control cells exhibited a concentration gradient of S-GFP 
between 5-15 fold (on the level of individual cells), this gradient was reduced in cells cells 
accumulating NES-β17 to a range of 1 to 6. Therefore, a fraction of cells showed even an equal 
distribution of S-GFP between the two compartments. This result clearly demonstrated a severe 
interference of cytoplasmic β protein aggregation with nuclear protein export.  
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Figure 72 | Cellular distribution of S-GFP in absence and in presence of β proteins, Htt96Q, or ParkinΔC aggregates. The 
nucleo-cytoplasmic concentration gradient of S-GFP was determined by its fluorescence intensity ratio between the two 
compartments in HEK293T cells 40 h after transfection. 75-150 cells were analyzed per condition. Averages and SD from 3
independent experiments. Significances compared to control cells under the same condition (+/- LMB), as determined by 
unpaired Student’s t-test. 
** 
** 
*** 
* 
*** 
* 
n. s. 
n. s. 
 100  ∙  Results 
After inhibiting nuclear protein export by LMB, the nuclear concentration gradient of S-GFP 
decreased from 6-fold in control cells to around 3-fold in cells expressing NES-β17. Hence, in 
presence of NES-β17 aggregation, nuclear transport problems occurred in both directions. The 
relative decrease of nuclear S-GFP export (no LMB) was stronger than the nuclear import.  
The breakdown of nuclear export became even more dramatic in cells with Htt96Q and ParkinΔC 
aggregates. On average, S-GFP was even slightly concentrated in the nucleus (1.5-fold, without LMB 
treatment). In addition, the distribution of S-GFP in individual cells of the population appeared over a 
broad range, which might be related to the sudden outbreak of aggregate formation, as often 
observed for the polyglutamine-expanded huntingtin (Ossato 2010).  
However, cells containing Htt96Q and ParkinΔC aggregates were responding to LMB treatment. The 
average nuclear-cytoplasmic concentration gradient of S-GFP increased from 1.5 to 3 after nuclear 
export inhibition, a very comparable value to NES-β17. This rather subtle reaction demonstrated that 
the cells were still alive, harboring a residual transport capacity between two (still) separated 
compartments. However, the transport rates fell so low in the presence of cytoplasmic aggregates, 
that it appears unlikely that many protein gradients between the two compartments could be 
maintained in a physiological range.  
NES-β23 had a very similar effect on S-GFP as NES-β17. However, NES-β23 coaggregated stronger 
with the fluorescent sensor S-GFP, impeding quantification. The soluble αS824 had no apparent 
influence on the cellular distribution of S-GFP.  
After discovering the inhibitory effect on N-κB activation, the experiments with S-GFP demonstrated 
that the presence of different kinds of cytoplasmic aggregates interfered with the active transport of 
proteins carrying a classical NES or NLS in both directions. Again, β protein aggregates in the nucleus 
behaved very inert. 
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Cytoplasmic aggregation of importin α proteins 
Importin α proteins recognize and bind nuclear localization signals on proteins in the cytoplasm. 
Then the importins arrange Ran-dependent nuclear import through nuclear pore complexes. In the 
nucleus, substrates are released, and the importins become cargo of specific export complexes 
(CAS/Ran-GTP). Finally, the complex translocates back to the cytoplasm and dissociates (Cook 2007). 
Importin α1 (KpnA2) has been identified to interact with the β proteins (Olzscha 2011). Importin α3 
(Kpna4) was reported to be the main import carrier of nuclear NF-κB translocation upon activation of 
the signaling pathway (Fagerlund 2005). As we observed major defects in NF-κB import and in 
general nucleo-cytoplasmic protein transport (S-GFP), we became interested in exploring the cellular 
distribution of importins in cells challenged with misfolding and aggregation. 
 
In wildtype HEK293T cells, importin α1 and importin α3 were distributed over cytoplasm and nucleus, 
being enriched in the cytoplasm. Expressing β proteins targeted to the cytoplasm for 24 h caused a 
significant fraction of both importins to become sequestered into the cytoplasmic β protein 
aggregates. In cells with Htt96Q or ParkinΔC aggregates, the two importins formed separate 
inclusions in the cytoplasm, which did not overlap with the exogenous protein aggregates. Only in 
cells with nuclear β protein aggregates, the importins remained soluble and showed a wildtype-like 
distribution. 
Conclusively, we found a clear association between inefficiencies of the active nucleo-cytoplasmic 
transport and (co-)aggregation of importin α proteins, the executive molecular machinery carrying 
out active transport processes in cells. 
Figure 73 | HEK293T cells expressing aggregation prone proteins (red) for 24 h, labeled for importin α1 (green, left panel) 
or importin α3 (green, right panel), and for nuclear DNA (DAPI, blue). In wildtype cells, the importins were distributed over 
cytoplasm and nucleus, being enriched in the cytoplasm. In cells expressing cytoplasmic β proteins, importins were 
sequestered into aggregates. In cells with nuclear β proteins, the importins showed a wildtype-like distribution. In cells 
expressing Htt96Q or ParkinΔC, the importins formed separate cytoplasmic inclusions. Representative images of 3 
independent experiments. Scale bar length 10 µM. 
 102  ∙  Results 
Nuclear mRNA accumulation in cells with cytoplasmic protein 
aggregation  
Unsuccessful NF-κB translocation revealed nuclear import defects on the example of an essential 
cellular transcription factor. Experiments on S-GFP, a nucleo-cytoplasmic transport model protein, 
demonstrated transport inefficiencies occurring in both directions – into and out of the nucleus. 
Furthermore, the results suggested that the import defects we observed on NF-κB stand exemplary 
for many other transport inhibitions in cells with cytoplasmic protein aggregates. Consequently, the 
nuclear export of another central cellular molecule raised our attention: messenger RNA (mRNA).  
mRNAs are synthesized in the nucleus as a transcript of genomic DNA by RNA polymerases. The 
resulting precursor mRNAs are then processed within small nuclear ribonucleoprotein particles 
(snRNPs). snRNPs consist of proteins and catalytically active RNAs (Wahl 2009). Noncoding introns 
are removed by the splicosomes, and specific splice variants may appear in distinct cells and tissues. 
After several highly coupled processing steps, mature mRNAs are exported through the nuclear pore 
complexes to the cytoplasm. The whole process is mediated by mRNA processing and export 
proteins, among them the TREX (transcriptional export) machinery including the THO complex and 
Aly/REF (THOC4), which directly interacts with the mRNA export receptor TAP:p15 (Braun 2002, 
Köhler 2007, Carmody 2009).  
In a SILAC based mass spectrometric analysis we previously identified mRNA processing and export 
factors as interactors of the β proteins in HEK293T cells (Olzscha 2011), and recently in primary 
mouse neurons (analysis performed by Li Rebekah Feng, Daniel Hornburg, Felix Meissner, and 
Matthias Mann). Especially proteins of the THO complex with extended low-complexity regions 
raised our awareness of potential interferences with mRNA export.  
HEK293T and SH-SY5Y cells were transfected with β proteins, Htt96Q, TDP-F4, or ParkinΔC. Cells were 
fixed and labeled for poly(A) RNA with a fluorescent Cy5-(d)T30 oligonucleotide probe (most mRNAs 
are polyadenylated after transcription). Aggregating proteins were labeled with respective 
antibodies.  
In control cells, poly(A)-tailed RNA (corresponding to mRNA) was distributed fairly homogenously 
over the cytoplasm. The majority of nuclear mRNA concentrated in snRNPs, giving rise to small, 
fluorescently bright spots within the nuclear matrix (distinct from nucleoli). Remarkably, in cells 
expressing cytoplasmic β proteins, the vast majority of cellular mRNA accumulated in the nucleus, 
where numerous fluorescently bright structures appeared. These spherical structures did not reflect 
the tiny snRNPs of wildtype cells, but formed “nuclear mRNA bodies” of significantly increased size 
and brightness. Simultaneously, the cytoplasm was virtually free of mRNA. 
The β proteins directed to the nucleus did not cause any nuclear accumulation of mRNAs, despite 
their neighborhood to mRNA processing and export functions. The cellular mRNA distribution 
appeared completely normal in form of distributed mRNA in the cytoplasm and snRNPs in the 
nucleus. Only in a few percent of cells, nuclear β proteins showed signs of nuclear mRNA 
accumulation.  
NES-EGFP demonstrated that overexpression of NES-tagged proteins were not overloading the 
nuclear export capacity by itself. 
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Figure 74 | Cytoplasmic aggregation-prone proteins inhibit nuclear mRNA export and cause mRNA to accumulate in 
“nuclear mRNA bodies”. HEK293T cells were analysed for their polyA RNA (green) distribution 24 h after transfection with 
β proteins, Htt96Q, TDP-F4 (red), or empty vectors (control). Nuclear DNA was stained with DAPI (blue). In control cells, the 
mRNA was distributed homogenously over the cytoplasm. In the nucleus, mRNA localized to snRNPs for processing of 
premature mRNAs. Cellular mRNA distribution was seriously disturbed in cells expressing cytoplasmic β proteins, Htt96Q, or 
TDP-F4. Here, the mRNA accumulated in “nuclear mRNA bodies” of clearly increased size compared to wildtype snRNPs. 
Cytoplasmic mRNA levels vanished. In contrast, cells expressing β proteins in the nucleus behaved very similar to control 
cells. The cellular distribution of mRNA appeared undisturbed. Representative images of at least 3 independent 
experiments. Scale bar length 10 µM. 
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Figure 75 | Cytoplasmic aggregation-prone proteins inhibit nuclear mRNA export and cause accumulation in “nuclear 
mRNA bodies” in SH-SY5Y (neuroblastoma) cells. SH-SY5Ycells were analysed for their polyA RNA (green) distribution 24 h 
after transfection with β proteins, Htt96Q, TDP-F4 (red), or empty vectors (control). Nuclear DNA was stained with DAPI 
(blue). Similar to HEK293T cells, the cellular mRNA accumulated in nuclear bodies, and cytoplasmic mRNA levels vanished in 
cells with cytoplasmic β proteins, Htt96Q, or TDP-F4. mRNA was distributed wildtype-like in cells with nuclear β proteins, or 
NES-EGFP. Representative images of at least 3 independent experiments. Scale bar length 10 µM. 
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Nuclear accumulation of mRNA was furthermore observed in cells expressing Htt96Q and TDP-F4.  
However, here we observed a rather intermediate phenotype regarding the cellular distribution of 
mRNA: next to the presence of bright nuclear mRNA bodies, lower levels of residual mRNA remained 
distributed over the cytoplasm of many cells. Although a nuclear accumulation with mRNA bodies of 
increased size and brightness was present in cells with Htt96Q or TDP-F4 aggregates, not all cells 
were affected as strongly as in case of cytoplasmic β proteins.  
 
While the nuclear export of S-GFP was disturbed to a greater extend in cells with Htt96Q and 
ParkinΔC aggregates, the β proteins caused a stronger nuclear mRNA accumulation. Although similar 
cellular pathways and functions were affected, the respective impact of different misfolding and 
aggregating proteins appeared to be of different strength. The distinct physiochemical nature of the 
individual aggregating sequence may be responsible for such variations. Individual sequence 
properties may thus aggravate or alleviate detrimental interactions and associated cellular 
malfunctions.  
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Figure 76 | Quantification of HEK293T cells 
with nuclear mRNA accumulation upon 
expression of the indicated 
aggregation-prone proteins. 
Cells were analyzed 24 h after transfection. 
Averages and SD from 3 independent 
experiments. At least 100 cells were 
analysed per experiment. 
Figure 77 | Cellular mRNA profiles presenting the distribution of mRNA along a route straight through the middle of a cell 
(red line). (A) The fluorescence intensity (y-axis) along a path through a HEK293T cell (x-axis) represents the mRNA 
distribution. In control cells, mRNA levels are high in the cytoplasm (cyto), and generally lower in the nucleus, where “RNA 
spikes” corresponding to snRNPs appeared. Cells expressing nuclear β proteins showed a similar distribution, in contrast to 
cells expressing cytoplasmic β proteins. Here, the mRNA levels in the cytoplasm decreased strongly, while a high 
fluorescence in the nucleus indicated that mRNA accumulated in large nuclear mRNA bodies. Their size and fluorescence 
intensity reached far beyond those of wildtype snRNPs. (B) Exemplary route through a cell (red line), along which the polyA 
RNA fluorescence (green) was measured and plotted.  
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Isolation and quantification confirms diminished cytoplasmic mRNA  
To quantify cytoplasmic mRNA levels biochemically, cytoplasmic and nuclear fractions of transfected 
HEK293T cells were separated after lysis of the cellular membranes and sedimentation of preserved 
nuclei. PolyA RNA was purified from the separated cytoplasmic fraction by poly-d(T)-coupled beads 
(small uniform polystyrene-latex particles for improved quantification; Oligotex, Qiagen). 
40 h after transfection, HEK293T cells were collected and cellular membranes were lysed in 4 °C cold 
PBS with 0.3% TritonX-100 and RNase inhibitor. Intact nuclei were sedimented. The cytoplasmic 
lysate (supernatant) was incubated with poly-d(T)-coupled beads for mRNA hybridization. The beads 
were washed and rehybridized to remove residual ribosomal RNAs. The mRNA was eluted at 70 °C. 
Quality and quantity of the mRNA were assessed on a NanoDrop spectrometer (absorption at 
260/280 nm).  
 
 
Cytoplasmic mRNA levels were lowered in cells expressing NES-β17 and TDP-F4, as expected. mRNA 
levels decreased to 66% and 75% of control cells, respectively. For cells expressing NLS-β17, mRNA 
levels remained high at 98%. At a concentration of 5 µg/mL, Actinomycin D inhibits general 
transcription by RNA polymerase II. Cytoplasmic mRNA levels decreased to 32% in this control 
experiment. Equal GAPDH levels demonstrate that equal amounts of cells were lysed for the mRNA 
purification. 
Since the proportion of cells expressing the transgenic proteins is limited by the transfection 
efficiency, while the whole cell population was analyzed, the measured values represent most likely 
an underestimation of the real decrease of cytoplasmic mRNA in single cells with cytoplasmic 
aggregates. Nevertheless, the biochemical analysis demonstrates a significant decrease of 
cytoplasmic mRNA levels in agreement with our observations by immunofluorescence. 
Figure 78 | Purification of cytoplasmic mRNA by poly(T) DNA coupled Oligotex beads. (A) Scanning electron micrographs 
of Oligotex particles (1 µm in diameter) and oligo-dT cellulose at the same magnification. The small and uniform Oligotex 
particles (Qiagen) allow a quantitative purification (figure from Qiagen). (B) Quantification of cytoplasmic mRNA purified 
from HEK293T cells expressing the indicated proteins, or treated with Actinomycin D, a general transcriptional inhibitor. 
NES-β17 and TDP-F4 show a significant reduction of cytoplasmic mRNA (averages and SD from 3 independent experiments). 
(C) GAPDH levels of HEK293T lysates (input). 
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Proteasomal inhibition induces nuclear mRNA accumulation  
Proteasomal inhibition by MG132 prevents the removal of misfolded proteins from cells. Misfolded 
structures accrue increasingly over time (Zhao 2010, Ros 2004, Obeng 2006) and might disturb the 
cellular proteostasis similarly to the expression of individual aggregating proteins.  
The anticancer drug Bortezomib is a reversible 20S proteasome inhibitor causing a dose-dependent 
peripheral neuropathy. A study on the side effects of Bortezomib described unexpected nuclear 
retention and granule formation of polyA RNA in sensory ganglia neurons (Casafont 2010). Here we 
observed the distribution of mRNA in our system under proteasomal inhibition by MG132. Over time, 
MG132 treatment increasingly caused a cytoplasmic depletion and a nuclear accumulation of mRNA 
in SH-SY5Y cells.  
 
 
These experiments demonstrate that nuclear mRNA accumulation appeared as a consequence of 
long-term stress in cells. Shorter stress, such as 2 h of heat shock at 43 °C, did not cause a nuclear 
accumulation of mRNA.  
  
Figure 79 | SH-SY5Y cells under proteasomal inhibition by MG132 for the indicated durations. MG132 caused nuclear 
retention of mRNA (green) similar to cells expressing aggregation prone proteins in the cytoplasm. Representative images 
of 3 independent experiments. 
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mRNA disturbances in the R6/2 Huntington’s disease mouse model  
R6/2 mice are transgenic for exon 1 of human huntingtin, carrying an extended polyglutamine 
(polyQ) repeat of around 150 glutamines. R6/2 mice develop a progressive neurodegenerative 
phenotype, including involuntary stereotypic movements, tremor, epileptic seizures, brain shrinkage, 
and premature death (Mangiarini 1996).  
First symptoms were observed in R6/2 mice starting between 9 and 11 weeks of age (Mangiarini 
1996). The mice usually survive 13-14 weeks (Zhang 2003). Since we were interested in observing 
neurons suffering from early effects of huntingtin aggregation, but without major cell death yet, we 
decided to explore the distribution of mRNA in R6/2 mouse brains at 9 weeks of age. At his time, 
intraneuronal huntingtin aggregates were already forming, but symptoms just started to become 
apparent (Zhang 2003, Li 2005). Indeed, only one out of four R6/2 mice tested in this study showed 
initial tremors. The genotypes of R6/2 mice and littermates were confirmed by PCR. 
Particularly cortical and striatal neurons were reportedly affected by aggregation of polyglutamine-
expanded huntingtin in R6/2 mice (Mangiarini 1996), similar to human patients suffering from 
Huntington’s disease (Graveland 1985, DiFiglia 1997, Li 2005). Different antibodies recognize a 
variety of cellular huntingtin inclusions, such as somatic, neutrophil, or nuclear oligomers or 
aggregates (Ko 2001, Miller 2011). These diverse observations suggest a coexistence of 
distinguishable, potentially compartment-specific fragments and conformations of the huntingtin 
protein or its fragments. We decided to apply the monoclonal 3B5H10 antibody in our study (Miller 
2011). This antibody was selected to recognize specifically low-molecular-weight states of expanded 
polyQ proteins. These structures were strongly correlated to neuronal death in situ. 3B5H10 did not 
recognize polyQ repeats in higher molecular weight forms, as they appear in the major inclusion 
bodies (Miller 2011). Applying this antibody allowed us to observe specifically the early, potentially 
very toxic forms of huntingtin, and to correlate the appearance of these structures to the distribution 
of mRNA in neurons of R6/2 mice.  
Brains of R6/2 mice and littermates (controls) were fixed by paraformaldehyde and cut into sections 
of 20 µm thickness. In neurons of wildtype mice, the mRNA (hybridized to Cy5-(d)T30) was distributed 
over soma and neurites. The nuclear matrix appeared rather void of mRNA, which was concentrated 
in a small number of snRNPs, similar to cultured human cell lines. 
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In cortical and striatal neurons of R6/2 mice, neuronal phenotypes could be classified into three 
groups regarding their cellular distribution of mRNA: firstly, neurons with a wildtype-like, healthy 
distribution; secondly, neurons with lowered mRNA fluorescence in the cytoplasm and increased 
mRNA fluorescence in a number of speckled nuclear particles (2.4% of total neurons; partial nuclear 
mRNA accumulation); thirdly, neurons with a very low fluorescence of residual mRNA in the 
cytoplasm, and lowered levels of nuclear mRNA, which appeared rather in speckled structures than 
in the classical snRNP morphology (8.9% of neurons; complete nuclear mRNA accumulation). 
For most neurons showing a partial or complete nuclear mRNA accumulation, mainly cytoplasmic 
diffuse material or aggregates were stained by the 3B5H10 antibody, or cytoplasmic in combination 
with nuclear structures. Purely nuclear polyQ aggregates were hardly detected by 3B5H10.  
An abnormal distribution with nuclear accumulation of mRNA originally discovered in cultures of 
immortalized human cells could thus not only be reproduced in primary mouse neurons 
(experiments by Li Rebekah Feng; Woerner 2016), but also in cerebral neurons of the R6/2 huntingtin 
mouse model. Aggregate formation and accompanying toxicity progresses in animals rather over 
days and weeks than over hours as in cell culture models. The two distinct mRNA related phenotypes 
in R6/2 mice may therefore correspond to variations in aggregation progression, which may appear 
chronologically in individual neurons. Observations at different mouse ages or other disease models 
may allow further insights into the mRNA related cell pathology. 
 
Figure 80 | Distribution of mRNA (polyA RNA, green) in neurons of 9 week old wildtype and R6/2 mice, transgenic for 
human polyQ-expanded Htt exon 1. (A) Brain slices of 20µm thickness were labelled with an antibody specific for extended 
polyQ sequences (3B5H10, red), and nuclear DNA was stained with DAPI (blue). Cells showed mRNA accumulations in the 
nucleus with residual mRNA remaining in the cytoplasm (partial retention), or with strongly reduced mRNA levels in the 
nucleus and vanished mRNA in the cytoplasm (full retention). Representative images from 3 wildtype and 4 R6/2 mice. Scale 
bar length 10 µM. (B) Quantification of neurons with partial or complete nuclear mRNA retention phenotypes in wildtype 
and R6/2 mice.  
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Figure 81 | Brain sections of 9 week old wildtype and R6/2 mice were stained for mRNA (polyA RNA, green) and 
extended polyQ sequences (red). PolyQ extended human Huntingtin was stained with an antibody specific for extended 
polyQ sequences (3B5H10, red), and nuclear DNA by DAPI (blue). Neurons with partial (arrowheads) and complete nuclear 
mRNA retention (arrows) are indicated. Representative images from 3 wildtype and 4 R6/2 mice. Scale bar, 50 µm. 
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Low apoptosis signaling in 9 week old R6/2 mice 
As different populations of cells with distinct mRNA phenotypes were found in 9 week old R6/2 mice, 
their state of viability caught our interest. Especially cells with very low levels of cytoplasmic mRNA 
might have already been in a rather advanced stage towards cells death. Zhang et al. reported 
previously a sequential activation of caspases in R6/2 mice (Zhang 2003). They described a rather low 
activation of caspase-3 and caspase-9 in 9 weeks old R6/2 mice that significantly rose during the 
course of the following 3 weeks. At 12 weeks of age, caspase-8 and the pro-apoptotic mitochondrial 
Bax/Bim proteins became activated, concomitant to increased cell death by apoptosis trigerring the 
mortality of R6/2 mice (Zhang 2003).  
To analyze potential apoptosis signaling and cell death in association with the observed mRNA 
phenotypes, brain sections of R6/2 mice and littermates were stained for proteolytic activation of 
caspase-3. Therefore, a cleavage-specific antibody (cl.CAS-3) was applied to the brain slices of 9 week 
old R6/2 mice. Neurons displaying a partial or complete nuclear accumulation phenotype were 
generally not recognized by this antibody. A small fraction of cells stained positively for cleaved 
caspase-3 (< 0.1% of total neurons). These cells had almost undetectable levels of mRNA, which was 
likely already degraded at this stage. In wildtype mice, even fewer cells were recognized by 
antibodies against cl.CAS-3. Therefore, we conclude that the observed mRNA phenotypes (partial and 
complete mRNA accumulation) appear in an early stage towards cell death, which might rather 
appear as consequence of defective mRNA export and other malfunctions within the subsequent 
days.  
 
Figure 82 | Brain section 
from 9 week old R6/2 
mouse stained for cleaved 
caspase-3 (cl.CAS-3, 
yellow), mRNA (polyA 
RNA, green), polyQ-
expanded sequences
(3B5H10, red), and 
nuclear DNA (DAPI, blue).
(A) Overview over a brain 
section containing a single 
cleaved caspase-3 positive 
neuron. Scale bar length
50 µm. (B) Magnification 
of the cleaved caspase-3 
positive neuron marked in 
(A). Scale bar length
10 µm. 
B 
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Cytoplasmic mislocalization and aggregation of RNA exporter THOC2 
The majority of mRNAs are transcribed by RNA polymerase II and undergo cotranscriptional 
processing in snRNPs (small nuclear ribonucleoprotein particles), before mature mRNAs are exported 
to the cytoplasm. Involved in processing and export are the exon-junction-complex (EJC) and the 
transcriptional export complex (TREX). TREX comprises the THO complex and numerous accessory 
factors (Chi 2013). One of the largest associated proteins is THOC2 (>180 kDa) with a disordered 
region of around 400 amino acids at its C-terminus (low complexity region, disorder predicted by 
IUPRed; Meszaros 2009). THOC2 has been identified as a major interactor of the β proteins in 
HEK293T cells and in murine primary neurons (Olzscha 2011, Woerner 2016).  
Observing major mRNA distortions and mRNA accumulation in the nucleus, we became interested in 
the fate of THOC2 in cells with protein aggregation. In wildtype cells, the majority of THOC2 was 
distributed in the nuclear matrix. Similarly, in cells expressing nuclear β proteins, THOC2 was omitted 
from nuclear substructures, most likely nucleoli, as THOC2 surrounded the nuclear β protein 
aggregates.  
However, in cells expressing cytoplasmic β proteins, THOC2 mislocalized to the cytoplasm, where it 
was partly distributed, and partly sequestered into β protein aggregates.  
 
 
 
 
Figure 83 | HEK293T cells labeled 
for the mRNA export protein 
THOC2 (green), which is a major 
factor of the transcriptional 
export (TREX) complex, in 
absence or presence of 
cytoplasmic or nuclear protein 
aggregates (red). In control cells, 
THOC is distributed over the 
nuclear matrix, omitting certain 
substructures (supposedly 
nucleoli, see NLS-β17, with a 
wildtype-like distribution of 
THOC2). In cells expressing 
NES-β17 THOC2 was mislocalized 
to the cytoplasm and partially 
coaggregatied with the 
β proteins. While THOC2 was also 
mislocalized to the cytoplasm in 
cells expressing Htt96Q and TDP-
F4, here THOC2 formed separate 
inclusions in proximity to the 
aggregating proteins, contrary to 
the β proteins that directly 
recruited THOC2 into their own 
inclusions. Nuclear DNA stained 
with DAPI (blue). Representative 
images of 3 independent 
experiments. Scale bar length 
10 µM. 
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THOC2 likewise mislocalized to the cytoplasm of cells expressing Htt96Q or TDP-F4. Contrary to the 
β proteins, THOC2 now became secluded into separate aggregates, distinct from the Htt96Q or TDP-
F4 inclusions. Partly, a fraction of THOC2 remained nuclear, especially in case of TDP-F4. The 
mislocalization and aggregation of THOC2 occurred in all cases of nuclear mRNA retardation in 
presence of cytoplasmic protein aggregates, as described above.  
In cells expressing cytoplasmic β proteins, Htt96Q, and in part TDP-F4, mislocalized THOC2 was 
obviously unable to (re-)enter the nucleus. This may either occur due to sequestration of THOC2 into 
misfolded low- or high-molecular-weight structures, or possibly, due to defects in nuclear import. 
Also nuclear mRNA processing and export proteins require a functional nuclear import on their own, 
at least once after their cytoplasmic synthesis, or continuously in case of shuttling factors. 
Furthermore, cytoplasmic mislocalization of THOC2 was found in brains of R6/2 mice. Neurons that 
were recognized by antibodies against extended polyQ sequences (3B5H10) often contained 
cytoplasmic THOC2, which was missing at its natural nuclear localization. 
 
 
 
  
Figure 84 | Brain sections of 9 week 
old wildtype and R6/2 mice were 
stained for THOC2 (green) with an 
antibody specific for extended polyQ
sequences (3B5H10, red), and for 
nuclear DNA (blue). Neurons of R6/2 
mice with visible aggregates often 
contain cytoplasmic THOC2, which is 
strongly enriched in the nuclei of 
unaffected cells. Representative 
images from 3 wildtype and 4 R6/2 
mice.  
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siRNA-induced silencing of the transcriptional export complex protein THOC2  
THOC2 is an essential protein of the transcriptional export complex (TREX). Inactivation of THOC2 e.g. 
through misfolding, mislocalization, or recruitment into aggregates likely causes severe mRNA 
processing and transport problems (Chi 2013). Therefore, we were interested in the phenotype of 
cells with low levels of functional THOC2. 
3 days after transfection of siRNA targeting human THOC2, cellular THOC2 levels were decreased to 
13 ± 3% in HEK293T cells. At the same time, cytoplasmic mRNA levels vanished, while the nuclear 
mRNA speckles remained. Their size was comparable to snRNPs of wildtype cells (but significantly 
smaller compared to the protein aggregation-induced nuclear mRNA bodies; Figure 86).  
However, silencing of THOC2 was sufficient to cause nuclear mRNA retention, resulting in a strong 
decrease of cytoplasmic mRNA levels. Control siRNA targeting firefly luciferase had no effect on 
cellular THOC2 levels or on mRNA distribution.  
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Figure 85 | Knockdown of THOC2 by 
siRNA leads to a nuclear export 
inhibition of mRNA. (A) HEK293T and 
(B) SH-SY5Y cells were transfected with 
siRNA targeting human THOC2 for 3 
days. Cells were stained for mRNA 
(green), THOC2 (red), and nuclear DNA 
(blue). Knocking down THOC2 caused a 
strong reduction of cytoplasmic mRNA 
levels, but nuclear snRNPs remained 
wildtype-like. Differential interference 
contrast is shown in (B). Representative 
images of 3 independent experiments. 
Scale bar length 10 µM. (C) 
Immunoblotting for THOC2 
demonstrated the decrease in THOC2 
levels after 3 days of siRNA treatment. 
GAPDH levels shown for comparison.  
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Aggravated nuclear mRNA bodies in cells with pathogenic protein aggregation 
The nuclear mRNA bodies observed in cells with cytoplasmic protein aggregation were of strongly 
increased size and brightness in comparison to wildtype or THOC2 siRNA-treated cells. This result 
suggests that the presence of toxic protein aggregates in the cytoplasm caused a more severe 
phenotype with a potentially different composition of the nuclear mRNA structures.  
 
 
Under selective knockdown of THOC2 by targeted siRNA, nuclear mRNA processing or cellular 
responses to missing mRNA export may still be functional. In the presence of toxic protein 
aggregation, additional defects such as insufficient processing of premature mRNAs or a disturbed 
nuclear RNA degradation may be an explanation for the increased size of the nuclear mRNA bodies. 
Associated (misfolded?) proteins might furthermore increase the volume of the nuclear mRNA 
bodies, e.g. RNA binding and processing proteins.  
Sole nuclear mRNA export inhibitions might have different consequences for mRNA fate. The mRNA 
might be rapidly degraded, e.g. by the exosome, a nuclear quality control RNase (Houseley 2006). Or 
the mRNA may accumulate for longer times in the nucleus, accidently or for temporal storage and 
subsequent export. Depending on the outcome, lowered or increased mRNA levels may be found. 
To quantify the mRNA content of single cells, the complete mRNA fluorescence of was integrated 
(representing mainly nuclear mRNA in cells with cytoplasmic β protein aggregates) and compared to 
surrounding untransfected cells with a normal mRNA conent and distribution. Compared to wildtype 
cells, the integrated mRNA fluorescence of cells expressing cytoplasmic β proteins roughly doubled. 
In addition, the mRNA content of cells expressing Htt96Q and TDP-F4 rose significantly (to ~160-
175%; only cells with mRNA retention were analyzed for this quantification). Again, only a marginal 
increase in mRNA levels was found for cells expressing nuclear β proteins (~105-120%). The 
observed raise of cellular mRNA levels points towards a real, physical accumulation of mRNA in the 
nucleus. The mRNA was neither exported to the cytoplasm, nor immediately degraded in the 
nucleus. Protein misfolding and aggregation in the cytoplasm resulted in brightly fluorescent, nuclear 
bodies with substantially increased amounts of mRNA. 
Figure 86 | mRNA distribution (green) in SH-
SY5Y cells transfected with empty control
plasmids, siRNA against THOC2, or β23-EGFP 
(red). The mRNA is distributed over the 
cytoplasm and concentrated in nuclear 
snRNPs of control cells. The cytoplasmic 
mRNA vanished in cells lacking THOC2 or 
expressing β23-EGFP. While the nuclear 
snRNPs in cells treated with siRNA against 
THOC2 appeared almost wildtype-like, size 
and brightness of the nuclear mRNA bodies 
were strongly increased in cells with protein 
aggregates. 
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It would be highly interesting to analyze the RNA and protein content of the nuclear mRNA bodies in 
cells with cytoplasmic protein aggregates. A profound analysis of mRNA sequences may reveal 
functional and defective steps during mRNA processing. Especially mRNA splicing might be affected, 
while the polyA tail appeared to be synthesized due to the usage of a fluorescent poly(d)T probe. 
Identification of absent snRNP proteins or appereance of atypical factors should allow us to gain 
further insights into the mechanisms of nuclear mRNA body formation and associated cellular 
(dys-)functions. 
  
Figure 87 | Single cell quantification of total mRNA. (A) SH-SY5Y cells transfected with NES-β23 and stained for mRNA 
(polyA RNA, green), NES-β23 (c-Myc antibodies, red), and nuclear DNA (DAPI, blue) 24 h after transfection. The cellular 
polyA RNA fluorescence of cells with NES-β23 aggregates was integrated (red dashed line) and set in ratio to the integrated 
polyA RNA fluorescence of untransfected cells (white dashed lines) on the same focal area. (B) Quantification of total 
cellular mRNA content of single cells with the indicated protein aggregates and a nuclear mRNA accumulation phenotype, in 
relation to untransfected cells set to 100% (≥3 independent experiments; n = 4-13 cells, each). Cells with β proteins directed 
to the cytoplasm, Htt96Q, or TDP-F4 show an increase in cellular mRNA content, originating from an mRNA accumulation in 
the nucleus. Cells with nuclear β protein aggregates show no significant increase of cellular mRNA levels.  
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Cytoplasmic β proteins inhibit the cellular protein synthesis  
The loss of cytoplasmic mRNA should have immediate consequences on cellular protein synthesis. To 
examine the total translation, a 35S-Met pulse was performed in HEK293T cells. Methionine (Met) in 
newly synthesized proteins was labeled with the radioactive sulfur-35 isotope.  
24 h after transfection with β proteins, αS824, or empty plasmids, cells were treated with 35S-Met for 
20 min, washed intensely with cold PBS (4°C), and lysed instantly. Cell lysates were separated by SDS-
PAGE and evaluated by autoradiography and Coomassie Brilliant Blue staining. The incorporated 35S-
Met reflected the relative amount of newly synthesized proteins during the pulse. Coomassie Brilliant 
Blue stained the total protein of the lysates. Expressing β proteins in the cytoplasm (NES-β17, NES-
β23) drastically decreased the capacity of cells to synthesize new proteins, similar to β23 without any 
targeting sequence (Olzscha 2011). Calculating with a transfection efficiency of 50%, the protein 
synthesis rate of cells expressing NES-β23 fell to 26% of control cells, and cells expressing NES-β17 
reached a level of 50%. In contrast, the protein synthesis of cells expressing nuclear β proteins was 
only marginally decreased.  
The 35S-Met pulse experiments demonstrated that the general protein synthesis is strongly affected 
in cells expressing β proteins in the cytoplasm. Conversely, β proteins in the nucleus had only a minor 
impact. Defects in nuclear mRNA export and general nucleo-cytoplasmic transport inhibitions are 
therefore reflected in a strongly diminished protein synthesis rate. Consequently, cells become 
unresponsive towards external or internal signals and lose their capability of completing emergency 
responses to overcome stress situations.   
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Figure 88 | Inhibition of protein biosynthesis in presence of cytoplasmic aggregates. (A) HEK293T cells were transfected 
with β proteins or control vectors. 24 h after transfection, cells were pulse-labelled with 35S-Met for 20 min. Cell lysates 
were analyzed by SDS PAGE, autoradography, and Coomassie Brilliant Blue staining to detect newly synthesized proteins
(left) and total proteins (right). (B) Quantification of relative 35S-Met incorporation from (A). Averages and SD from three 
independent experiments are shown. Only the cytoplasmic β proteins caused a significant decrease of protein translation.  
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Translation initiation factors (eIFs) are trapped into cytoplasmic 
β protein aggregates 
In eukaryotes, enormous complexes of proteins come together with ribosomal subunits to form an 
elongation competent ribosome, making protein translation a highly complex and regulated process 
(Jackson 2010). Several protein translation initiation and elongation factors were found to interact 
with the β proteins in a co-immunoprecipitation experiment followed by a SILAC based mass 
spectrometric analysis (Olzscha 2011). The detected factors included subunits of the complexes eIF3, 
eIF4 and eEF1. Aberrant interactions with the β proteins might disturb their normal cellular activity 
or render them dysfunctional. 
Immunocytochemistry and confocal fluorescence microscopy was applied to analyze possible 
interactions between the β proteins and translation initiation factors. HEK293T cells were labeled 
with antibodies for eIF3A and eIF4G. In control cells, the translation initiation factors uniformly 
distributed within the cytoplasm, as they did in cells expressing nuclear β proteins or αS824. 
However, cytoplasmic β proteins partially coaggregated with the eIFs, especially NES-β17 and 
NES-β23. The only slightly toxic NES-β4 showed almost no colocalization with the two eIF proteins. 
Coaggregation of translation initiation factors as part of the cellular translation machinery may 
therefore contribute to toxicity and aggravate translational defects caused by nuclear mRNA 
retardation.  
 
Figure 89 | Eukaryotic translation initiation factors (eIF3A, eIF4G; green) interact and coaggregate with cytoplasmic 
β proteins NES-β17 and NES-β23 (red). Neither the only slightly toxic NES-β4, nor the nuclear β proteins or αS824 (red) 
disturbed the cytoplasmic homogenous distribution of eIF3A and eIF4G significantly. HEK293T cells were analysed 24 h after 
transfection with β proteins, αS824, or empty vectors. Nuclear DNA was stained with DAPI (blue). Representative images of 
at least 3 independent experiments.  
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Outlook: β proteins targeted to mitochondria are toxic and cause 
mitochondrial swelling 
To gain insights into mitochondrial proteostasis and the reaction of the organelles upon the 
appearance of local misfolding and aggregation, β proteins were fused to N-terminal mitochondrial 
targeting signals (originating from human COX8 or mitochondrial Hsp60, combined with a c-Myc 
sequence).  
Mito-β4 and mito-β17 were successfully targeted to mitochondria. They appeared distributed over 
the mitochondrial matrix without visible aggregate formation. 
 
 
Mitochondria were stained with the membrane potential dependent MitoTracker Red CMXRos. The 
dye stains mitochondria in living cells according to the physiological state of their mitochondria. 
While in wildtype cells mitochondria formed a fine tubular network, mitochondria were highly 
fluorescent, swollen in size and apparently rather separated from one another in cells expressing 
Figure 90 | β proteins targeted into the mitochondrial matrix of HEK293T cells. Mitochondria were stained with 
fluorescent MitoTracker Red CMXRos that accumulats in living cells depending on their mitochondrial membrane 
potential. Mito-β4 and mito-β17 were efficiently targeted to the mitochondria, which as consequence appeared swollen in 
size, forming visibly separated, highly fluorescent organelles (a phenotype described as “mitochondrial swelling”, typical for 
mitochondria initiating apoptosis/necrosis). In wildtype cells, a fine, interconnected mitochondrial network became 
apparent. Mito-β23 apparently formed cytoplasmic aggregates, whereby no mitochondria could be visualized by 
MitoTracker Red in these cells (24 h after transfection). The absence of mitochondria in these cells may suggest that mito-
β23 already disrupted the organells, potentially releasing their content to the cytoplasm, where the aggregation of β23 
proceeded. Representative images of 3 independent experiments. 
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mito-β4 or mito-β17. Such mitochondrial phenotypes have been known to occur under various forms 
of cellular stress (Blondin 1967), including high Ca2+ levels or increased amounts of reactive oxygen 
species. Swollen mitochondria are characteristic for cells undergoing apoptosis or necrosis. During 
the process of mitochondrial permeability transition, the mitochondrial inner membrane potential is 
rapidly lost due to an uncoupling channel. This channel is presumably formed by the c-subunit of the 
F1FO ATPase (Alavian 2014). Opening results in swollen, unconnected mitochondria with vanishing 
cristae, which consequently leads to cell death (Blondin 1967, Kim 2003). 
Mito-β23 in contrast did not colocalize with mitochondria, but formed large cytoplasmic aggregates 
instead. Moreover, the membrane potential-dependent MitoTracker Red staining was entirely 
absent in cells expressing mito-β23 (24 h after transfection). Mito-β23 likely reached the 
mitochondria and caused their destruction already within this period (since the targeting of mito-β4 
and mito-β17 was successful, and cytoplasmic/non-targeted β23 did not cause obvious damage to 
mitochondria; see below). Mito-β23 aggregation might then have proceeded in the cytoplasm. 
Observing different time points of cells transfected with mito-β proteins may be more conclusive. 
However, targeting β proteins to mitochondria impaired cell viabilities in the classical sequence-
dependent manner (β23>β17>β4). Hence, the β proteins localized to mitochondria were harmful for 
cellular life and caused significant toxicity.  
 
 
Two mitochondrial interactors of the (non-targeted) β proteins were mitofilin (IMMT) and ChChd3 
(Olzscha 2011). These proteins form a complex controlling and maintaining cristae formation. Upon 
downregulation of one of the proteins, mitochondria lose their morphology, cristae do not form any 
more, and mitochondria start to fragment (Darshi 2011, John 2005). Loss-of-function of these 
proteins results furthermore in mitochondrial swelling and dissociation of the mitochondrial 
network. A comparable phenotype was observed expressing mito-β4 or mito-β17. Deleterious 
interactions to these proteins might therefore contribute to the deleterious effects of β proteins 
targeted to the mitochondrial matrix. Deleterious interactions with mitochondrial proteins might 
happen in conjunction with or alternatively to the formation of the mitochondrial permeability 
transition pore.  
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Figure 91 | Viability of HEK293T cells expressing 
β proteins targeted to the mitochondrial matrix 
(here by fusion to the human mitochondrial-Hsp60 
targeting sequence). Viability was determined by 
the capability of the cells to reduce MTT. Cells 
expressing β proteins fused to a COX8 mitochondrial 
targeting sequence showed equal phenotypes and 
similar toxicities. The relative, sequence-dependent 
toxicity of the β proteins remained preserved. 
Averages and SD from 4 independent experiments. 
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However, expressing non-targeted β proteins aggregating in cytoplasm and nucleus did not cause any 
obvious deleterious effects to the mitochondria. Mitochondrial swelling was not observed, and 
mitochondrial morphology appeared wildtype-like.  
 
 
 
Targeting β proteins directly into the mitochondria increases the likelihood of interactions with local 
mitochondrial proteins, and thus to cause local damage. Most of the mitochondrial proteins are 
encoded in the nucleus and translocated into the mitochondrial matrix in an unfolded, chaperone-
bound state (Hartl 1986, Hartl 1987, Neupert 2007). Non-targeted β proteins in the cytoplasm most 
likely interacted mainly with newly-synthesized mitochondrial proteins (Olzscha 2011), before these 
were able to reach the mitochondria. Immediate mitochondrial damage did not occur under these 
conditions.  
 
Figure 92 | β proteins expressed in HEK293T cells, stained with the membrane potential dependent MitoTracker Red 
CMXRos. Cells with β protein aggregates (red) showed a wildtype-like mitochondrial MitoTracker fluorescence (green), no 
mitochondrial swelling, but normal interconnected mitochondrial networks. Representative images of 3 independent 
experiments. 
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Discussion 
Rationally designed β proteins are inherently toxic for cellular life 
Rationally designed β proteins were expressed in E. coli (bacteria), Saccharomyces cerevisiae (yeast; 
as demonstrated by Matthias Antonin), HEK293T and SH-SY5Y cells (human neuronal precursor cells 
isolated from kidney (Shaw 2002, He 2010) and neuroblastoma cells), and in primary cortical neurons 
(mouse; experiments performed by Li Rebekah Feng). The β proteins formed inclusions and caused 
toxicity in all these organisms. The relative, sequence-dependent toxic impact was preserved over 
the different kingdoms of life (β23>β17>β4). The β proteins are no natural sequences, so that their 
proteotoxicity arouse from their detrimental properties and interactions (toxic gain-of-function). 
When cellular proteins get recruited into β protein aggregates or otherwise lose their native 
functions, e.g. due to an imbalance in proteostasis, their absence certainly contributes to toxicity 
(secondary loss-of-function). The toxicity of the β proteins was not only maintained over the different 
life forms. Experiments on E. coli growth demonstrated furthermore that we could rationally modify 
the β protein sequences resulting in explainable effects on their toxicity. Mutations that disturbed 
oligomerization and fibril assembly significantly increased bacterial growth rates, while the addition 
of unpaired β-sheets offered “sticky” interaction surfaces and aggravated toxicity. The experiments 
confirm the notion that amyloid-like oligomer and fibril assembly impairs cellular life by general 
proteotoxic effects (e.g. Knowles 2014, Campioni 2010, Beerten 2012, Yang 2014 SciRep).  
Purified β protein aggregates were added to the culture medium of HEK293T cells, where they 
caused toxicity from the extracellular space. Pretreatment by sonication may break extended fibrils 
and create oligomers with increased surface hydrophobicity (as demonstrated by ANS fluorescence). 
This observation is congruent with the idea that mature, growth-saturated fibrils behave rather inert 
inside as well as outside of cells, whereas small diffusible oligomers with unsaturated sticky surfaces 
are increasingly prone to erroneous interactions. Such interactions may also occur towards cellular 
membranes or membrane receptors, e.g. facilitating cellular uptake by endocytosis (Tomiyama 2008, 
Haass 2007, Kayed 2003). We could show that the human prion receptor PrPC recognizes misfolded 
structures, such as the β proteins, Aβ, or infectious prion proteins. Upon binding to extracellular 
sites, PrPC induced neurotoxic signaling leading to apoptosis (Resenberger 2011). While this very 
specific mechanism may also owe protective functions, many other unspecific interactions may 
induce erroneous signaling and thereby disturb the cellular homoeostasis. 
β proteins targeted to the mitochondrial matrix or the endoplasmic reticulum (ER; Lisa Vincenz-
Donnelly; Dolfe 2016) were toxic despite no visible aggregate formation. The β proteins may be held 
soluble by binding to factors, such as BRICHOS in the ER (Dolfe 2016). Nonetheless, vital functions 
were affected. Mitochondria fragmented and seemed to initiate apoptosis. Whether toxicity arose 
mainly through an overload of specific chaperones or other detrimental interactions, remains to be 
elucidated. Misfolded structures were toxic in all these compartments – but significantly less in the 
nucleus. 
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β proteins structurally resemble natural amyloid proteins 
The β proteins were rationally designed to fold into β-sheet conformations by their polar-
hydrophobic side-chain pattern. Indeed, they assembled into fibrils in vitro independently of their 
exact amino acid sequence (West 1999).  
Purified from E. coli inclusion bodies in a denatured state, the β proteins reassembled in a 
physiological solution (salt, pH) into amyloid-like fibrils (Knowles 2014, Balbach 2002, Fowler 2007, 
Lindgren 2005). Electron microscopy demonstrated fibrils of several 100 nm length and around 3 nm 
in diameter. Especially β23 assembled into spherical oligomers, potentially highly toxic structures in 
and on cells (Chiti 2006, Haass 2007, Tomiyama 2008). Higher order fibrils occurred increasingly 
under mildly acidic conditions, which counterbalanced the overall negative net charge of the 
β sequences. In highly crowded cells, this negative net charge may be compensated by surrounding 
biomolecules and ions, causing their sequestration into aggregates. 
β-sheet structure and amyloid-like nature of purified and reassembled β protein fibrils were 
demonstrated by their spectroscopic properties. The CD-spectroscopic analysis revealed that the 
polypeptide chains were folded into β-sheet structures. Up to 30% of the sequence may be rather 
unstructured, which represents a significant deviation from the design.  However, it appears unlikely 
that a library of artificial sequences folds completely into a desired secondary structure, especially 
since the intramolecular complementarity of individual residues was not included in the design (West 
1999). Non-complementary residues cause steric hindrances in the inner core of the β proteins, 
which may lay the foundation for the unstructured regions and potentially for cellular toxicity. If all 
hydrophobic residues were perfectly packed into the inner core of a six-stranded β protein 
monomer, the β proteins might still assemble into fibrils through hydrophobic interactions on the 
front and back surface of a monomer. However, such fibrils may behave rather inert within living 
cells. Completely surrounded by shielding polar residues, fibrils should not be very prone to engage 
in unspecific interactions (Mannini 2014, Bolognesi 2010, Beerten 2012, Sant'Anna 2014, Calamai 
2003, Lazaridis 2013).  
 
 
Figure 93 | Schematic representation of an “ideal” β protein monomer, folded into a flat six-stranded β-sheet protein 
(left). The hydrophobic side chains (yellow) are perfectly packed into the interior, presenting open hydrophobic surfaces 
only on the front and back surfaces. Three β proteins monomers (turned by 90°, right) assemble into an amyloid-like 
fibril via their open hydrophobic surfaces. Only polar residues (red) remain on the surface. The structural model 
represents an ideal six-stranded β-sheet protein with a perfectly complementary hydrophobic core. In reality, the individual 
residues may not be matched so perfectly, resulting in structural deviations, such as partly twisted β-sheets or hydrophobic 
side-chains protruding to the surface of oligomeric or fibrillary assemblies. Such deviations may increasingly engage in 
aberrant interactions with metastable or unfolded proteins in the cell (figure adapted from Wang 2002). 
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Cellular proteins may cover imperfections in the β-sheet design (hydrophobic and flexible surfaces), 
so that metastable or not fully folded proteins are sequestered in a misfolded state. They may 
expose sticky surfaces on their own and recruit other cellular proteins into the now growing 
aggregates. Indeed, hydrophobic side chains of β23 occupied the highest volume, and ANS 
fluorescence revealed the largest hydrophobic surface patches on the most toxic among the 
β sequences. Structural deviations from the optimal cross-β-sheet template may also influence the 
formation and stability of oligomers. They may arise from sudden ruptures in fibril growth or fibril 
truncations, or follow off-the-road pathways to fibril assembly. Also here, especially β23 formed 
stable spherical oligomers from purified protein in vitro. 
FTIR spectroscopy on the β proteins confirmed the presence of β-sheet structures in an antiparallel 
arrangement. The global maximum of the Amide I band revealed flat cross-β-sheet structures, in 
contrast to rather twisted β-sheets occurring in many native proteins. The flat alignment of the 
β-sheets allows growth into continuous, linear fibrils. Detailed structures of spherical oligomeric 
assemblies as detected in the electron micrographs of β23 remain to be elucidated. However, the 
spectroscopic properties indicated high β-sheet contents in the overall populations of in vitro 
refolded β proteins, including the oligomers.  
Further evidence for the amyloid-like nature of the β protein assemblies came from their binding of 
amyloid-specific dyes, such as Thioflavin T, NIAD-4, and Congo Red. Thioflavin T and ANS allowed us 
to study the refolding of the β protein assemblies in vitro after dilution from denaturant (8 M 
guanidine). From denaturant, all three β proteins re-aggregated very rapidly into growing fibrils. The 
six-stranded β-sheet proteins fold most likely in an antiparallel orientation and form mostly short-
ranging interactions, which allows similar β-sheet domains to fold within milliseconds (de Alba 1999, 
Kuwata 2001). This initial nucleation phase could not be followed by the applied methods of this 
study. Contrary to disease-related amyloid proteins, the β protein monomers directly fold into 
β-sheet rich conformations, and then oligomerize via their major hydrophobic surfaces. Monomers 
as building blocks of amyloid fibers appear therefore in a high concentration very rapidly, resulting in 
very fast fibril assembly (Thioflavin T, NIAD-4 binding). On electron micrographs, oligomers and short 
(proto-)fibrils appeared within minutes, but matured into longer amyloid fibrils over several hours.  
 
Figure 94 | Process of protein aggregation leading 
through misfolding of native structures to 
nucleation, creating soluble on- or off-pathway 
oligomers. Some oligomers transform into smaller, 
ordered protofibrils, and consequently mature into 
bundled amyloid fibers. The β proteins were 
designed to fold into amyloid-like β-sheet structures. 
They folded in a high concentration from an 
unfolded state (in guanidine) directly into a β-sheet 
rich conformation (the “native state” of the 
β protein monomers), likely similar to the structures 
present in soluble oligomers and protofibrils. Thus, 
they omit the usually extended nucleation time of 
functional cellular proteins, required for misfolding 
and oligomerization (figure adapted from Soto 
2003).  
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Hydrophobic surfaces, conformational flexibility, and low-molecular-
weight structures correlate with cellular toxicity 
Cerebral fibrils were recognized as the visible hallmarks of neurodegenerative diseases more than a 
century ago (Alzheimer 1907/1995). Meanwhile, molecular analyses demonstrated that most of 
these fibrils consist of one or a few major protein components, which may recruit further 
biomolecules into growing inclusions. It is generally expected that most sequences are in principle 
able to fold into stable cross-β-sheet conformations (Dobson 2003, Hartl 2009). However, only a 
restricted set of proteins is associated with human misfolding diseases, while thousands of cellular 
proteins are synthesized, folded, and degraded without major problems. This raises questions about 
specific physicochemical and structural properties of such disease-related proteins, as well as of their 
interactors.  
Toxicity caused by the β proteins correlated very well with their Thioflavin T and NIAD-4 binding in 
vitro, whereas the aggregation kinetics were equal for the three sequences. Thioflavin T supposedly 
forms tiny micelles that change their fluorescence properties upon binding to repetitive patterns 
along cross-β-sheet fibrils (Khurana 2005, Krebs 2005, Biancala 2010). High Thioflavin T and NIAD-4 
fluorescence may relate to high binding affinities or to increased fibril formation of the highly toxic 
β proteins. However, quantifying insoluble fractions from cell lysates did not indicate quantitative 
differences regarding aggregate formation in vivo (Olzscha 2011). Electron micrographs rather 
suggested an increase in oligomeric structures by the most toxic β23. As Thioflavin T is expected to 
bind along grooves parallel to the cross-β-sheet axis, these grooves may occur in a more regular 
manner in the highly toxic β protein assemblies. The binding grooves of β4 may be slightly distorted, 
a possibility supported by small deviations of the β4 CD and FTIR spectra from ideal β-sheet spectra. 
NIAD-4 was developed for specifically binding Aβ and other amyloid structures. The chemical 
structure of NIAD-4 (aromatic rings, aliphatic hydrocarbons) and its ability to cross the blood-brain 
barrier suggest that hydrophobic interactions may influence (increase) NIAD-4 binding, too. To 
interpret the relative differences of Thioflavin T and NIAD-4 binding regarding structural properties 
on proteotoxicity, high-resolution structures and more knowledge about the binding sites of the dyes 
would be helpful.  
In vivo, the differential binding of NIAD-4 to cytoplasmic and nuclear β protein aggregates suggests 
structural alterations between the β proteins in the two compartments. Conformational differences 
may include a different degree of order within the amyloid core or different amounts of exposed 
hydrophobicity. Sequestration of cellular proteins may contribute to the NIAD-4 binding of amyloid 
fibrils in cells. The cytoplasmic aggregates proposedly sequester significantly more misfolded 
proteins into their structures (such as importin α, THOC2, NF-kB, luciferase-EGFP, and others), while 
the nuclear β protein aggregates appeared rather protected from aberrant cellular interactions. 
Molecular shielding might further decrease the NIAD-4 binding e.g. through covering of binding sites 
on the amyloid fibers.  
Low-molecular-weight oligomers formed by misfolded proteins are suspected to be highly 
detrimental. Protofibrils and spherical oligomers were detected on electron micrographs and by the 
A11 antibody. A11 was originally raised against an Aβ fragment presenting oligomeric Aβ epitopes. 
Interestinly, A11 recognizes specifically the oligomeric species of very different amyloid-associated 
proteins (Kayed 2003, Kayed 2006, Mamikonyan 2007). Extracts from human cells expressing 
β proteins were A11 reactive (Olzscha 2011), and β proteins refolded in vitro formed prefibrillar 
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species recognized by A11. Spherical oligomers were mainly visible on electron micrographs of β23. 
The A11 reactivity was highly comparable between β4, β17, and β23. Here, A11 may also have 
recognized short protofibrillar structures, which were visible on the electron micrographs of all 
β proteins.  
Interesting results were achieved by size exclusion chromatography of lysates from HEK293T cells 
expressing cytoplasmic or nuclear β proteins, and the solubility analysis by sedimentation. 
Distributed low- to intermediate-molecular-weight oligomers were predominantly found in the 
cytoplasm with sizes of several hundred kilodaltons. An analysis of their composition may be 
especially interesting, since these highly mobile oligomers potentially interact with numerous 
cytoplasmic proteins of distinct properties. In the nucleus, most of the β proteins were secluded in 
immobile megadalton structures. Whether these structures form by self-association or under the 
stringent control of cellular factors (such as NPM-1 or chaperones) remains to be explored further.  
Soluble protein oligomers were described for many neurodegenerative and other protein misfolding 
diseases. Oligomeric particles were observed in affected tissues or forming in vitro (Ferreira 2008). 
The ability of oligomer-specific antibodies to neutralize toxicity in cell culture experiments speaks 
strongly for a pathogeny of the soluble misfolded oligomers. Moreover, such sequence-independent 
antibodies potentially describe a general, common, hazardous protein backbone conformation that 
appears to be linked to proteotoxicity (Kayed 2003). In the case of Alzheimer’s disease, various 
studies on patients and on in vitro assembled oligomers demonstrated their adverse effects on 
synaptic plasticity and neuronal function. In a group of Japanese patients, a mutation (APP E693Δ, Aβ 
E22Δ) caused enhanced oligomerization and prevented fibril formation. Even though the secretion of 
Aβ was markedly reduced, these patients suffered from Alzheimer’s-type dementia, and the mutant 
peptide inhibited hippocampal long-term potentiation in rats (Tomiyama 2008). The “arctic 
mutation” (APP E693G) strongly enhances oligomerization and causes familiar AD (Nilsberth 2001).  
Toxicity of oligomers may be based on their conformational dynamics, cellular mobility, or their 
interactive surfaces (Haass 2007, Campioni 2010, Miller 2011). The appearance of soluble Aβ 
oligomers correlated in various studies much better with disease progression than of amyloid fibrils, 
which could not always be unambiguously related to dementia (Lue 1999, Haass 2007). While this 
does not relieve large fibers from any pathogenic influence, the results of this and other studies 
strongly suggest an increased hazardousness of small dynamic oligomers in cells.  
The three β proteins showed very similar ANS binding kinetics during refolding. ANS fluorescence 
intensity and blueshift correlated positively with toxicity and is in general related to aggregation 
propensity (Chiti 2006), indicating the highly hydrophobic environment the β proteins exposed to 
their surroundings. Hydrophobic patches were not completely buried inside the fibrils, but remained 
partially exposed. For β23, the ANS fluorescence was higher than for rhodanese or the extremely 
slowly folding MBP double mutant, refolding from denaturant in absence of GroEL. Harmful 
hydrophobic surface patches may aggravate with an increased occurrence of the highly flexible 
hydrophobic side-chain isoleucine in the sequence of β23 (see Table 1). β4, β17, and β23 hardly vary 
regarding their number of aromatic residues (1 Tyr, 3 Phe; 2 His in β17 and β23). Formation of 
aromatic moieties may increase the “stickiness” of misfolded structures, due to their hydrophobicity 
and repetitive π-stacking interactions (as in double stranded DNA; Bemporad 2006, Gazit 2005). The 
β proteins offer an interesting basis for a more sophisticated mutational analysis to correlate 
structural details to general proteotoxicity. 
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Uncovered hydrophobic surfaces likely engage in cellular interactions with (partially) unfolded or 
misfolded proteins. Occurring in a limited number, such ANS positive patches can be shielded by 
cellular chaperones. Hsp110 increasingly recognized the more toxic β proteins offering more ANS 
binding sites, even in absence of additional co-factors (Hsp70/40). Hydrophobic stretches play an 
important role in substrate recognition of the closely related Hsp70 (Rudiger 1997, Polier 2010). 
When misfolded proteins with hydrophobic surfaces occur persistently in large amounts, chaperones 
become increasingly recruited to sites of misfolding. In pathologic cases, this may initiate a vicious 
cycle overloading the cellular chaperone capacity, which eventually might lead to proteostasis 
collapse. Surface accessible hydrophobicity on the β proteins strongly correlated with their toxicity, 
and may thus represent a major structural origin of the toxic gain-of-function of misfolded proteins.  
Structural analyses of the purified β proteins refolded in vitro identified hydrophobic surface patches 
and a high aggregation propensity (in terms of amyloid marker binding) as the major determinants 
correlating to in vivo toxicity. Unstructured regions, even though enriched in β protein interactors 
(Olzscha 2011), and conformational flexibility remain rather unaddressed for the β proteins so far. 
Experiments detecting hydrogen exchange (by mass spectrometry, FTIR, or NMR) or spin relaxation 
measurements (by NMR) may allow insights into structural dynamics of the different β protein 
sequences and structural assemblies (Konrat 2014).  
So what are the major risk factors of misfolded sequences for causing toxicity in cells? Our studies on 
the β proteins and their interactors as well as other studies on protein aggregation suggest that 
exceeding certain thresholds of hydrophobicity on the surface of proteins in combination with an 
overall conformational flexibility of the native state enables proteins to convert from native to 
misfolded states with a stable, mostly hydrophobic core. Polar zippers of extended polyglutamine 
sequences or the yeast prion Ure2p are examples for hydrophilic cores in amyloid fibrils, too (Perutz 
1994, Chan 2005). Stable fibril cores surrounded by flexible tails may then support stable but non-
native interactions e.g. via induced fit(-like) mechanisms (Koshland 1958) to a broader range of 
cellular interactors that become sequestered into the inclusions. While one or a few major protein 
components mostly form the fundament of such aggregates, sequestered cellular proteins 
subsequently lose their native functions and aggravate the aggregation process on their own.  
Agreeing with the fact that β protein interactors were not especially hydrophobic overall (Olzscha 
2011), a certain length of continuous hydrophobicity may be enough to form a stable aggregation 
core, even though the rest of the sequence contains less hydrophobicity (Sawaya 2007). The total 
hydrophobicity may therefore not be very conclusive, but rather its concentration at specific sites 
together with dynamics and physicochemical properties of surrounding side-chains (Goldschmidt 
2010, Beerten 2012). Hydrophobicity should mainly stabilize non-native cellular interactions, while 
conformational flexibility promotes the “kinetic energy” to expose such hydrophobic patches. 
Structural flexibility facilitates the evolution of protein function and arises from a complex balance 
act between several evolutionary pressures (Bloom 2004). Experiments on different types of HypF-N 
oligomers directly support the hazardous nature of combining hydrophobicity with flexibility, 
strengthening “structural flexibility and hydrophobic exposure” as the “primary determinants [] to 
cause cellular dysfuntions” (Campioni 2010). 
“Proteins comprise of a general toxic potential” is the conclusion emerging from these studies. 
Evolution limited hazardous sequences and conformations, strongly restricting the available 
sequence space for cellular life. Examples include alternating polar-hydrophobic side-chains (Broome 
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2000) and steric complementary zippers (Goldschmidt 2010), typical properties supporting amyloid 
formation. Hazardous conformations may however come to the surface in an aging population that 
was never subject to evolution before, in cases of sporadic missense mutations that continuously 
appear, or under the general influence of stressors of the cellular proteostasis (such as chemical 
toxins or irradiation).  
Aggregation and toxicity in cytoplasm and nucleus 
β proteins without cellular targeting signals formed cytoplasmic and nuclear inclusions; none of those 
were associated with mitochondria or the secretory pathway. 100-150 metastable proteins enriched 
in disordered regions preferentially interacted with these β proteins (Olzscha 2011). The selection of 
interactors raises questions about each individual’s contribution to the overall toxicity in cells. 
Sequestration of non-essential proteins may cause toxicity only under specific conditions, if at all. 
Recruitment into aggregates may not necessarily affect the cellular level of functional proteins, or 
only to a non-harmful degree. So which pathways and functions are seriously affected? 
Cytoplasm and nucleus are connected through selective pores permeable for most ions, metabolites, 
and proteins below 30-40 kDa (Mohr 2009). The two compartments fulfill very distinct cellular 
functions and contain adapted proteostasis machineries. Many components have been described, 
partly in high detail, but their complex interplay and further functions are still under investigation, 
especially for the nucleus (Kim 2013). To increase our understanding of nuclear and cytoplasmic 
proteostasis, we directed the β proteins specifically into the two compartments. Cytoplasmic 
β proteins aggregated in juxtanuclear spherical inclusions surrounded by distributed oligomers. In the 
nucleus, several larger, morphologically irregular aggregates were confined to the nucleoli and 
associated to NPM-1. The three human disease-associated proteins Htt96Q, TDP-F4, and ParkinΔC 
formed mainly spherical, juxctanuclear inclusion in the cytoplasm, accompanied by several smaller 
aggregates. Even when fused to a nuclear localization sequence, Htt96Q aggregated already in the 
cytoplasm in HEK293T and SH-SY5Y cells. On the contrary, Htt96Q without targeting sequence 
formed nuclear inclusions in murine neurons. Here, Htt96Q fragments may have been actively 
transported into the neuronal nucleus as a protective mechanism (Park 2013), demonstrating the 
variability and specificity of handling misfolded structures by different cell types.  
Strikingly, all cytoplasmic protein aggregates caused an aggregation of FG-repeat proteins (residing at 
the interior lining of the nuclear pore complex (NPC)). Either the NPC proteins were sequestered into 
the β protein aggregates, or they aggregated separately next to cytoplasmic inclusions of Htt96Q, 
TDP-F4, or ParkinΔC. The fluorescence intensity around the nuclear envelope decreased significantly, 
indicating a real loss of functional proteins. The nuclear β proteins in contrast had no visible influence 
on NPC proteins, and the nuclear morphology appeared wildtype-like. Nuclear envelope and 
chromatin structure was often disturbed by cytoplasmic aggregation. Irregularities of nuclear pores 
and NPC proteins were previously reported for cells expressing extended polyglutamine proteins and 
on biopsies of Alzheimer’s patients (Suhr 2001, Sheffield 2006). Interfering with the nuclear pores 
might be especially harmful in view of the findings that a part of the NPC proteins are extremely long-
lived and insufficiently replaced after cell differentiation. Functional NPC levels indeed decrease 
during aging, which may lie behind an age-dependent deterioration of nucleo-cytoplasmic transport 
(Toyama 2013). These initial findings attracted our attention to study the nucleo-cytoplasmic 
transport in presence of misfolding and aggregation in the two respective compartments.  
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Inhibition of NF-κB by cytoplasmic protein aggregation may shift the 
balance between neuronal life and death 
We studied active nucleo-cytoplasmic transport on three different substrates: the transcription 
factor NF-κB, the general transport model S-GFP, and messenger RNA. In all cases examined here, 
cytoplasmic misfolding and aggregation generated severe transport inefficiencies in and out of the 
nucleus, whereas nuclear β proteins remained unreactive and caused virtually no disturbances.  
NF-κB is a ubiquitous transcription factor present in practically all cell types and tissues. NF-κB is 
widely known for its central role in immune cells, in the inflammatory response, in developmental 
processes, and for its influence on the balance between survival and apoptosis (Oeckinghaus 2011, 
Sen 2011). 
In neurons, NF-κB reportedly plays a role in neuronal plasticity, long-term memory formation, 
neuronal development, and survival. Brain-specific activators including glutamate (via both AMPA/KA 
and NMDA receptors) and neurotrophins point towards an involvement of NF-κB in synaptic 
plasticity. NF-κB (p50 -/-) knockout mice had low learning abilities and were sensitive to neurotoxins 
(O’Mahony 2006, Kaltschmidt 2009, O'Neill 1997). “NF-κB can therefore be considered as one of the 
most important transcription factors characterized in brain to date and it might be as crucial for 
neuronal and glial cell function as it is for immune cells” (O'Neill 1997). The deep involvement of 
NF-κB signaling in neuronal processes described over the past decade highlights the importance of 
effective NF-κB activation. Transcriptional regulation requires its translocation from cytoplasm 
(including distant parts of neurites) into the nucleus – for learning, long-term memory, neuronal 
plasticity, and, strongly connected to all that, neuronal survival (Salles 2014). 
As long as being functional, NF-κB signaling induced by e.g. Aβ complexes leads to neuronal 
protection and enhanced cell survival, however only in early disease states. In contrast to that, 
missing activation of NF-κB sensitized cells towards apoptosis, e.g. in knockout animals or inhibited 
model systems (O'Neill 1997). Thus, it may behave similarly in neurons of AD patients.  
NF-κB signaling is mainly regulated by binding to inhibitor κB (IκB) and upstream signaling arriving at 
the IκB kinase complex in conjunction with the NF-κB essential modulator (IKK/NEMO). NF-κB resides 
in its inhibited state in the cytoplasm, in neurites and synapses. NF-κB contains an NLS and a DNA 
binding site, which are both covered by complexing with IκB. Steps of activation e.g. by TNFα through 
the TNF receptor include phosphorylation and ubiquitination of IKK/NEMO. Then IκB and p65 (NF-κB) 
become phosphorylated, and IκB is ubiquitinated and degraded. Released NF-κB then is translocated 
through the nuclear pore for transcriptional regulation. Nuclear import is mediated by RanGTPase 
dependent karyopherins (importin α; Karin 2000, Salles 2014).  
NF-κB signaling is highly influenced by crosstalk among several signaling pathways, and many 
receptors send signals in opposing directions. The TNF receptor simultaneously induces a caspase-8 
dependent proapoptotic response that is usually outbalanced by prosurvival signaling of NF-κB. The 
highly integrating response changes from acute to chronic situations, so that a defective nuclear 
translocation of NF-κB preventing a transcriptional regulation can directly shift the equilibrium from 
prosurvival to apoptosis and cell death (Oeckinghaus 2011). NF-κB and upstream factors are target of 
many post-translational modifications (Salles 2014). The E3 ubiquitin ligase Parkin promotes survival 
through linear ubiquitination of NEMO, which prevents the induction of premature, stress-induced 
apoptosis and shifts the complex equilibrium towards prosurvival signaling (Müller-Rischart 2013).  
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The nuclear import of NF-κB was inhibited in practically all HEK293T cells with β proteins aggregating 
in the cytoplasm, and in most cells with Htt96Q, TDP-F4, or ParkinΔC inclusions (Figure 68). The 
translocation of NF-κB was prevented by the β proteins despite a functional upstream signaling up to 
p65 phosphorylation and IκB degradation. NF-κB levels were comparable to wildtype cells, 
demonstrating a strong blockage of nuclear NF-κB 
import. The fraction of cells with aggregates of Htt96Q 
or TDP-F4 was too low to quantify accurately p65 
phosphorylation and IκB degradation by 
immunoblotting. Single-cell observations or improved 
expression conditions may clarify the situation for 
these proteins. In contrast, cells with β proteins 
aggregating in the nucleus promoted quantitative 
nuclear NF-κB import.  
As described above, inhibition of transcriptional 
regulation through NF-κB shifts the signaling 
equilibrium towards apoptosis. Initiator caspase-8 is 
activated through TNFR-1, and caspase-8 transmits its 
signaling to downstream effector caspases directly in 
the cytoplasm. Once activated, caspase-9 and 
caspase-3 further inactivate nuclear transport and 
permeabilize the nuclear envelope, allowing caspases 
to enter the nucleus even by passive diffusion (Faleiro 
2000). Once a certain threshold or duration is reached, 
protein misfolding interfering with nucleo-cytoplasmic 
transport may therefore cause a vicious cycle that 
ultimately leads to cell death. This appears particularly 
harmful to neurons under proteome stress, especially 
if NF-κB is supposed to promote neuronal 
development and memory formation. 
Figure 95 | Activation of NF-κB by tumor 
necrosis factor receptor 1 (TNFR1) and its 
crosstalk to apoptosis signaling via caspase-8.
Activation of TNFR e.g. by TNFα causes the 
ubiquitin-dependent recruitment of linear 
ubiquitin chain assembly complex (LUBAC), 
which conjugates ubiquitin chains onto IKK. 
Phosphorylation and ubiquitination of IκB
results in its release from NF-κB. Itself 
phosphorylated, NF-κB reveals its NLS and is 
actively translocated into the nucleus. If not 
simultaneously inhibited by a transcriptional 
response of NF-κB, TNFR-associated via death 
domain (TRADD) activates the platform for 
caspase-8, finally inducing cell death through 
apoptosis (figure adapted from Gyrd-Hansen 
2010). 
Figure 96 | Induction of apoptosis by TNFα in the 
presence of cycloheximide. Cycloheximide inhibits 
protein synthesis and thereby prevents a response of 
activated NF-κB (amongst other effects). TNFα 
treatment in presence of cycloheximide prevents a 
regulated NF-κB through missing protein synthesis, 
but activates cellular apoptosis in absence of 
counteracting signals.  Consequently, nuclear 
transport becomes inhibited (cytoplasmic RAN) and 
the nuclear membrane are permeabilized, allowing 
apoptotic factors such as cytochrome c or caspase-3 
to enter the nucleus (figure adapted from Faleiro 
2000).  
  Discussion  ∙  131 
General defects in nucleo-cytoplasmic protein transport 
NF-κB is a highly regulated transcription factor influenced by complex signaling networks. To 
investigate the general nucleo-cytoplasmic protein transport we created S-GFP (NES-NLS-EGFP), 
which is continually transported in both directions through the nuclear pores. Quantifying the 
fluorescence of S-GFP in the two compartments revealed its inter-compartmental concentration 
gradient. These gradients were significantly decreased from 6-8 in wildtype cells (+/- nuclear export 
inhibitor, Leptomycin B) to only 3 fold in cells with β17 aggregates in the cytoplasm (Figure 72). The 
export efficiency went further down in cells expressing Htt96Q or ParkinΔC. Again, the β proteins 
targeted to the nucleus did not significantly interfere with the nucleo-cytoplasmic transport of S-GFP.  
Quantification of the S-GFP gradients demonstrated a significant loss of efficiency in general nuclear 
protein import and export, but not a complete blockage. UV irradiation and oxidative or other forms 
of stress have been reported to cause inhibitions of nucleo-cytoplasmic protein transport and to 
translocate only specific stress proteins, such as Hsc70 (Miyamoto 2004, Velazquez 1984, Kose 2012). 
The sequence of events and causal relationships remained however elusive so far. Depending on the 
circumstances, the loss of transport capacities might be a cellular accident, resulting from a damage 
caused by specific stressors (such as protein misfolding). Or cellular transport may be prevented as 
part of a cellular response mechanism, trying to overcome detrimental impacts and to recover 
cellular homoeostasis. Located at “predetermined breaking points”, even metastable sequences 
might then appear during evolution to induce a specific response, corresponding to a switch between 
the normal functional and a stress-triggered conformation. 
Interferences with nuclear mRNA export  
The experiments on S-GFP revealed serious protein transport inhibitions in and out of the nucleus in 
cells with cytoplasmic protein aggregation. These experiments generalize the inhibition of NF-κB 
translocation, since a set of karyopherins (importins and CRM-1) mediates the nucleo-cytoplasmic 
transport of most targeted proteins. Lowered cytoplasmic levels of S-GFP indicated that nuclear 
export of proteins is similarly affected as nuclear import. Messenger RNAs (mRNAs) are transported 
through the nuclear pores by a multitude of proteins and protein-RNA complexes. Many of these 
proteins are especially enriched in low-complexity regions that form disordered stretches, which 
supposedly mediate inducible protein-RNA interactions (Spolar 1994, Dyson 2002). Such proteins 
with prolonged disordered regions were shown to be prone for misfolding and aggregation, 
especially under a challenged proteostasis or in an unsuitable cellular environment (Raychaudhuri 
2009, Olzscha 2011).  
Consequently, we became interested in the efficiency of nuclear mRNA export. In HEK293T and SH-
SY5Y cells and in murine cortical neurons with cytoplasmic aggregates of the β proteins, Htt96Q, or 
TDP-F4, we observed a strong accumulation of mRNA in the nucleus, and simultaneously a reduction 
of cytoplasmic mRNA. No interferences were observed between mRNA export and nuclear β proteins 
or nuclear Htt96Q in murine cortical neurons (experiments performed by Li Rebekah Feng; Woerner 
2016).  
The morphology of the aggregation induced nuclear polyA-RNA-rich bodies was clearly distinct from 
the structure of polyA stained snRNPs in wildtype cells. The nuclear mRNA bodies were of 
significantly increased size and bright fluorescence, corresponding to an increase of nuclear mRNA 
levels beyond the total mRNA levels of control cells, which we confirmed by single cell quantification.  
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Similarly, a prolonged inhibition of the proteasome accumulated misfolded, polyubiquitinated 
proteins (Zhao 2010, Ros 2004, Obeng 2006) and caused an accumulation of mRNA in the nucleus 
with decreasing levels in the cytoplasm. Accumulation of nuclear mRNA was previously described in 
sensory ganglia neurons due to a dose-limiting neurotoxicity causing sensory ataxia, which appeared 
as a side-effect of the proteasomal inhibitor Bortezomib applied in cancer therapy (Casafont 2010). 
Polyubitquitinated proteins and a reduction of transcriptional activity were associated with nuclear 
mRNA granules. These granules contained several RNA-binding proteins, but lacked the mRNA export 
factors THOC4 (Aly/Ref) and Y14. The mechanistic origins of the nuclear polyA RNA granule formation 
remained unresolved in this case. It occurred however under a disturbed removal of misfolded 
proteins, and RNA export proteins were missing at their functional sites (Casafont 2010). 
THOC2 and the whole THO complex have been identified to interact with the β proteins in HEK293T 
cells and murine cortical neurons (Olzscha 2011, Woerner 2016). Confocal microscopy revealed 
cytoplasmic mislocalization and coaggregation of THOC2 in cells with cytoplasmic β proteins, or 
separate cytoplasmic aggregation of THOC2 next to Htt96Q or TDP-F4 inclusions. siRNA-mediated 
knockdown of THOC2 reduced cytoplasmic mRNA levels, while nuclear RNA appeared relatively 
wildtype-like. The knockdown demonstrated that THOC2 is an essential factor for mRNA export to 
the cytoplasm. Defective mRNA export can thus reproduce a similar, although less severe mRNA-
related phenotype as caused by protein misfolding and aggregation. Next to THOC2, knockdown of 
several individual THO proteins have recently been shown to cause a nuclear accumulation of mRNA. 
Thereby, the strong coupling of mRNA processing and export and its dependence on mRNA quality 
control was again demonstrated (Chi 2013). 
Huntington’s disease (HD) is a genetic disorder caused by an extended polyglutamine (polyQ) 
sequence in the first exon of Huntingtin. Transgenic R6/2 mice express this exon of human huntingtin 
with approximately 150 glutamines driven by the endogenous human Huntingtin promoter 
(Mangiarini 1996). R6/2 mice display a progressive neurological phenotype mimicking many features 
of HD in humans. Aggregation proceeds in the mouse brains over weeks in a physiological 
environment accompanied by aging phenomena. At weaning, the R6/2 mice were indistinguishable 
from their wildtype littermates. Starting from week 9-11 initial symptoms such as involuntary 
movements, shaking, and increased stress sensitivity appeared. After exhibiting increasingly severe 
symptoms for 2-3 weeks the mice died (Mangiarini 1996, Zhang 2003).  
In many neurons of 9 week old R6/2 mice, the mRNA was distributed equally to wildtype litter mates. 
The mRNA was distributed over the neuronal soma (cytoplasm) reaching out into neurites, while the 
mRNA was concentrated in distinct snRNPs in the nucleus. Nevertheless, a fraction of cells in R6/2 
mice developed phenotypes with disturbed mRNA distributions. About 2.5% of neurons showed a 
partial nuclear mRNA retention with increased levels of nuclear mRNA, accompanied by lowered 
mRNA levels in the cytoplasm. These neurons appeared similar to HEK293T and SH-SY5Y cells 
expressing Htt96Q, where the cytoplasmic mRNA was not as strongly depleted as in presence of 
β proteins or TDP-F4. In about 9% of neurons with a complete nuclear mRNA retention, cytoplasmic 
mRNA was virtually lost in addition to strongly decreased nuclear mRNA levels.  
The R6/2 mice thereby exhibited phenotypes with reduced mRNA levels in the nucleus that were not 
observed in this form after 1-2 days of transient Htt96Q expression in HEK293T or SH-SY5Y cells. 
Thus, mRNA degradation may occur in the mouse brain, potentially as a consequence of nuclear 
mRNA export defects. Addition of the polyA tail may also become affected, hiding the mRNA from 
poly(d)T probes. A third phenotype was detected in cells with cleaved caspase-3, which was hardly 
present in 9 weeks old R6/2 mice. Neurons positively stained for activated caspase-3 had almost 
entirely lost their cellular mRNA. As studied by Zhang et al., activation of caspases highly increased in 
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R6/2 mice beyond 12 weeks of age (Zhang 2003). Neurons of 9 week old R6/2 mice did not yet reach 
this stage. 
A cell cannot survive and keep up its normal functions, if significant amounts of mRNAs are not 
exported to the cytoplasm. A breakdown of most cellular functions has to follow, as proteins are 
continuously turned over. Cells lose their ability to respond to stimuli or stress situations, when 
translations of new transcripts vanish. Therefore, two scenarios are possible: either mRNA export to 
the cytoplasm is restored after an acute stress phase, or ongoing mRNA export defects will ultimately 
lead to cell death. Accordingly, it may be reasonable to assume that the different phenotypes 
observed in R6/2 neurons represent snap-shots of a development over time. The low frequency of 
neurons exhibiting decreased cytoplasmic and high nuclear mRNA levels (partial nuclear mRNA 
accumulation) might suggest a transient phenomenon that develops into a state defined by vanished 
cytoplasmic and low nuclear mRNA (complete nuclear mRNA accumulation). Finally, caspases are 
activated, inducing apoptosis and neuronal death, accompanied by a complete degradation of mRNA 
(Bushell 2004). 
 
Reduced cytoplasmic RNA and nucleolar volumes in dementia patients  
It would be highly interesting to observe interferences of protein aggregation with mRNA export and 
turnover during aging of different disease-related model animals, but even more in cerebral neurons 
of human patients. This should shed a light on the real chronology of events and the incidence of 
such mRNA processing and export interferences in human neurodegenerative disorders. 
First indications of a reduced cytoplasmic RNA content in neurons of patients suffering from senile 
dementia have been observed in the cerebral cortex in 1975 (Oksova 1975 AA Gist Embr/ Z Nevropat 
Psikhiat ISS Korsakova). Another group confirmed this finding two years later and determined mean 
losses of cytoplasmic RNA of often 30% in various regions of the brain (Mann 1977). The authors 
applied cytometric assays with the RNA binding fluorescent dyes azure A or B (Bennion 1975, Khan 
2016). In subsequent studies, similar reductions in cytoplasmic RNA have been described in 
conjunction with reduced nucleolar diameters in the neurons of patients of senile dementia or 
Alzheimer’s disease (Mann 1978, Mann 1983, Neary 1986). These obversavtions are highly 
interesting in the context of our findings that misfolded proteins associated to nucleolar structures, 
while partially altering their morphology (NPM-1). Nowadays, advanced techniques offer studying 
proteins and RNAs involved in this process in much higher detail. This should enable us to resolve the 
cellular mechanisms behind the findings from the 70s, which were hardly followed during the last 
decades any more. 
Figure 97 | Possible chronology of events during nuclear mRNA accumulation caused by polyglutamine expanded 
Huntingtin in neurons of R6/2 mice. The distinct neuronal states were observed at 9 weeks of age, but they may appear 
chronologically in individual cells. Neurons expressing polyglutamine expanded Huntingtin start to accumulate increasing 
amounts of mRNA in the nucleus, whereas cytoplasmic levels decline. Consequently, the nuclear mRNA is degraded, or 
general transcription ceases. Apoptosis is induced in a later stage of disease progression. mRNA (green), polyglutamine 
expanded human Huntingtin exon 1 (red), and nuclear DNA (blue) are labeled in representative images. R6/2 mice image 
from The Jackson Laboratory (left).  
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Localization of Huntingtin aggregates in cell cultures, mouse models, 
and human patients 
Cortical and striatal neurons of R6/2 mice were analyzed regarding disturbances of mRNA 
homeostasis (mRNAstasis). Beyond these brain regions, Huntingtin aggregates as well as the 
described mRNA phenotypes were found practically throughout the whole R6/2 brain. Already 
before, Huntingtin pathology has been described not to be restricted to certain brain areas in R6/2 
mice (Rattray 2013), possibly due to the extreme expansion of around 150 glutamines. Huntingtin in 
human patients comprises mostly of 37-60 glutamines. In humans, cortex and striatum were 
reported to be most sensitive and to become most strongly affected during disease progression 
(DiFiglia 1997).  
Under experimental conditions, the intracellular distribution of mutant Huntingtin strongly depends 
on cell types, specific constructs (fragments, GFP fusions, flanking sequences), and the selective 
visibility caused by the applied detection method. Many anti-Huntingtin antibodies are selective for 
certain species or conformations (Ko 2001, Miller 2011). In HEK293T and SH-SY5Y cells, Htt69Q 
mostly formed aggresome-like inclusions in the cytoplasm (even when fused to an NLS), while in 
murine embryonic neuronal cultures mostly nuclear aggregates were observed.  
In human patients and in HD mouse models, Huntingtin aggregates were distributed over cytoplasm 
and nucleus in a dynamic equilibrium (DiFiglia 1997, Hodgson 1999, Liu 2015). Overall, especially 
short N-terminal fragments are imported into the nucleus, whereas larger fragments or the full 
length protein accumulate preferentially in the cytoplasm (Sieradzan 1999, Hodgson 1999, Lunkes 
2002). Most likely, aggregation in both compartments contributes to neuronal toxicity, although the 
general omnipresence of the misfolded structures and the selectivity of the applied detection 
methods often challenge a clear, meaningful analysis (Hackam 1999 HuMolGen, Cooper 1998, 
Hackam 1999 PhilosTrans BiolSci). Toxicity of mutant Huntingtin was even described in the absence 
of visible aggregate formation. In R6/2 mice and in cell culture, we observed some cases of nuclear 
mRNA accumulation in the absence of Htt96Q or TDP-F4 aggregates, but in presence of distributed, 
presumably oligomeric material, so that distributed oligomerization might furthermore obscure the 
real origin of cellular toxicity (Hodgson 1999). 
In other studies, amelioration of symptoms in R6/2 mice could be achieved by a reduction of proteins 
that coaggregate with or modulate cytoplasmic Huntingtin (Mielcarek 2013). Intracellular antibodies 
selectively directed against cytoplasmic Huntingtin aggregates promoted their ubiquitination and 
degradation (Wang 2008), furthermore attesting a toxic role of cytoplasmic mutant Huntingtin.  
Intracellular aggregates of polyglutamine expressing cells were reported to sequester proteins of the 
nuclear pore complex and envelope, among them Nup62 and Lamin B (Suhr 2001). Recently, in R6/2 
mice and in HEK293T cells cytoplasmic, perinuclear Huntingtin inclusions were found to interact with 
and possibly disrupt parts of the nuclear envelope (Liu 2015). As consequence, the cell cycle of 
terminally differentiated neurons was reactivated, leading to cell death and progressive neuronal loss 
(Liu 2015). Similar to our observations, distorted nuclear membranes and a loss of nuclear pore 
complex proteins (the FG-repeat rich Nup-62) around the nuclear envelope appeared in HEK293T 
cells.  
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In their study, Huntingtin inclusions formed in the cytoplasm and to a small percentage in the nucleus 
(10-25%; Liu 2015). Live cell imaging showed that these inclusions maintained their location and grew 
in the respective compartment of initial formation. Perinuclear inclusions came into close contact 
and were surrounded by nuclear envelope proteins, but never crossed the nuclear envelope entirely. 
Intranuclear inclusions were never covered in nuclear pore proteins, suggesting their local formation 
(Liu 2015). When misfolded Huntingtin oligomers reached a seeding threshold at one site, rapid 
growth accumulated the vast majority of distributed mutant huntingtin within minutes (Ossato 
2010). There is no evidence for any endocytosis-like processes at the nuclear envelope, which could 
transport whole inclusions into or out of the nucleus e.g. for degradation. In agreement with our 
studies, increased mortality strictly correlated with perinuclear inclusions. They caused damage to 
the nuclear envelopes followed by cell death. Neurons with nuclear aggregates remained post-
mitotic and viable (Liu 2015).   
Figure 98 | Huntingtin-exon1-97Q-GFP (green) in HEK293T cells formed either cytoplasmic, perinuclear aggregates 
surrounded by nuclear pore proteins (Nup62, red) or inclusions within the nucleus (blue, DAPI). (A) Different classes of 
Huntingtin inclusions observed 24 h after transfection. (B) 3D reconstruction of a perinuclear Huntingtin aggregate that 
penetrated into the nucleus and caused severe deformations of the nuclear morphology from the cytoplasmic side, still 
being separated by the nuclear lamina (visible on individual z-stack images). Scale bar length 5 µM (figures from Liu 2015). 
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Cytoplasmic proteostasis – how does it promote misfolding and 
toxicity? 
The cytoplasm is the site of protein synthesis and the compartment most associated with protein 
folding, signaling, and metabolism, while in the nucleus genetic information is stored and 
transcribed. Cytoplasm and nucleus are connected through large nuclear pore complexes (NPCs). 
These are not only selection filters for large proteins (> 30-40 kDa), but also serve as platform for the 
nucleo-cytoplasmic transport machinery to actively enrich all kind of biomolecules in the two 
compartments.  
In our experiments on the consequences of cytoplasmic and nuclear aggregation, we observed many 
differences between these two compartments. Aggregation occurring in the cytoplasm was much 
more harmful to cells than in the nucleus. The toxicity of cytoplasmic aggregation became not only 
apparent by reduced viability and growth, but also by concrete cellular malfunctions including 
nucleo-cytoplasmic transport inhibitions, failing stress responses, mislocalization and coaggregation 
of proteins, and formation of nuclear mRNA bodies.  
Distributed, lower-molecular-weight structures mainly formed in the cytoplasm. Conformational 
differences between cytoplasmic and nuclear aggregates were indicated by an increased cytoplasmic 
solubility and a differential staining of the aggregates by the amyloid sensor NIAD-4. Aggregation 
appears to be strongly modulated by the compartment-specific environment. Additional factors 
regulating local aggregation and proteostasis remain to be explored, especially for the nucleus. 
Cytoplasmic aggregates recruited many cellular proteins and caused their mislocalization or separate 
aggregation, even of primarily nuclear proteins. Nuclear aggregates on the contrary appeared very 
unreactive, did not interfere with surrounding proteins, even those that were sequestered into 
cytoplasmic inclusions. Nuclear β proteins accumulated at nucleolar sites apparently isolated from 
the nuclear matrix and from chromatin.  
Nuclear luciferase-EGFP only aggregated under proteasomal inhibition, while under the same 
conditions cytoplasmic luciferase-EGFP remained largely soluble. This observation indicates the 
significance of proteasomal degradation of misfolded and unstable structures in the nuclear 
environment, where such structures otherwise rapidly accumulate. Nuclear proteostasis is 
characterized by the absence of autophagy and by lower chaperones levels. Beyond, this observation 
also demonstrates the influence of the local proteostasis machinery on the stabilization of misfolded 
structures in the cytoplasm. This may prevent their aggregation, but does also prevent their 
degradation and promote their distribution? 
Several mechanisms investigated in this study revealed how cytoplasmic aggregation disturbs 
fundamental cellular processes such as signaling transduction and the regulated translation of 
genetic information into new proteins. Mislocalization and (co-)aggregation of transport-related 
proteins likely contribute to the multiplicity of toxicity described for so many protein misfolding 
disorders (Soto 2003 and many others).  
However, especially proteins with extended polyglutamine sequences potentially appear to cause 
additional damage in the nucleus. Expanded polyglutamine proteins show a distinct aggregation 
mechanism (mainly driven by hydrogen bonds, forming polar zippers). Transcriptional dysregulations 
were ascribed to the high affinity of polyqlutamine sequences towards RNA-binding proteins and 
transcription factors in the nucleus (Schaffar 2004, Sugars 2003, Perutz 1994, Woulfe 2007). 
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Protein folding environment in the cytoplasm – keeping unstable structures alive? 
One of the potentially most hazardous situations may occur when newly synthesized and not yet fully 
folded proteins come into contact to misfolded proteins with hydrophobic or unstructured surface 
regions. A large number of newly synthesized proteins were found to interact with the β proteins, 
likely trapped before the structures folded and reached their cellular destination (Olzscha 2011).   
Similarly, large proteins with prolonged unstructured regions were prone to interact with misfolded 
and aggregated structures in the cytoplasm (Olzscha 2011). However, this does not seem to happen 
in the nucleus, where many, especially RNA-binding proteins, naturally contain extended 
unstructured regions. However, newly synthesized proteins do not appear here, and misfolded 
structures such as the β proteins are secluded to nucleoli. In the cytoplasm in contrast, partially 
unfolded structures have to be stabilized – to promote protein synthesis and folding and to prevent 
their immediate aggregation. This stabilization may however also increase the concentration of 
vulnerable, premature, or temporarily misfolded structures. While this may not be a problem under 
the control of a highly sophisticated chaperone and proteostasis machinery in a healthy cell, it may 
potentially turn harmful during aging, cellular stress, or the appearance of protein mutants or toxins 
that may overload or defeat the cytoplasmic proteostasis capacity, especially under chronic 
conditions. 
Several sub-compartmental structures harboring misfolded proteins with distinct properties were 
described for the cytoplasm. While a proteasome rich “juxtanuclear quality control” compartment 
(JUNQ) contains ubiquitinated proteins and the disaggregase Hsp104, terminally aggregated 
structures including mutated Huntingtin and prions were sequestered into “insoluble protein 
deposits” (IPOD), as described for S. cerevisiae (Kaganovich 2008). Precise properties of comparable 
misfolded structures in human neurons remain to be detailed. However, as observed also in this 
study, cellular proteins either were sequestered into major aggregates or formed separate inclusions, 
confirming the notion that their structural properties might influence their aggregation behavior. The 
number of distinct inclusions and their characteristics under typical disease conditions remain 
intriguing research questions. 
Efficient degradation or secluded deposition – a new role of the nucleus in 
proteostasis 
It is becoming clearer now that the nucleus may play an important role in the degradation and 
storage of misfolded protein structures, and thereby in the overall proteostasis of the cell. The 
protein folding environment of the cytoplasm is absent in the nucleus. Instead of nascent chains and 
not-yet fully folded proteins we find high concentration of proteasomes (Wojcik 2003, Chowdhury 
2015, Kleinschmidt 1983). Unstable structures may thus either be degraded directly, or be secluded 
from the nuclear matrix into insoluble localized particles. Both mechanisms need to be analyzed in 
more detail in future. A very rapid degradation of thermally misfolding luciferase supports the idea of 
a highly efficient removal of misfolded structures in the nucleus, compared to other compartments 
(Hageman 2007). Recent observations indicate that the cytoplasm even takes advantage of these 
nuclear characteristics, as distinct misfolded structures were specifically transported into the nucleus 
for degradation (Park 2013, Nielsen 2014). 
Nuclear chaperone levels increase during cellular misfolding stress (Velazquez 1984, Welch 1984, 
Kose 2012). Downregulation of a stress-specific nuclear Hsp70 importer (Hikeshi) “delays the 
attenuation and reversion of multiple heat shock-induced nuclear phenotypes”, a finding that clearly 
demonstrates the positive influence of molecular chaperones on nuclear proteostasis under stress 
(Kose 2012). 
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Cellular transport systems – high susceptibility towards misfolding? 
Between cytoplasm and nucleus, many proteins and some RNAs are actively transported by 
members of the karyopherin β family, regulated by the GTPase Ran (Cook 2010). Other proteins and 
complexes involved in molecular transport through the nuclear pore complexes (NPCs) include 
TAP:p15 and the THO complex for mRNAs (Braun 2002, Chi 2013), Xpot for tRNAs, and Xpo5 for 
snRNAs. The major transport proteins share structural similarities. They are large proteins (>100 kDa) 
with multiple binding sites. They contain prolonged disordered regions, which may become 
structured upon substrate binding (Kobe 1999, Cook 2007). They transit through multiple 
conformations and several compartments (Cook 2007, Cook 2010). Most likely, the interconnection 
of structural and functional features increases the vulnerability of transport proteins towards 
aberrant interactions or aggregation. Large proteins with tolerant multi-substrate binding sites, 
hydrophobic surface patches, conformational flexibility, and multiple native states are highly 
endangered species, especially when challenged with an unbalanced proteostasis (Chiti 2006, 
Olzscha 2011). Molecular transport factors adopt various distinct conformations, such as empty vs. 
substrate bound, import vs. export competent, or cofactor bound vs. released states. Different 
chemical and biological environments additionally challenge the structural stability of nucleo-
cytoplasmic transporters. While newly synthesized proteins cross the borders of most compartments 
in an unfolded and chaperone escorted state, large molecular complexes including associated 
transport proteins travel between nucleus and cytoplasm (Cook 2007).  
 
RNA processing and export proteins contain even longer disordered polypeptide regions. Apparently, 
these low complexity sequences of almost exclusively polar side chains create unique properties that 
keep these proteins soluble in the nuclear environment. But are they compatible with the presence 
of misfolded structures or a disturbed proteostasis in the cytoplasm? Here, such proteins may 
become trapped, engage in detrimental interactions, or aggregate. Once mislocalized, they may 
further aggravate transport inefficiencies. Several THOC proteins contain extended intrinsically 
unstructured regions, as predicted by different algorithms (IUPred, ANCHOR, DisProt). Many 
unstructured regions are potentially stabilized upon binding to cellular factors or complex formation 
in cells. Certain conditions may attract unstructured regions to engage in unspecific interactions, 
especially if their native interaction partners are missing. An abnormal cellular environment under 
Figure 99 | Structures and drawings 
illustrate the large conformational 
adjustments of nuclear exporters of 
importin α (Cse1) and tRNA (Xpot) in a 
cytoplasmic, free vs. a nuclear, substrate 
bound state.  Large conformational 
rearrangements accompany the transition 
from the autoinhibitory (Cse1) or open 
(Xpot) conformation in the cytoplasm to 
cargo and RanGTP association in the 
nucleus. While Cse1 folds back on itself in 
the cytoplasm in a compact state, RanGTP 
binding causes Cse1 to open up, revealing 
its importin α binding site. Differently, 
Xpot remains in a closed conformation 
until tRNA and RanGTP bind in the 
nucleus, whereas Xpot opens up for 
substrate release in the cytoplasm. 
Especially open conformations in a 
substrate-free state reveal large binding 
surfaces, which may explain the increased 
vulnerability of transport proteins towards 
deleterious interactions with misfolded 
species (figure adapted from Cook 2010).  
Cytoplasm 
Nucleus 
  Discussion  ∙  139 
proteostasis stress may furthermore support erroneous interactions. Intrinsically unstructured 
regions that were predicted to gain stabilization energy upon binding are common among the THOC 
proteins (Figure 100). With ~400 residues THOC2 contains next to an especially long unstructured 
region, which might be a reason why the protein was preferentially sequestered into aggregates of 
the β proteins (Olzscha 2011).  
 
Nucleo-cytoplasmic and other forms of molecular transport steadily keep up cellular gradients of 
proteins, RNAs, and other biomolecules. For a cell with an already overloaded chaperone capacity, 
defects in a second, such essential system as the molecular transport undoubtedly risks losing 
cellular homoeostasis, once a threshold of malfunction has been crossed. Interferences in cellular 
transport have been observed quite early in the cellular pathology here. Thus, they may be very 
crucial for the whole disease pathogenesis, and beyond lay the foundation for numerous further 
malfunctions that have been associated with protein misfolding and aggregation in neurons and 
other cells.  
Induction of cellular responses is central to regenerate homeostasis in cellular stress situations 
(Schröder 2005, Chakrabarti 2011). The defective Hsp70 promoter induction demonstrated that 
cytoplasmic β proteins strongly inhibited stress responses upon heat shock and cytoplasmic protein 
misfolding stress. Defects in stress response induction and regulated termination have been 
implicated in numerous neurodegenerative disorders. Consequences are ineffective chronic stress 
responses that are unable to restore homeostasis (Cowan 2003, Prahlad 2011, Halliday 2014). For 
example in mouse models of Parkinson’s disease, phosphorylation of eIF2α reduced the burden of 
newly synthesized proteins, but further limited the cellular capabilities to react upon chronic 
misfolding (Colla 2012, Parlato 2014). Ineffective transport inevitably interferes with signaling 
pathways and thereby potentially multiplies the original damage.  
Remarkably, deficiencies in subcellular protein targeting are even applied by nature in cellular stress 
sensors. The mitochondrial stress reporter ATFS-1 contains a mitochondrial and a nuclear localization 
sequence (equivalent to our S-GFP). ATFS-1 is usually imported into mitochondria, where it is 
degraded. Deficiencies in mitochondrial import adjust the nuclear concentration, which results in a 
mitochondrial unfolded protein response (Nargund 2012, Wolff 2014). This stress response system 
beautifully describes how evolution utilizes cellular malfunctions for stress sensing, finding nature’s 
own way of circumventing problems. If not now, then at some point in the future.  
Figure 100 | Human THOC proteins contain multiple intrinsically unstructured regions predicted to be energetically 
stabilized upon binding (blue regions; ANCHOR algorithm, Meszaros 2009). Intrinsically unstructured regions are present in 
many nuclear nucleic acid binding proteins. Such regions preferentially interact with proteins prone to misfolding and 
aggregation (Olzscha 2011, Raychaudhuri 2009, Meszaros 2009). 
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What makes neurons especially vulnerable? 
Many protein misfolding diseases are neurodegenerative disorders. They destroy distinct regions of 
the brain and give rise to specific symptoms of dementia (Ryan 2013, Braak 1991, Finkbeiner 2011, 
Clavaguera 2009, Levenson 2014). Additionally, protein misfolding has recently been associated to 
several non-neuronal disorders, such as diabetes (Mukherjee 2015), cancer (Silva 2014), and various 
other forms of systemic amyloidoses (Blancas-Mejia 2013). In case of damage, individual cells are in 
general easier to replace outside of the nervous system, so that a loss of single cells does not directly 
accrue in a dysfunctional organ. Terminally differentiated neurons and glia cells connect during 
embryonic development and childhood in an extremely complex and unique way, which explains 
their irreplaceable nature. Despite recent reports about cerebral stem cells (Gage 2013, Ming 2011), 
neuronal connectivity is essential for an efficient cognition and cannot easily be reproduced by 
neuronal replacement (Geerlings 2014, Meunier 2014, Williams 2013, Thompson 2004, Wen 2011). 
When irreplaceability encounters increased vulnerability in neurons of an aging organism, certain 
areas of the brain accumulate increasingly damage, until the first symptoms of dementia appear.  
In our studies on the fundamentals of protein misfolding in cells we focused on the structural 
properties of proteins that are especially prone to interact and become recruited into misfolded 
assemblies (Olzscha 2011). Proteins interacting with the toxic β proteins were often at central (hub) 
positions within cellular interactions networks. Such proteins often contain hydrophobic patches at 
interaction sites, in contrast to polar surfaces that shield proteins from their surroundings and keep 
the structures soluble. Many interactors of the β proteins contain prolonged unstructured regions 
(Olzscha 2011). These occur to an increased number in nuclear proteins. Many of these are RNA 
binding and processing proteins that may become structured upon substrate binding (Dyson 2002, 
Dyson 2005). Determining the cellular interactors of the β proteins should help to identify cellular 
functions and pathways that become disturbed early in cells affected from aggregation. Among the 
interactors were proteins involved in subcellular transport. Such proteins contain many and 
extensive interaction surfaces, as they bind not only numerous substrates, but also cofactors within 
large transport complexes, NPC proteins, release factors, and retrograde transporters that return the 
transporters to their original location (Cook 2007).  
Neurons are connected to each other with up to 60,000 connections in an extremely complex, self-
regulated manner. The longest cells of the human body with axons of up to one meter length are 
part of the neuronal system (Debanne 2011). Establishing activity-dependent connections strongly 
relies on the transmission of signals, which includes electric signaling as well as extensive molecular 
transport of proteins, RNA, and small organic signaling molecules or peptides to site-specific 
locations. Key areas of molecular trafficking include long distance transports between nucleus, soma, 
neurites, and synapses. For example, mRNA is specifically located for targeted protein expression at 
the synapse (Kanai 2005, Moon 2009, Hirokawa 2010). Signaling molecules are retrotranslocated 
from the synapse to the nucleus, a central mechanism for mediating neuronal plasticity (Castillo 
2012). And at least certain misfolded proteins are transported to the nucleus for clearance by the 
proteasome, a pathway that itself is susceptible to aggregation (Park 2013). In neurons, such 
misfolded proteins may have to travel over extremely long distances, along which they can spread 
misfolding and damage cellular systems. Beyond nucleo-cytoplasmic, neuron-wide transport is 
essential for neuronal activity and survival.  
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In Drosophila, expression of cytoplasmic polyQ proteins disrupted axonal transport by titrating out 
soluble motor proteins (Drosophila huntingtin). By a different mechanism, nuclear polyQ proteins 
induced neuronal apoptosis in the absence of axonal blockages, most likely caused by transcriptional 
dysregulation (Gunawardena 2003, Long 2014). Cytoskeletal transport problems caused synaptic loss 
in early stages of Alzheimer’s disease and mild cognitive impairment (Scheff 2006, Knobloch 2008). 
Especially the damage of synaptic terminals was described as early structural correlate to dementia 
progression and an early cause of injury in the neuronal network (Serrano-Pozo 2011).  
For neurons, effective communication among the extensive cytoplasmic protrusions and the nucleus 
is fundamental for neuronal activity, plasticity, and survival (Chevalier-Larsen 2006). Neuronal 
plasticity, brain wiring, and higher brain functions strongly depend on nuclear import and export, 
which we described to be compromised multifaceted through cytoplasmic misfolding and 
aggregation. Recently, mutant huntingtin has been shown to inhibit mitochondrial protein import by 
interacting directly with the TIM23 mitochondrial import complex. The mitochondrial import defects 
and subsequent neuronal cells deaths was attenuated by overexpression of TIM23 (Yano 2014). 
These findings further demonstrate the high vulnerability of protein transport factors towards 
aberrant interactions. 
Additional reasons for a high neuronal susceptibility may originate from a different role of autophagy 
in these highly complex cells. Neurons mainly live on glucose and protect their proteomes. Even 
under starvation, neurons show only limited autophagy. While artificially enhancing protein turnover 
by autophagy caused serious neuronal damage, inhibiting autophagy under stress increased their 
survival. Unspecific protein turnover may be too harmful for the complex neuronal architecture, so 
that neurons cannot fully make use of autophagy without damaging themselves (Koike 2008, 
Yamamoto 2014). 
Perturbation of cellular transport seems to be an early and widespread event in the multifactorial 
disease pathology of neurodegenerative disorders. Transport problems consequently trigger a 
cascade of cellular malfunctions that ultimately lead to neuronal failure and death, spreading over 
non-replaceable regions of our brain (Gunawardena 2003, Soto 2003).  
Figure 101 | Dendritic and axonal 
trafficking of protein complexes, 
RNA granules, vesicles, and 
organelles. In a typical neuron, 
numerous dendrites and a single 
axon (on the right) extend from 
the cell body. Molecular motors 
of mostly the kinesin and dynein 
families transport cargo along 
microtubules in the anterograde 
and retrograde direction, 
respectively. Dendrites, axons, 
and synapses strongly depend on 
a defined local environment and 
the delivery of site-specific 
cargos, e.g. for local translation of 
membrane receptors or other 
signaling-related molecules. RNA 
is thereby transported in the form 
of ribonucleoprotein granules 
(Kanai 2004) in both directions 
with the help of kinesin or dynein 
motors (figure adapted from
Hirokawa 2005).  
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Therapeutic strategies 
Exploring the fundamentals of protein misfolding and aggregation and corresponding cellular 
defense mechanisms may lead us to novel starting points in drug development or for innovative 
therapies. This study revealed that intracellular molecular transport inefficiencies likely contribute 
early in the pathogenesis of neurodegenerative and other protein misfolding diseases. Defects in 
nucleo-cytoplasmic transport have been furthermore implicated in dipeptide repeat disorders and in 
cancer development (Jovicic 2015, Zhang 2015, Freibaum 2015; Mor 2014). An early recovery of this 
central function may prevent many detrimental consequences arising from the loss of cellular 
gradients and of a correct localization of biomolecules in the cell. 
However, reversing the pathologic defects resulting from protein misfolding and consequent 
aberrant interactions is highly challenging if not impossible, since malfunctions are not limited to a 
single factor or pathway. Toxicity arising from misfolded proteins interferes with the activity of 
numerous metastable proteins that are often part of large protein complexes or interaction networks 
(Olzscha 2011). A significant part of the cellular proteome and other biomolecules may be 
functionally deactivated, destroyed, or even gain toxic functions on its own (Oskarsson 2015, Olzscha 
2011, Kretzschmar 2013, Butterfield 2010). This includes the nucleo-cytoplasmic transport and the 
large, highly coupled mRNA processing and export machinery. Avoiding a single or few of these 
detrimental interactions or trying to repair their consequences leaves behind a variety of remaining 
dysfunctions. A classical single target - single molecule strategy may therefore never be able to 
reverse the dysfunctions originating from gain-of-function related proteotoxicity.  
A new role for the nucleus in the prevention of toxic protein aggregation? 
Avoiding damage therefore seems especially advisable for all neurodegenerative and other 
amyloidoses. Priority lies in the removal of the “toxic compound”, referring to all aberrant toxic 
protein species and aggregated assemblies that may give rise to further misfolding, as interferences 
in the aggregation process or attempts to dissolve cellular aggregates may distribute even more toxic 
material (Sperling 2011, Campioni 2010, Haass 2007). Thus, the whole range of misfolded states and 
their potential recognition signatures need to be characterized in high detail, attempting e.g. an early 
removal via cellular degradation pathways. Innovative strategies may thereby include cellular 
proteins that recognize hazardous species, transport them to less sensitive (sub-)compartments, or 
hand them over to degradation machineries directly. The nucleus may thereby move into the focus 
of basic and therapeutical research, as this study demonstrated the high tolerance of the 
compartment towards misfolded structures. Moreover, recent work indicated the targeted 
translocation of cytoplasmic misfolded proteins into the nucleus for degradation (Park 2013). A 
similar approach may be based on chaperone-mediated autophagy, where potentially toxic 
conformations are specifically recognized and targeted to autophagosomes (Filimonenko 2010). 
Despite the single factors that have been described, such as the misfolding selective Hsp40 
chaperone Sis1p and the autophagy adaptor complex ALFY, respective cellular machineries remain 
largely to be explored (Park 2013, Filimonenko 2010).  Therefore, the specific nuclear or 
autophagosomal targeting of defined misfolded structures represents a promising approach to 
release the cytoplasm from an overwhelming burden of hazardous conformations. Ideally, this may 
lead to preventive therapies, removing misfolded structures long before they accumulate and cause 
serious damage to cells. 
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Increasing proteostatic resilience 
In all cells, misfolded protein conformations are continuoesly forming and being removed. A novel 
therapeutic strategy may lie in enhancing the proteostasis machinery to increase cellular resilience 
towards the occurrence of misfolded species. This includes their removal and turnover, but 
furthermore the cellular capabilities of protein folding, maintenance, and aggregation prevention.  
Indeed, aging seems to be accompanied by an accumulation of misfolded soluble and insoluble 
proteins (Gupta 2011, De Cecco 2011, David 2010). While protein synthesis and oxidative 
phosphorylation decline, including the levels of the respective cellular machineries, protein 
degradation and the activity of small heat shock proteins seem to gain in significance (Walther 2015, 
Jonker 2013, Li 2013). Age-dependent adaptions of the proteostasis network already occur naturally, 
which may be protective or harmful. The intriguing question remains, whether targeted modulations 
may help to reduce the damage of toxic conformations, increasing cellular viability and finally life 
expectancy of humans. In a long-lived mutant of Caenorhabditis elegans, increased levels of small 
heat shock proteins sequestered misfolded proteins into chaperone-enriched aggregates, 
accumulating potentially highly toxic soluble structures into less harmful insoluble aggregates 
(Walther 2015, Lu 2014). Despite such strategies may not ultimately heal neurodegenerative disease 
patients yet, a sophisticated intervention into the proteostasis network may help one day to 
significantly improve neuronal proteostasis in aging humans and to improve the quality of life for 
many years. 
Neurodegenerative damage associated to protein misfolding can barely be repaired once it reached a 
certain threshold. A powerful and therapeutically fine-tuned proteostasis machinery is required 
(Morimoto 2008), equipping cells with the capabilities to proactively prevent exceedingly harmful 
misfolding damage. Recent research as well as our studies have shown that cells may be either 
unable to mount stress responses under conditions of neurodegenerative diseases, or misfolding 
might result in a chronic response that is unable to clear the aggregation load and finally leads to 
chronic inflammation, apoptosis and cell death (Roth 2014, Roberts 2014, Zhang 2008, Hoozemans 
2005). Strategies investigated so far include the induction of a full, Hsf-1 regulated heat shock, which 
simultaneously increases the levels of multiple molecular chaperones, or the activation of autophagy 
e.g. by the mTOR inhibitor rapamycin. However, these approaches were accompanied by respective 
side-effects (Scheper 2015). A hyperactive heat shock response may induce cancer or even other 
protein misfolding disorders.  
The nuclear proteostasis machinery and its connection to the whole proteostasis network remains to 
be explored in detail (Nielsen 2014, Hipp 2014, Labbadia 2015). Finding and understanding new key 
members that mediate proteostasis balance between the different cellular compartments may offer 
a great potential for a therapeutic refinement. More sublte, targeted interventions into the 
proteostasis network include a specific induction of individual effectors or of specific arms of stress 
response pathways. Such strategies may shift the balance from irreversible to reversible aggregation 
(Kaganovich 2008) and enable an early and efficient refolding or removal of misfolded proteins, long 
before proteostasis is at serious risk. Maintaining cellular proteostasis hopefully may allow us one 
day to keep our memories and skills in forms of neuronal and glial networks viable for many more 
years. 
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Experimental procedures 
Molecular genetics 
Expression systems 
For expression in mammalian cells, all β-proteins, S-GFP (NES-NLS-EGFP), and the cytoplasmic, 
nuclear or mitochondrial targeted versions of Luciferase-EGFP (Gupta 2011) were cloned into 
pcDNA3.1 Myc-His A vectors (Invitrogen) via KpnI and XbaI. All sequences were followed directly by a 
stop codon, excluding the expression of any 3’ c-Myc- and His-tags of the vector. 
Myc-Htt96Q was cloned into pcDNA3.1 Hygro(+) by Gregor Schaffar (Schaffar 2004). 
TDP-F4 was received from the nonprofit repository Addgene (TDP-43-EGFP construct 4; Yang 2010). 
ParkinΔC (ParkinW453X) was kindly provided by Dr. Konstanze Winklhofer (Winklhofer 2003).  
For bacterial expression (E. coli), the N-terminally c-Myc-tagged β proteins and αS824 were cloned 
into pTrcHis (IPTG inducible; Invitrogen) or pBad (titratable expression by carbon sources such as 
arabinose, glucose, glycerol), excluding expression of His-tags included in the vector. For purification, 
αS824 was cloned into the pProEx HT vector N-terminal of the His tag, which was cleaved off by TEV 
protease during purification of the protein. 
Sequence design 
The β proteins and αS824 were fused to an N-terminal c-Myc tag (MCEQKLISEEDLG) directly 
followed by (Olzscha 2011, West 1999):  
β4   
MQISMDYQLEIEGNDNKVELQLNDSGGEVKLQIRGPGGRVHFNVHSSGSNLEVNFNNDGGEVQFHMH 
β17 
MQISMDYEIKFHGDGDNFDLNLDDSGGDLQLQIRGPGGRVHVHIHSSSGKVDFHVNNDGGDVEVKMH 
β23 
MQISMDYNIQFHNNGNEIQFEIDDSGGDIEIEIRGPGGRVHIQLNDGHGHIKVDFHNDGGELQIDMH 
αS824 
MYGKLNDLLEDLQEVLKNLHKNWHGGKDNLHDVDNHLQNVIEDIHDFMQGGGSGGKLQEMMKEFQQVLDELNNHLQGGKHTVHHIEQNIKEIFHHLEELVHR 
NES-β4/β17/β23/αS824 were generated by integrating a consensus NES (LELLEDLTLG; la Cour 
2004) behind the c-Myc tag of the β proteins and αS824, resulting in 
(MCEQKLISEEDLELLEDLTLG).  
NLS-β4/β17/β23/αS824 were generated by inserting two repeats of the SV40 derived NLS 
(DPKKKRKV) N-terminal of c-Myc tagged β proteins or αS824, resulting in 
(MAADPKKKRKVDPKKKRKVDTYGAGEQKLISEEDLNGASS).  
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Mito-β4/β17/β23/αS824 I and II were generated by inserting either the mitochondrial leader 
sequence of human mtHsp60 (MLRLPTVFRQMRPVSRVLAPHLTRAYAKDVKFGCEQKLISEEDLGMQ 
IS) or of human COX8 (MSVLTPLLLRGLTGSARRLPVPRAKIHSLCEQKLISEEDLG) followed by a 
c-Myc sequence N-terminal to the β proteins or αS824. Both leader sequences were functional.  
To generate EGFP fusion proteins, the N-terminally c-Myc tagged β proteins or αS824 were fused 
N-terminal to EGFP (amplified from pEGFP-N1), connected via a flexible 16 amino acid long linker 
sequence (TSGSAASAAGAGEAAA; Chang JMB 2005) and cloned via KpnI and XbaI into pcDNA3.1 
Myc-His A (Invitrogen). Any 3’ tags of the vector are not expressed, omitted by a stop codon directly 
behind the EGFP sequence. 
The NLS-β23 (K7T, K15T) and NLS-EGFP (K7T, K15T) nuclear import mutants were generated by site-
directed mutagenesis, amplifying the respective NLS plasmids by PCR with an oligonucleotide 
carrying the nucleobases to be exchanged (Kalderon 1984, Hodel 2001). 
S-GFP was generated by inserting the described NLS and NES connected via short linkers with an 
HA tag (MAADPKKKRKVDPKKKRKVDTYGAGYPYDVPDYALLELLEDLTLSGSDL) N-terminal to EGFP 
(from pEGFP-N1) via KpnI and XbaI into pcDNA3.1 Myc-His A (Invitrogen), omitting other tags of the 
vector. 
Targeting versions of the β proteins and αS824 and constructs fused to EGFP were created by PCR 
amplification, fusing oligonucleotides with overlapping sequences and amplifying the fused 
constructs with short 5’ oligonucleotides for both strands. Integrated KpnI and XbaI restriction sites 
allowed restriction and ligation into the described vectors. See below for details of the individual 
steps of cloning. 
American firefly luciferase, in form of the wild type protein or including a single or a double point 
mutation selected for thermal destabilization of luciferase, was fused to EGFP for use as fluorescent 
proteostasis sensors (Gupta 2011). Here, the luciferase-EGFP proteins were combined with nuclear 
export signals, nuclear localization sequences, or mitochondrial targeting sequences (as described for 
the β proteins, excluding the c-Myc tag) to direct the sensors specifically into these compartments. 
The targeting signals were fused N-terminally by PCR and ligated into pcDNA3.1 vectors using KpnI 
and XbaI restriction sites.   
Agarose gel electrophoresis 
DNA fragments were separated in 0.8-1.5% agarose gels (LE agarose, Biozym) casted in TAE buffer 
(50x stock per liter: 242 g TRIS base, 57 mL acetic acid, 37 g EDTA), including 0.01% SYBR Safe DNA 
Gel Stain (Invitrogen). Samples were applied in DNA loading buffer (6x stock solution: 30% glycerol, 
0.25% bromophenol blue) with a 1 kb DNA ladder (Promega) and run at 100 V in TAE. For visualizing, 
the gel was illuminated using blue light (Sage Imager 2.0, Invitrogen). 
Polymerase chain reaction (PCR) 
For molecular cloning or sequence analysis, DNA fragments were amplified by PCR (Mullis 1986). The 
components of a standard PCR are described below. In case of inefficiency, concentrations of 
primers, template, magnesium ions, or the annealing temperature were modified.  
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The PCR reaction was run including Herculase DNA Polymerase (Agilent Technologies) or Pfu DNA 
Polymerase (Promega) in T3 Thermocyclers (Biometra). For mutagenesis, the complete plasmids 
were amplified in 20-25 cycles, syntheses of inserts for cloning or fusion of DNA fragments were 
performed in up to 30 cycles. 
 
Table 2 | Standard PCR setup. 
Reagent Volume 
DNA template (50-300 ng/µL) 1 µL 
5’-Primer 0.1 µM 5 µL 
3’-Primer 0.1 µM 5 µL 
dNTPs (2.5 mM each nucleotide) 5 µL 
10x Herculase buffer 5 µL 
Herculase (5 U/µL) 1 µL 
ddH20 added to a final volume of 50 µL 
 
Table 3 | Standard PCR cycling program. 
Reaction Step Temperature Time 
Initial denaturation 95°C 2 min 
Denaturation 95°C 30 sec 
Annealing 40-60°C 30-60 sec 
Elongation 72°C 1 min/kb 
Final Elongation 72°C 10 min 
Storage 4°C ∞ 
 
PCR products were purified with the Wizard SV Gel and PCR Clean-Up System (Promega).  
Site-directed mutagenesis (mutations, insertions, and fusion proteins) 
Site-directed modifications of genetic sequences were created by PCR.  
Site-directed mutations, such as an exchange of single codons in the SV40 nuclear localization signal 
rendering it functionally ineffective, were introduced by amplifying the complete gene or the entire 
plasmids with synthetic oligonucleotide primers carrying the desired modifications (exchange of a 
single or a few nucleotides). Afterwards, the original methylated plasmids were digested by DpnI 
(NEB) for 60 min at 37 °C, and the remaining solution was added to chemically competent DH5α cells 
for transformation. 
For insertions or deletions of e.g. protein targeting signals or antibody binding sites, similar 
oligonucleotide primers were applied containing the desired sequences including restriction sites.  
Fusion proteins (such as EGFP fusions, introduction of protein targeting signals) were created by 
amplifying DNA sequences carrying overlapping sequences. Overlapping sequences were therefore 
introduced running a PCR with primers containing the respective sites at their 5’ or 3’ ends. These 
PCR products were purified and fused in a second PCR reaction, where the overlapping sequences 
bind to each other so that DNA polymerase can prolong residual complementary sequences. 
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Additional short primers at the 5‘ ends of the complete fusion sequence allowed amplifying the 
entire fused sequences selectively in the same reaction. The fusion sequences were then purified, 
restricted and ligated into desired vectors. 
Molecular cloning (restriction, ligation) 
The restriction of plasmids and linear DNA inserts was performed applying site-specific restriction 
enzymes (NEB or Fermentas). Restricted plasmid backbones were dephosphorylated to prevent self-
religation (Calf Intestinal Alkaline Phosphatase, NEB). Concentrations, buffers, and incubation times 
were chosen according to the manufacturers’ instructions or modified, if necessary. Results were 
controlled by agarose gel electrophoresis. DNA fragments of interest were selected and purified for 
further processing (Wizard SV Gel and PCR Clean-Up System, Promega). 
For ligation, 0.5 µL of T4 DNA ligase (Promega) was added to a total volume of 30 µL reaction mix, 
containing 50-200 ng restricted vector, 3-7 times (molar ratio) restricted inserts, and ligation buffer 
(Promega). Restrictions were carried out overnight at 16 °C under agitation. Up to 5 µL of the ligated 
sample were added to chemically competent DH5α cells for transformation. 
Preparation and transformation of chemically competent E. coli cells  
An appropriate E. coli strain (DH5α for plasmid preparations or BL21 (DE3) for protein purification) 
was plated out on LB agar. From this, a single colony was grown in a small pre-culture to inoculate 1 L 
LB medium growing to an OD600 of < 0.5. Cells were centrifuged at 6,000 x g for 10 min at 4 °C and 
resuspended in ice-cold sterile Ca2+/glycerol solution (60 mM CaCl2, 10 mM Pipes, 15% glycerol, pH 
7.0). After a second centrifugation and resuspension, cells were kept on ice for 30 min. A third 
centrifugation followed, cells were resuspended in 10 mL ice-cold Ca2+/glycerol buffer and dispensed 
in e.g. 200 µL aliquots. Cells were immediately frozen in liquid nitrogen and stored at -80 °C (adapted 
from Davis 1994).  
For transformation, 50 µL chemically competent cells per sample were thawed on ice, and 10-500 ng 
plasmid DNA or up to 5 µL of a ligation reaction mix were added. After incubation on ice or at 4 °C for 
20 min, cells were heat shocked at 42 °C for 45 sec and cooled on ice for further 5 min. 1 mL of LB 
medium was added, and the cells were incubated at 37 °C shaking for 1 h. Cells were sedimented and 
400 µL of fresh LB medium was added. The cells were plated on LB agar plates containing antibiotics 
for selection (100 µg/mL ampicillin or 50 µg/mL kanamycin) and incubated overnight at 37 °C.  
Plasmid preparation 
Plasmids were prepared from selective LB cultures starting from a single colony of DH5α cells 
transformed recently.  
Plasmids for bacterial transformation or cloning applications were prepared using the Wizard Plus SV 
Minipreps kit (Promega). Endotoxin free plasmids for human cell culture were prepared utilizing the 
EndoFree Plasmid Maxi Kit (Qiagen) according to the supplier’s instruction.  
Concentration and quality of purified DNA was determined by UV spectroscopy (260/280 nm), and 
sequences were confirmed by DNA sequencing (core facility, MPI of Biochemistry).  
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Protein purification 
De novo β proteins 
To purify β proteins from E. coli BL21 (DE3) cells, single colonies were picked and grown in selective 
LB medium at 37 °C overnight. On the next morning, precultures were diluted and grown at 37 °C 
until an OD600 of 1.0 was reached, induced with 0.5 mM isopropyl-D-thiogalactoside (IPTG), and 
grown for protein expression for 4 h. Cells were harvested by centrifugation at 5000 x g for 10 min 
and resuspended in 25% sucrose, 50 mM Tris (pH 8.0), 1 mM EDTA, supplemented with complete 
protease inhibitor (Roche) and 1 mg/mL lysozyme (Sigma). The cells were lysed by repeated freeze-
thaw cycles and DNA was digested by Benzonase (Novagen). 
Inclusion bodies were isolated by repeated washing in 0.5% Triton X-100, 1 mM EDTA, and 
centrifugation at 20,000 x g for 15 min. The pellet was dissolved in 8 M urea and separated on a 
MonoQ 10/100 HR16/10 column in 8 M urea, 25 mM Tris pH 7.5, applying a gradient from 0 to 1 M 
NaCl. The fractions containing β proteins were further purified by size exclusion chromatography on 
Sephacryl S-300 HiPreP 26/60 in 8 M urea, 0.1 M NaCl, 25 mM Tris pH 7.5. After dialysis into 150 mM 
KCl, 0.5 mM MgCl2, 25 mM HEPES pH 7.5 (or originally 0.1 M NaCl, 25 mM sodium phosphate, pH 7.5) 
overnight, the proteins formed invisible soluble oligomers, which eluted shortly after the excluded 
volume of Sephacryl S-300 size-exclusion columns run on the same buffer solution. All protein 
samples were stored at -80°C (based on West 1999).  
De novo α-helical protein αS824 
The soluble 6 x His-tagged αS824 protein was purified after expression for 3 h from E.coli cells, lysed 
(lysis buffer see above) and centrifuged at 20,000 x g for 15 min. The supernatant was applied to Ni-
NTA agarose for 30 min at 4 °C under agitation. The material was loaded on a column and washed 
with 300 mM NaCl, 30 mM Imidazol in 25 mM phosphate buffer, pH 8, until the eluate showed an 
OD280 < 0.05. The pure protein was finally eluted in the same buffer containing 250 mM Imidazol and 
dialyzed into 100 mM NaCl, 25 mM sodium phosphate, pH 7.5.  
Hsp110 (Hsp105) 
Purification of 6 x His-tagged Hsp110 (cloned into pProEx) was performed from E. coli BL21 (DE3) 
cod+ RLI cells (Novagen). Hsp110 expression was induced at an OD600nm of 0.6 with 1 mM IPTG, 
accompanied by a temperature shift from 37°C to 18°C. After overnight expression, cells were 
harvested and resuspended in 350 mM KCl, 25 mM HEPES (pH 7.5), 5 mM imidazole, 1 mM PMSF, 
and 0.5 mg/mL lysozyme incubating at RT for 20 min, followed by lysis through repeated freeze-thaw 
cycles. After sedimentation of cell debris by centrifugation at 20,000 g for 15 min at 4°C, the resulting 
supernatant was loaded onto a Ni-NTA charged 5 mL HiTrap Chelating HP column at 4 °C. After 
washing with 350 mM KCl, 25 mM HEPES (pH 7.5), 5 mM imidazole, including 1 mM PMSF (until 
OD280 < 0.05), 6 x His-tagged Hsp110 was eluted by a gradient from 5-200 mM imidazole in the same 
buffer. This gradient resulted in a separation of full length 6 x His-Hsp110 and cleavage products 
present in the lysate. For cleavage of the 6 x His-tag, the eluted full length protein was incubated for 
60 min at RT with TEV protease at a molar ratio of 20:1 in the presence of 5 mM β-mercaptoethanol. 
After dilution into the same buffer containing 5 mM imidazol, the solution was again applied to a Ni-
NTA column to remove uncleaved 6 x His-Hsp110 and 6 x His-TEV protease. In a final purification 
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step, Hsp110 was passed through a Sephacryl S-300 HiPreP 26/60 size exclusion column equilibrated 
in 150 mM KCl, 0.5 mM MgCl2, 25 mM HEPES pH 7.5. Eventually, Hsp110 containing fractions were 
concentrated in a Vivaspin 50000 MWCO ultrafiltration tube (modified from Dragovic 2006). 
Protein analytics  
Determination of protein concentration  
The concentration of the purified β proteins was determined by UV absorbance of the protein 
backbone at 210 nm, since the β proteins do not contain any tryptophan. The peptide bond absorbs 
at 210 nm with an extinction coefficient of 20 for 1 mg/mL protein solution (up to 24, in case of a 
protein containing tryptophan; Scopes 1974). The molar concentration depends on the length of the 
polypeptide chain (number of peptide bonds). 
The concentration of the purified, His-tagged αS824 protein was determined by its UV absorbance at 
280 nm. The extinction coefficient of (Ɛ280 = 12,950 M
-1 cm-1) was calculated using the ProtParam tool 
at the ExPaSy Bioinformatics Resource Portal (http://web.expasy.org/cgi-bin/protparam/protparam; 
Edelhoch 1967, Pace 1995) based on the amino acid sequence of αS824 (three tryptophans).  
Discontinuous, denatured SDS-PAGE 
Discontinuous SDS-PAGE (sodium dodecylsulfate polyacrylamide gel electrophoresis) under 
denaturing and reducing conditions (including SDS and β-mercaptoethanol) is widely used to 
separate proteins (Laemmly 1970). The binding of negatively charged SDS molecules to polypeptides 
allows a separation according to the mass of proteins, since the number of binding detergent 
molecules is relatively proportional to the length of the polypeptide chains, and therefore 
determines their charge in the electrical field. Electrophoresis was performed on a Mini-Protean 3 
System (BioRad).  
Table 4 | Polyacrylamide gel formulation for SDS-PAGE (for 2 gels / 10 mL solution) 
Acrylamide  
gel 
dd H2O 
 
 
(mL) 
30%  
Acrylamide/ 
Bis-acrylamide 
(mL) 
Gel buffer 
solution 
 
(mL) 
10%   
SDS (w/v) 
 
(mL) 
4% 6.1 1.3 2.5 0.1 
5% 5.7 1.7 2.5 0.1 
6% 5.4 2.0 2.5 0.1 
7% 5.1 2.3 2.5 0.1 
8% 4.7 2.7 2-5 0.1 
9% 4.4 3.0 2.5 0.1 
10% 4.1 3.3 2.5 0.1 
11% 3.7 3.7 2.5 0.1 
12% 3.4 4.0 2.5 0.1 
13% 3.1 4.3 2.5 0.1 
14% 2.7 4.7 2.5 0.1 
15% 2.4 5.0 2,5 0.1 
16% 2.1 5.3 2.5 0.1 
17% 1.7 5.7 2.5 0.1 
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Up to 2.5 mL of dd H2O was replaced by 2 M sucrose. The resolving gel buffer consists of 1.5 M Tris 
(pH 8.8), the stacking gel buffer of 0.5 M Tris (pH 6.8). The polymerization was started by the addition 
of 50 µL 10% APS (ammonium persulfate) and 5 µL TEMED (resolving gel) or 50 µL 10% APS and 10 µL 
TEMED (stacking gel). 
Discontinuous gels concentrate the protein sample at the border between the highly permeable 
stacking gel and the lower permeable resolving gel, which leads to a high resolution of protein 
separation. Assuring a high quality, resolving gels were covered in dd H2O until complete 
polymerization, before stacking gels were casted. 
Protein samples were dissolved in 2x SDS loading buffer (60 mM Tris (pH 6.8), 2% SDS, 25% glycerol 
(v/v), 0.01% bromphenolblue (w/v); 5% β-mercaptoethanol (v/v) added prior to use), heated to 95 °C 
for 5 min, and immediately vortexed to achieve complete denaturation. Gel electrophoresis was 
performed using SDS-PAGE running buffer (5x stock/L: 15 g Tris, 75 g glycine, 5 g SDS, pH ~8.4) at 
initially 70 V (protein sample in stacking gel), later 100-250 V (running gel). Prestained Protein 
Marker (Fermentas) was added as a size marker. Protein samples were stored at -80 °C. 
Coomassie Brilliant Blue staining 
Gels were quickly washed in dd H20 after electrophoresis, proteins were fixed (10% acetic acid), 
stained (50% ethanol, 10% acetic acid, 0.25% Serva Blue R) and destained (50% methanol or ethanol, 
10% acetic acid), leading to a specific blue coloration of protein bands. The gels were scanned 
electronically or dried on filter paper. 
Immunoblotting 
Electrophoretically separated proteins were blotted from polyacrylamide gels on nitrocellulose or 
(methanol activated) PVDF membranes for immunodetection (Towbin 1979) with a Mini Trans-Blot 
Cell Western blotting device (Bio-Rad). According to the setup, the protein was transferred at a 
constant electrical voltage (100V) for 90-120 min in Western Blot Transfer Buffer (25 mM Tris, 
192 mM glycine, 20% ethanol, pH ~8.4). After transfer, membranes were washed quickly in TBS-T 
(25 mM Tris (pH7.6), 150 mM NaCl, 0.1% Tween 20) and then incubated with primary antibodies 
against a desired epitope in TBS-T containing 5% (w/v) skimmed milk (Saliter) for blocking unspecific 
interactions for 1 h at room temperature up to overnight at 4°C. After extensive washing with TBS-T, 
a secondary antibody (standard dilution 1:3000) directed against the primary species and conjugated 
to horseradish peroxidase was incubated for 1-3 h at room temperature. After extensive washing in 
TBS-T, the immunoblots were developed using the chemiluminescence Rodeo ECL solutions (USB) 
and analyzed on a LAS-3000 image reader (Fujifilm) and by AIDA software (Raytest). If desired, the 
blots were stripped (Restore Western Blot Stripping Buffer, 21059, ThermoFisher Scientific) for 15-
30 min and washed in TBS-T for another immunolabeling. 
Native dot blots for immunodetection of A11 reactive species 
The β-sheet proteins were freshly refolded from denaturant (8 M guanidine hydrochloride or 10 M 
urea) into physiological buffer (150 mM KCl, 0.5 mM MgCl2, 25 mM HEPES (pH 7.5)) for several hours. 
3 µL of 20 µM protein solutions were pippeted on a nitrocellulose membrane, which was incubated 
with A11 antibodies (1:2000, Prof. C.Glabe) or anti-c-Myc (9E10, Santa Cruz; 1:3000) in 25 mM Tris, 
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150 mM NaCl, 0.1% Tween 20 and 1% BSA at pH 7.6 overnight. After extensive washing with TBS-T, a 
secondary antibody conjugated to horseradish peroxidase was incubated for 1 h. The blots were 
developed after extensive washing with TBS-T. The A11 reactivity was compared to control proteins 
such as the α-helical αS824, BSA, or MBP.  
For analyzing the effect of sonication on β protein structures, the protein solutions were sonicated at 
2 µM concentrations in physiological buffer for 2-60 sec with a microtip (intensitiy level 5, Ultrasonic 
Processor XL, Misonix Inc.), directly pippeted on a nitrocellulose membrane, and developed as 
described. 
Spectroscopy 
Fluorescence spectroscopy 
The fluorescence spectroscopic measurements were accomplished on a FluoroLog-3 
Spectrofluorometer (HORIBA Jobin Yvon).  
The refolding and aggregation kinetics were recorded by diluting denatured β proteins out of 8 M 
guanidine hydrochloride 1:400 into physiological buffer (150 mM KCl, 0.5 mM MgCl2, 25 mM HEPES, 
pH 7.5) at a final protein concentration of 3 µM protein. 
For steady state measurements, the protein concentration was kept at 3 µM in physiological buffer 
containing 20 µM of the fluorescent dyes Thioflavin T (Sigma) or ANS (8-Anilino-1-
naphthalenesulfonic acid, Sigma), or 1 µM of NIAD-4 (ICX Nomadics). Thioflavin T fluorescence was 
exited at 440 nm, NIAD-4 fluorescence at 475 nm, and ANS fluorescence at 375 nm. Refolding 
kinetics were analyzed by Thioflavin T emission observed at 482 nm, NIAD-4 emission at 590 nm, or 
ANS emission at 490 nm. 
Circular dichroism (CD) spectroscopy 
CD measurements were performed on a Jasco CD Spectrometer J-715 at 25C in 6 mM HEPES, 25 mM 
KCl, pH 7.5 at a protein concentration of 0.1 mg/mL. Spectra were recorded in a 0.1 mm quartz 
cuvette between 197 and 250 nm (with a bandwidth of 1 nm and a scanning speed of 50 nm/min). 
Each single spectrum was averaged from 3 accumulative scans. Secondary structure content was 
analyzed by the CDSSTR algorithm (Johnson 1999; Jasco software). 
Fourier transform infrared spectroscopy (FTIR) 
The β-sheet proteins were dialyzed overnight against 10 mM potassium phosphate, 10 mM NaCl, 
pH 6.0, α-S824 was dialyzed against 10 mM potassium phosphate, 10mM NaCl, pH 7.5. Infrared 
spectra were measured in the Vertex 70 spectrophotometer (Bruker, Germany) equipped with a TGS 
detector using attenuated total reflection (ATR) with parallelogram-shaped Germanium crystals as 
internal reflection plates (Korth Kristalle, Germany). A thin film of 50-100 mg of the respective 
protein was dried under N2 on one side of the Germanium crystal that was placed in a homemade 
gas-tight chamber (Heinz et al., 2003). H-D exchange was performed by flushing D2O-saturated N2 
through the chamber and monitored every 1 to 3 min until the spectra were stable (usually after 45 
min). Spectra were recorded before and after H-D exchange with a nominal resolution of 2 cm-1 in 
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the double-sided, forward-backward mode, collecting 1024 scans per sample. Water vapor and CO2 
contributions were corrected for using the atmospheric compensation of the OPUS software (version 
6.5) from Bruker. The spectral region of the amide I band (1705 to 1595 cm-1) was extracted, 
corrected for the base line, and scaled so as to obtain a constant integral value for comparison. Peak 
positions of spectral components were analyzed using Fourier-self deconvolution and the second 
derivative of the spectra. 
Electron microscopy 
Carbon-coated copper grids were covered in β protein aggregates either in 25 mM HEPES, 150 mM 
KCl, 0.5 mM MgCl2, pH 7.5 or 10 mM potassium phosphate buffer at pH 6.0 (after overnight dialysis 
into the respective buffer) for 1 min, washed 3 times, stained for 1 min in 2% uranyl acetate, and air-
dried. A CM200 FEG transmission electron microscope (FEI, Eindhoven) with a CCD-camera was used 
at an accelerating voltage of 160 kV and at a magnification of 55,000 x.  
Human cells: culture and transfection 
Cultivation and passage of human cells 
Cell lines utilized in this study were grown in cell culture flasks with a hydrophilic surface of carboxy- 
and hydroxygroups (Cellstar, Greiner Bio-One). Cells were cultured in supplemented DMEM 
(Dulbecco's Modified Eagle Medium, Gibco) containing 2 mM L-glutamine, 0.1 mM MEM non-
essential amino acids and 100 U/mL penicillin and 100 µg/mL streptomycin (all from Gibco), enriched 
by 10% FBS (fetal bovine serum, Gibco). Cells were grown at 37 °C and 5% CO2 in a water vapor 
saturated atmosphere.  
For subcultivation, cells were washed with PBS (Gibco), and for dissociation treated for 3 min in 
TrypLe Express (Gibco) at 37 °C. Fractions of 5-50% of the cells were transferred into cell culture 
flasks with supplemented enriched medium. 
Cryopreservation 
During exponential growth (80-90 % confluence), cells were washed (PBS), treated with TrypLe 
Express (Gibco) and centrifuged at 300 x g.  After aspiration of the medium cells were suspended in 
freezing medium comprising 10% sterile DMSO, 25% FBS (Gibco), and 65% DMEM (Gibco). Cells were 
then transferred into sterile cryovials and placed at -20 °C for 2 h and at -80 °C overnight, before 
keeping them at -80 °C for several months or in liquid nitrogen for long time storage.  
For revitalizing, the cryovials were taken out of the liquid nitrogen and immediately warmed up in a 
37 °C water bath. The cellular suspension was transferred into 37 °C prewarmed medium and 
centrifuged at 300 x g, the medium was aspired. Resuspended in fresh supplemented enriched 
medium, the cells were cultured under standard conditions.  
Determining cell numbers 
For cellular counts, a fraction of cells were stained for dead cells with 0.4% Trypan Blue Solution 
(Sigma) and pipetted on a Neubauer counting chamber. All living cells of one large square (1 mm2 or 
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0.1 mm3), comprising 25 small squares, were counted (at least 100 cells) and multiplied by 10,000 to 
calculate the cell number per milliliter.  
Transient transfection by electroporation 
For electroporation, HEK293T cells were washed, treated with TrypLe express, counted, and 
resuspended in electroporation medium (25% FBS and 75% non-supplemented DMEM, Gibco). Cells 
were then mixed with expression plasmids prepared utilizing the EndoFree Plasmid Maxi Kit (Qiagen). 
2-30 µg of plasmids were added to 2-10x106 cells in 400 µL electroporation medium, and the mix was 
transferred to 0.4 cm electroporation cuvettes (Bio-Rad). The electroporation was conducted at 225 
V, ∞ Ω, 950 µF exponential wave for HEK293T cells (modified from Barry 2004 and Jordan 2008) with 
the GenePulser XCell System (Bio-Rad), optimized on our distinct device. After electroporation, cells 
were kept at room temperature for 10 min for recovery, and then resuspended in 5 mL 
supplemented DMEM. After centrifugation at 300 x g for 3 min, cell pellets were resuspended in an 
appropriate volume of fresh supplemented DMEM to remove dead cells or detrimental cellular 
factors released during the pulse. The cells were cultivated for several hours up to 3 days for protein 
expression (based on Barry 2004, Jordan 2008). 
Electroporation conditions were adapted for neuroblastoma cell lines (SH-SY5Y or SK-N-SH). For 
these cells, optimal conditions for protein expression and a strong cytotoxicity of β proteins relative 
to control cells transfected with empty vectors were found at a 225 V, 20 ms square wave pulse 
(similar to Jordan 2008).  
Transient transfection by lipofection 
HEK293T or SH-SY5Y cells were seeded one or two days before transfection in appropriate cell 
culture vessels for equilibration and growth. For lipofection, 1 µg of plasmid in 300 µL OptiMem I 
(Life Technologies) was mixed with 2.5 µL Lipofectamine 2000 (Life Technologies) diluted in 300 µL 
OptiMem I after 5 min of incubation, gently vortexed, and incubated for 20 min at room 
temperature. The mixture was added to cells growing on a surface of 4 cm2 (standard 12 well plate). 
For other cultivation areas, measures were adapted linearly to the surface. After 3 h, the transfection 
mix was replaced by supplemented DMEM omitting antibiotics. 
Confocal fluorescence microscopy 
Fixation and immunostaining of human cells 
Cells from mammalian tissue culture were grown on poly-L-Lysine coated coverslips (German glass, 
BD BioCoat, BD Biosciences) for 24-72 h, fixed in 4% formaldehyde/PBS for 10 min, permeabilized in 
0.1% (v/v) Triton X-100/PBS for 5 min, and washed with PBS. Cells were treated with primary 
antibodies against a target epitope at dilutions of 1:200 to 1:3000 in 1% BSA/PBS for 1 h at room 
temperature up to overnight at 4 °C, followed by secondary antibodies conjugated to fluorescent 
dyes for one or several hours at room temperature. Cells were then incubated in DAPI/PBS at 
0.25 µg/mL for 10 min, washed in PBS, and dipped shortly in dd H20 before mounting them in 
fluorescence mounting medium (DAKO) on a glass slide. To detect amyloid species, cells were 
additionally stained with 100 nM NIAD-4 (ICX Nomadics) in PBS for 30 min after fixation and 
permeabilization. The specimens were kept at 4 °C.  
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Confocal immunofluorescence and image acquisition 
Image acquisition was performed on a LEICA TCS SP2 AOBS or on a LEICA TCS SP8 AOBS confocal laser 
scanning microscope equipped with LEICA HCX PL APO 63x/NA1.4 oil immersion objectives.  
Up to four different fluorescent dyes were applied for cellular localization of proteins, DNA, or RNA. 
In multifluorescent samples, emission bandwidth settings and signal amplification intensities were 
set to exclude erroneous co-localizations. Therefore, single stained controls were prepared. 
Fluorescence in situ hybridization (RNA FISH) 
HEK293T or SH-SY5Y cells were grown on poly-L-Lysine coated coverslips (German glass, BD BioCoat, 
BD Biosciences) for 24-72 hours, fixed in 4% paraformaldehyde in ultrapure SSC solution (15 mM 
saline-sodium citrate, 150 mM NaCl, pH 7.0 (UltraPure SSD, Thermofisher Scientific), DEPC treated dd 
H2O) for 10 min, permeabilized with 0.1% (v/v) Triton X-100 in ultrapure SSC for 5 min, and washed in 
FISH buffer (UltraPure SSC, 10% formamide) for 10 min at 37 °C. Fluorescently labeled Cy5-(d)T30 
(desoxythymidine) oligonucleotides were applied at 0.1 µM in FISH buffer including 10% dextran 
sulfate (average molecular weight > 500 kDa, Sigma) for 2-3 h in a humidified chamber at 37 °C. Cells 
were washed 2 times with FISH buffer at 37 °C. Antibody and DAPI staining followed subsequently as 
described in PBS based buffers.  
Fluorescence in situ hybridization on murine brain sections (RNA FISH) 
Animal experiments were performed in compliance with institutional and governmental regulations. 
R6/2 mice and wildtype litter mates were received from The Jackson Laboratory (B6CBA-
Tg(HDexon1)62Gpb/1J). Mice were anaesthetized with 5% chloral hydrate in PBS and transcardially 
perfused with 4% paraformaldehyde/PBS. The brains were post-fixed for 2 h in 4% 
paraformaldehyde/PBS at 4 °C and cryoprotected in 30% sucrose/PBS for 24 h at 4 °C. Brains were 
embedded in Tissue-Tek O.C.T. Compound (Sakura) at -20 °C, 20 µm coronal sections were cut on a 
freezing microtome (Leica), dried on glass slides overnight on air and stored at -20°C until usage. 
Sections were thawed and washed in prewarmed FISH tissue buffer (15 mM saline-sodium citrate, 
150 mM NaCl, pH 7.0 (ultrapure SSD, Thermofisher Scientific), 10% formamide, 0.3% Triton X-100 
(v/v)) at 45 °C. A higher hybridization temperature than for cultured cells was necessary to prevent 
background binding to nuclear DNA. Hybridization to Cy5-(d)T30 oligonucleotides was performed in a 
humidified chamber in prewarmed fish tissue buffer including 10% dextran sulfate (average 
molecular weight > 500 kDa, Sigma) for 1-3 h at 43 °C. Afterwards, sections were washed with FISH 
tissue buffer for 10 min at 45 °C.  
For immunostaining, the hybridized sections were washed in 0.3% TritonX-100/PBS, and stained for 
extended polyQ tracts (monoclonal anti-polyglutamines antibody, mouse, clone 3B5H10, Sigma, 
P1874; Miller 2011) in 1% BSA, 0.3% TritonX-100/PBS), for active apoptosis (cleaved Caspase-3 Asp75 
antibody, rabbit, Cell Signaling Technology, #9661), or for THOC2 (HPA047921, Sigma) overnight at 
4 °C, followed by fluorescently labeled secondary antibodies. Sections were subsequently incubated 
in DAPI/PBS at 0.25 µg/mL for 10 min and washed 2 times in PBS before covering them under a glass 
slide (Menzel Gläser #1, Thermo Scientific) in fluorescence mounting medium (DAKO).  
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Fixation and staining of mitochondrial matrix proteins 
The cell-permeant MitoTracker Red CM-H2XRos (M7513, Invitrogen) is a reduced, non-fluorescent 
dye that fluorescents upon oxidation and accumulates in mitochondria in living cells in a membrane 
potential dependent manner. MitoTracker Red was added to HEK293T cells 24 h after transient 
transfection, growing on poly-L-Lysine coated coverslips, at 100 nM in DMEM (including glutamate) 
for 1 h at 37 °C. Cells were washed with PBS and subsequently treated as described for 
immunostaining. After paraformaldehyde fixation, cells were additionally permeablilized in ice-cold 
methanol at -20 °C for 10 min, enabling an antibody staining of mitochondrial matrix proteins.  
Cellular experiments and assays 
Cytotoxicity measurements by MTT assay 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid) is a yellow, water soluble dye, 
which upon reduction by cellular enzymes becomes a water insoluble, blue formazan product. The 
viability of the cells is reflected in their capacity to reduce MTT by cellular reducing agents.  
Intracellular expression of β proteins 
Transiently transfected cells were incubated (usually 25x, 40x, and 70x105 cells in 3 replicates in 
24 well plates) for 72 hours under standard conditions. The culture medium was aspired and 0.5 mL 
of 0.5 mg/mL MTT dissolved in non-supplemented DMEM was added for 1 h at 37 °C. Cells were 
lysed by addition of 0.5 mL of 20% SDS (w/v) and 50% DMF (v/v) in water and repeated pipetting. 
Absorbance was detected at 570 nm (KC4 software, Synergy-HT, BioTek) and compared to empty-
vector control cells and cell-free control wells (Shearman 1995).  
Extracellular addition of purified β proteins to the culture medium 
Untransfected cells were incubated with purified β proteins (usually 25x, 40x, and 70x105 cells in 
3 replicates in 24 well plates) for 24-48 hours in supplemented DMEM. Immediately before addition 
to the culture medium, purified β proteins (in form of soluble, non-precipitated oligomers in 
physiological buffer) were sonicated with a tip sonicator (Ultrasonic Processor XL, Misonix Inc.) at 
level 5 for 5-10 sec, and applied in concentrations of 20 nM up to 2 µM in supplemented DMEM.  
E. coli growth inhibition 
BL21 cells were freshly transformed with pTrcHis vectors containing β proteins or α-helical proteins 
and grown overnight on selective LB agar plates. Single colonies were selected and grown in selective 
6 mL LB liquid cultures overnight. On the next morning, cultures were diluted to an OD600nm of 0.15 
into fresh selective 100 mL LB. Protein expression was induced after an initial recovery from 
stationary phase at an OD600nm of 0.4. Growth of the cultures was followed photometric (OD600nm) 
until a plateau was reached after ~4 h. The growth of BL21 cells carrying an expression plasmid was 
compared to control cells transformed with an empty vector control.  
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NF-κB activation and translocation 
HEK293T cells were transiently transfected with 25 µg of pcDNA3.1 plasmids encoding β proteins, 
Htt96Q, TDP-F4, ParkinΔC, or with control vectors (empty or αS824) by electroporation or lipofection, 
and incubated for 40 hours. NF-κB signaling was then activated by the addition of 20 ng/mL human 
TNFα (recombinant E.coli cytokine from Jena Bioscience (PR-430) or Biomol GmbH (50435)). TNFα 
was added for 15 min before cells were collected for immunoblotting (best timing to observe p65 
phosphorylation and IκB degradation) or for 30 min for immunofluorescence (best timing for nuclear 
translocation of p65). Samples were fixed and immunostained as described above.  
Compartmental quantification of S-GFP  
S-GFP carries a combined N-terminal NES and NLS and is therefore permanently actively shuttled 
between cytoplasm and nucleus. HEK293T cells were transfected (by electroporation) with 3 µg 
pcDNA3.1 encoding S-GFP in addition to 25 µg of plasmids encoding g the β proteins, Htt96Q, 
ParkinΔC, or with empty control vectors and incubated for 40 h in enriched DMEM. Cells were 
treated with either 10 ng/mL CMR1 inhibitor Leptomycin B (LMB) or DMSO for 15 min before fixation 
and immunostaining of aggregates.  
The relative concentration of S-GFP in the cytoplasm and nucleus were quantified by the 
fluorescence intensity ratio of around 75-150 cells per sample and condition, and three independent 
repetitions each. The fluorescence intensities in the cytoplasm and nucleus were quantified using 
ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2012.). The cytoplasmic/nuclear concentration gradient corresponds 
directly to the cytoplasmic/nuclear fluorescence ratio. The relative nuclear localization (N) or relative 
cytoplasmic localization (C) of S-GFP was calculated from the fluorescence ratio (R) 
nucleus/cytoplasm by =100/(1+1/), assuming that N+C=100% and N/C=R, and that cytoplasm and 
nucleus similar volumes.  
THOC2 knockdown by siRNA 
HEK293T or SH-SY5Y cells were seeded on poly-L-Lysine coated coverslips and grown overnight. Cells 
were transfected with siRNA targeting human THOC2 (Thermo Scientific, ON-TARGET plus human 
THOC2 siRNA L-025006-01) or by non-targeting control siRNA targeting firefly luciferase mRNA 
(Thermo Scientific, SMARTpool ON-TARGETplus non-targeting siRNA #2, D-001810-02-05). The 
transfection was performed at 50 nM (5 µL of 5 µM) siRNA and 2.5 µL DharmaFECT1 (Thermo 
Scientific) in 500 µL Opti-Mem I Reduced Serum Media (Gibco) for 3 h. Cells were incubated for 24 h, 
48 h, and 72 h in enriched DMEM and subsequently fixed, permeabilised (0.1% TritonX-100 in PBS) 
and (immuno-)stained for poly(A) RNA and THOC2, as described. The cellular knockdown of THOC2 
was verified by immunoblotting. 
Cellular distribution of mRNA after proteasome inhibition by MG132 
HEK293T or SH-SY5Y cells were seeded on poly-L-Lysine coated coverslips and grown overnight. Cells 
were treated with 5 µM MG132 in enriched DMEM for 0 h, 8 h, and 16 h. Cells were fixed, 
permeabilized (0.1% TritonX-100 in PBS), and (immuno-)stained for poly(A) RNA, as described. 
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Single cell quantification of total polyA RNA 
24 h after transfection with β protein, Htt97Q, TDP-F4 or control plasmids on poly-L-Lysine coated 
coverslips, HEK293T cells were fixed, permeabilized and (immuno-)stained for polyA RNA, 
aggregating proteins, and nuclear DNA (as described). The relative total polyA RNA fluorescence 
intensities of single cells containing aggregates and showing nuclear polyA RNA retention was 
quantified and set in ratio to untransfected cells on the same coverslip with wildtype-like distribution 
of polyA RNA (≥ 3 independent experiments, n = 4-13 cells in each experiment). The ratio describes a 
potential accumulation or degradation of polyA RNA in cells with protein aggregates compared to 
wildtype cells. 
Absolute quantification of cytoplasmic mRNA 
1.5x106 HEK293T cells were seeded in round 10 cm cell culture dishes for 24 h of growth. Cultures 
were transfected with 15 µg DNA (pcDNA3.1) and 40 µL Lipofectamin 2000 (Invitrogen) in 6 mL Opti-
Mem I Reduced Serum Media (Gibco) for 3 h, afterwards being replaced by 10% FBS supplemented 
DMEM (including glutamate, non-essential amino acids, antibiotics, as described above). After 40 h 
of protein expression, cells were trypsinized and collected at 500 x g by centrifugation. Resuspended 
in PBS, one third of the cells were processed for mRNA quantification, residual cells were lysed in SDS 
loading buffer (see SDS PAGE) for quantification of protein levels (GAPDH by immunoblotting). 
Cellular membranes were lysed in cytoplasmic extraction buffer (140 mM NaCl, 5 mM KCl, 10 mM 
Tris, pH 7.5, 0.3% TritonX-100, 1mM DTT and 1000 U/mL RNase inhibitor (RNasin, Promega)) at 4 °C 
for 10 min, keeping nuclei intact. Nuclei were sedimented by centrifugation for 2 min at 500 x g at 
4 °C and separated from the cytoplasmic lysate (supernatant). After addition of an equal volume of 
mRNA binding buffer (1 M LiCl, 20 mM Tris, 2 mM EDTA, pH 7.5, 1% SDS), the supernatant containing 
the cytoplasmic lysate was incubated with polyA+ RNA polystyrene-latex particles of uniform size (1 
µm diameter, Oligotex, Qiagen), covalently linked to dC10T30
 oligonucleotides at 70 °C for 3 min, 
followed by mRNA hybridization at 25 °C for 10 min.  
The following mRNA purification was performed based on the manufacturers’ instructions (Oligotex 
Handbook, Qiagen), modified to keep the procedure highly quantitative. Oligotex-mRNA complexes 
were sedimented at 16,000 x g, rehybridised, and washed to remove residually bound ribosomal 
RNAs. For elution, the oligotex-mRNA complexes were resuspended in 85 µL elution buffer at 70 °C 
(OEB, Qiagen) to release the bound mRNA, followed by a quick sedimentation of Oligotex particles 
(16,000 x g, 30 sec). For a precise quantification and different to manufacturer’s instructions, no spin 
columns were used during the elution. The supernatant containing the purified cytoplasmic mRNA 
was transferred to a separate tube for photometric quantification of concentration and purity 
(absorption at 260/280 nm, NanoDrop 1000 spectrophotometer, ThermoScientific). 
Actinomycin D was applied for general transcriptional inhibition by RNA Polymerase II at 5 µg/mL for 
16 h (Jablonski 2009) on cells transfected with an empty control plasmid. In a similar way, cells were 
treated with Actinomycin D and hybridized to Cy5-(d)T30 for labeling poly(A) RNA to demonstrate 
nuclear retention of cellular mRNAs microscopically. 
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Solubility of cytoplasmic and nuclear β proteins  
24 h after transfection of an equal amount of around 1x106 HEK293T cells with plasmids encoding 
β proteins or empty control plasmids, cells were collected by trypsination and centrifugation (300 x g 
for 2 min), and resuspended in (200 µL) PBS on ice. Samples were split 1:1 (v/v) for total lysate and 
fractionation. Cells were lysed by the addition of an equal volume of 2 x lysis buffer (2% TritonX-100, 
750 mM NaCl, 1 mM KH2PO4, 3 mM Na2HPO4, pH 7.4, Complete Protease Inhibitor Cocktail (Roche), 
and Benzonase Nuclease (Novagen)) under rotation at 4 °C for 15 min. Samples for fractionation 
were centrifuged at 20,000 x g for 5 min, the supernatant was completely taken off, and the pellet 
was resuspended in an equal volume of 1 x lysis buffer (200 µL). Total lysate samples were processed 
without centrifugation.  
For SDS-PAGE, 2 x SDS loading buffer (60 mM Tris, pH 6.8, 2% SDS, 25% glycerol (v/v), 0.01% 
Bromphenolblue (w/v); 5% β-mercaptoethanol (v/v) freshly added) was mixed with the sample 
before denaturation at 95 °C for 5 min and vortexing for 10 sec. Samples were run on a 15% SDS 
PAGE and transferred on PVDF membranes for immunoblotting against c-Myc, GAPDH, and Histone 
H3. 
Size exclusion chromatography of HEK293T lysates 
HEK293T cells were transiently transfected with NES-β17, NLS-β17, or empty plasmids (control). After 
24 h, cells were lysed in 1% Triton X-100, 420 mM NaCl, 1 mM KH2PO4, 3 mM Na2HPO4, pH 7.4, 
Complete Protease Inhibitor Cocktail (Roche), and Benzonase Nuclease (Novagen). The ionic strength 
was increased to enable a complete nuclear lysis. Debris was removed at 2,000 x g, and 1-2 µg of 
total protein was separated on a Superpose 6 column (30 mL, Pharmazia Biotech). Fractions were 
concentrated by TCA precipitation (15% TCA final concentration) at 4°C for 1 h. Resulting pellets were 
washed twice in ice-cold acetone (-20°C) and resuspended in PBS. 5x SDS-sample buffer was added 
(10% SDS, 10% β-mercaptoethanol, 60% glycerol, 0.1 M Tris, pH 6.8) and the pH was neutralized by 
addition of 1M Tris pH 6.8, as necessary. Samples were heated to 95 °C for 5 min and vortexed. SDS 
PAGE was performed on a NuPAGE 4-12% gradient BisTris SDS Mini Gel (Invitrogen), which was 
blotted on methanol activated PVDF membranes. 
Proteostasis sensors 
HEK293T cells were cotransfected by electroporation with 25 µg of plasmids encoding β-sheet 
proteins or of control plasmids in addition to 3 µg of plasmids encoding American firefly luciferase-
EGFP, targeted to cytoplasm or nucleus. After 24 h of protein expression, samples were fixed and 
immunostained.  
Examining the concentration dependent tendency of aggregation of the luciferase-EGFP sensors, 15 
µg of plasmids (5 times more than before) were transfected by electroporation and aggregation was 
evaluated. For proteasomal inhibition, cells were treated with 5 µM MG132 for 5 h in supplemented 
DMEM.   
FRAP (fluorescence recovery after photo bleaching) 
HEK293T cells were transiently transfected with vectors expressing C-terminally EGFP tagged β 
proteins, or EGFP. After 24 h, spherical ROIs (region of interests) were bleached for ~1 s reaching 5-
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20% of original fluorescence intensity in the respective ROI, and recovery was followed over time (at 
37 °C). Fluorescence intensities were normalized to 100% before and 0% after bleaching (first 
recording after bleaching).  
35S-Met radioactive pulse labeling of newly translated proteins 
2x106 HEK293T cells were transfected by electroporation with β proteins and control plasmids, 
grown in a 6 well plate for 24 h, and transferred to prewarmed Cysteine-/Methionine-free DMEM 
without FBS. 20 min later, 50 µCi/mL 35S-Met was added and incubated for 20 min at 37 °C. The pulse 
was stopped by aspirating the radioactive medium and washing with 4 °C cold PBS. Cells were 
collected and lysed in 1% Triton X-100/PBS including Complete Protease Inhibitor Cocktail (Roche) 
and Benzonase (Novagen), rocking for 30 min. After removal of insoluble parts by centrifugation at 
500 x g for 2 min, 2x SDS PAGE loading buffer (60 mM Tris, pH 6.8, 2% SDS, 25% Glycerol (v/v), 0.01% 
Bromphenolblue (w/v); 5% freshly added β-mercaptoethanol (v/v)) was mixed with the supernatant. 
The samples were denatured at 95 °C for 5 min, immediately vortexed and separated on a NuPAGE 
4-12% gradiend BisTris SDS Mini Gel (Invitrogen). The gel was stained with Serva Blue G (Serva), dried 
on a filter paper (Whatman) and analyzed by fluorography.  
Hsp70 promoter activation  
3x106 HEK293T cells were transiently cotransfected by electroporation with 25 µg of plasmids 
carrying genes of β proteins or controls (empty vector, αS824) and 2 µg of plasmid expressing Firefly 
luciferase, controlled by the Hsp70 promoter (Olzscha 2011). 7x105 cells per well were grown 
overnight in enriched DMEM in 12 well plates. After 20 h, cells were either kept at 37 °C or heat 
shocked for 2 h at 43.5 °C followed by a recovery for 2 h at 37 °C. Cells were then lysed with 300 µL of 
Cell Culture Lysis Reagent (Promega) for 15 min of incubation and gentle shaking. The luciferase 
activity measurement was performed after addition of 50 µL of luciferase substrate solution 
(Luciferase Assay System, Promega) to 20 µL of cell lysate on a Lumat LB9507 (EG&G Berthold).  
Observing mitotic cells 
HEK293T cells were transiently transfected with NES-β17, NLS-β17, or empty control plasmids. After 
48 h, cells were fixed, permeabilized, and stained with antibodies against aggregates (c-Myc) and 
NPM-1, and finally for nuclear DNA (DAPI). Cells of different mitotic states were selected by the 
distribution and morphology of their DNA, and the distribution of aggregates was observed.  
Statistics 
In general, for all experiments, at least three biologically independent repeats were performed. 
Means and standard deviations were calculated. 
Significance was analyzed by the two-tailed, heteroscedastic student’s t-test (significance levels: (*) 
for p<0.05, (**) for p<0.01, (***) for p<0.001).   
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Antibodies 
Antibody Epitope Host, clonality Source 
A11 (Anti-Aβ-1-11) 
Soluble amyloid 
oligomers (Aβ1-11) 
Rabbit, polyclonal 
Prof. Dr. Charles Glabe 
(University of 
California) 
c-Myc (9E10) 
p62 c-Myc, res. 408-
439 
Mouse, monoclonal Santa Cruz, Sc-40 
c-Myc-Cy3 (9E10) 
p62 c-Myc, res. 408-
439 
Mouse, monoclonal Sigma, C6594 
GAPDH (6C5) GAPDH Mouse, monoclonal Millipore, MAB374 
Histone-H3 Histone-H3 Rabbit, polyclonal Abcam, ab1791 
Polyglutamine 
(3B5H10) 
(Miller 2011) 
Early oligomerig forms 
of polyQ extended Htt 
Mouse, monoclonal Sigma, P1874 
Cleaved caspase-3 
Asp175 
Proteolytically 
activated caspase-3 
Rabbit, polyclonal 
Cell Signaling 
Technology, #9661 
Nucleophosmin-1 NPM-1 (B23) Mouse, monoclonal Invitrogen, 32-5200 
Importin α1 Kpna2 Rabbit, polyclonal Abcam, ab70160 
Importin α3 Kpna4 Rabbit, polyclonal Abcam, ab84735 
THOC2 THOC2 Rabbit, polyclonal Sigma, HPA047921 
NF-κB (XP, D14E12) p65 Rabbit, monoclonal 
Cell Signaling 
Technology, #8242 
Phospho-NF-κB (93H1) Phospho-p65 (Ser 536) Rabbit, monoclonal 
Cell Signaling 
Technology, #3033 
IκB-α (L35A5) IκB-α Mouse, monoclonal 
Cell Signaling 
Technology, #4814 
eIF3α (D51F4) eIF3α Rabbit, monoclonal 
Cell Signaling 
Technology, #3411 
eIF4G eIF4G Rabbit, polyclonal 
Cell Signaling 
Technology, #2498 
Nuclear Pore Complex 
Proteins (Mab414) 
Nuclear pore complex 
proteins, recognizes 
FXFG-repeat domains 
Mouse, monoclonal Abcam, ab24609 
Hsp105 (B-7) Hsp105 (Hsp110) Mouse, monoclonal Santa Cruz, sc-74550 
Mouse IgG-Alexa488 Mouse IgG 
Goat, F(ab')2 
fragments 
Cell Signaling 
Technology, #4408 
Mouse IgG-Alexa555 Mouse IgG 
Goat, F(ab')2 
fragments 
Cell Signaling 
Technology, #4409 
Rabbit IgG-FITC Rabbit IgG Goat, polyclonal Sigma, F9887 
Rabbit IgG-Atto488 Rabbit IgG Goat, polyclonal Sigma, 18772 
Rabbit IgG-Alexa555 Rabbit IgG 
Goat, F(ab')2 
fragments 
Cell Signaling 
Technology, #4413 
Mouse IgG Peroxidase Mouse IgG Goat, polyclonal Sigma, A4416 
Rabbit IgG Peroxidase Rabbit IgG Goat, polyclonal Sigma, A9169 
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Sequences of utilized constructs  
c-Myc tagged β proteins 
β4   
>MCEQKLISEEDLGMQISMDYQLEIEGNDNKVELQLNDSGGEVKLQIRGPGGRVHFNVHSSGSNLEVNFNNDGGEVQFHMH 
β17  
>MCEQKLISEEDLGMQISMDYEIKFHGDGDNFDLNLDDSGGDLQLQIRGPGGRVHVHIHSSSGKVDFHVNNDGGDVEVKMH 
β23  
>MCEQKLISEEDLGMQISMDYNIQFHNNGNEIQFEIDDSGGDIEIEIRGPGGRVHIQLNDGHGHIKVDFHNDGGELQIDMH 
αS824 
>MCEQKLISEEDLGMYGKLNDLLEDLQEVLKNLHKNWHGGKDNLHDVDNHLQNVIEDIHDFMQGGGSGGKLQEMMKEFQQVLD
ELNNHLQGGKHTVHHIEQNIKEIFHHLEELVHR 
 
Targeting signals and 
tags 
c-Myc tag 
 
Sequences 
>MCEQKLISEEDLGMQIS+ 
NES nuclear export 
sequence 
>MCEQKLISEEDLELLEDLTLGMQIS+ 
NLS nuclear 
localization signal 
>MAADPKKKRKVDPKKKRKVDTYGAGEQKLISEEDLNGASS+ 
NLS K7T, K15T  
inefficient NLS 
>MAADPKTKRKVDPKTKRKVDTYGAGEQKLISEEDLNGASS+ 
COX8 mitochondrial  
targeting signal 
>MSVLTPLLLRGLTGSARRLPVPRAKIHSLCEQKLISEEDLGMQIS+ 
mtHsp60 mitochondrial  
targeting signal 
>LRLPTVFRQMRPVSRVLAPHLTRAYAKDVKFGCEQKLISEEDLGMQIS+ 
Prenylation sequence 
Maurer-Stroh 2005         
>+GGGGSGGGGSCVIM 
 
β proteins-Linker16-EGFP (c-Myc+β proteins+16 a.a. linker+EGFP; Chang 2005) 
+TSGSAASAAGAGEAAAVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWP
TLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKED
GNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALS
KDPNEKRDHMVLLEFVTAAGITLGMDELYK 
β proteins – monomerizing lysine mutants (K) for E. coli growth inhibition 
β4  >MCEQKLISEEDLGMQISMDYQKEIEGNDNKVELQLNDSGGEVKLQIRGPGGRVHFNVHSSGSNLEVNFNNDGGEVQKHMH 
β17  >MCEQKLISEEDLGMQISMDYEKKFHGDGDNFDLNLDDSGGDLQLQIRGPGGRVHVHIHSSSGKVDFHVNNDGGDVEKKMH 
β23 >MCEQKLISEEDLGMQISMDYNKQFHNNGNEIQFEIDDSGGDIEIEIRGPGGRVHIQLNDGHGHIKVDFHNDGGELQKDMH 
β proteins – odd number of β-sheets for E. coli growth inhibition 
β17+4 >MCEQKLISEEDLGMQISMDYEIKFHGDGDNFDLNLDDSGGDLQLQIRGPGGRVHVHIHSSSGKVDFHVNNDGGDVEVKMHNDGGEVQFHMH 
β17+23>MCEQKLISEEDLGMQISMDYEIKFHGDGDNFDLNLDDSGGDLQLQIRGPGGRVHVHIHSSSGKVDFHVNNDGGDVEVKMHNDGGELQIDMH 
β23short  >MCEQKLISEEDLGMQISMDYNIQFHNNGNEIQFEIDDSGGDIEIEIRGPGGRVHIQLNDGHGHIKVDFH 
 
S-GFP (shuttling EGFP, NLS-HA-NES-Linker16-EGFP) 
>MAADPKKKRKVDPKKKRKVDTYGAGYPYDVPDYALLELLEDLTLSGSDLTSGSAASAAGAGEAAAVSKGEELFT
GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFF
KSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKN
GIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMD
ELYK 
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Human Huntingtin 96Q exon 1 (c-Myc tagged; Schaffar 2004) 
(sequenced construct actually contained 97 glutamines) 
>MCEQKLISEEDLGMQIRMATLEKLMKAFESLKSFQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ
QQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQPPPPPPPPPPPQLPQPPP
QAQPLLPQPQPPPPPPPPPPGPAVAEEPLHRP 
 
TDP-43-fragment 4-EGFP (TDP-43 amino acids 216-414; Yang 2010) 
>MDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGG
FGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREP
NQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGMRDPPVATMVSKGEELFTGVVPILV
ELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEG
YVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFK
IRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 
 
ParkinΔC (Parkin W453X; W453 replaced by stop codon (-); Winklhofer 2003) 
>MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPW
RKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVY
CKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSV
ALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIK
ELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHE
GECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNC
GCE(-)  
/missing 13 C-terminal residues of Parkin wildtype: >WNRVCMGDHWFDV 
 
Firefly luciferase-EGFP (Gupta 2011) 
>MEDAKNIKKGPAPFYPLEDGTAGEQLHKAMKRYALVPGTIAFTDAHIEVDITYAEYFEMSVRLAEAMKRYGLNT
NHRIVVCSENSLQFFMPVLGALFIGVAVAPANDIYNERELLNSMGISQPTVVFVSKKGLQKILNVQKKLPIIQKI
IIMDSKTDYQGFQSMYTFVTSHLPPGFNEYDFVPESFDRDKTIALIMNSSGSTGLPKGVALPHRTACVRFSHARD
PIFGNQIIPDTAILSVVPFHHGFGMFTTLGYLICGFRVVLMYRFEEELFLRSLQDYKIQSALLVPTLFSFFAKST
LIDKYDLSNLHEIASGGAPLSKEVGEAVAKRFHLPGIRQGYGLTETTSAILITPEGDDKPGAVGKVVPFFEAKVV
DLDTGKTLGVNQRGELCVRGPMIMSGYVNNPEATNALIDKDGWLHSGDIAYWDEDEHFFIVDRLKSLIKYKGYQV
APAELESILLQHPNIFDAGVAGLPDDDAGELPAAVVVLEHGKTMTEKEIVDYVASQVTTAKKLRGGVVFVDEVPK
GLTGKLDARKIREILIKAKKGGKIAVKPGIHRPVATMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDAT
YGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVK
FEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPI
GDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 
 
NES for NES-luciferase-EGFP (with HA-tag)          
>MSYPYDVPDYALLELLEDLTLSGSDL+ 
NLS for NLS-luciferase-EGFP                         
>MAADPKKKRKVDPKKKRKVDTYGAG+ 
Luciferase-EGFP single mutant: R188Q   (Gupta 2011) 
Luciferase-EGFP double mutant: R188Q, R261Q  (Gupta 2011)
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